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1
GENERAL INTRODUCTION
Vital sign monitoring at the general ward
Measurements of vital signs such as heart rate, respiratory rate, blood pressure, temperature 
and oxygen saturation are common in hospitalized patients and provide insight in the patients’ 
clinical condition.1 Nowadays, many vital signs can be measured (semi-)continuously with the 
possibility of remote monitoring. This is usual practice in high care environments such as the 
Intensive Care Unit (ICU), the Operating Theatre and the Emergency Department. In these care 
locations, care givers are immediately informed about deterioration of the patients’ vital signs. 
At the general ward, however, vital signs are measured discontinuously and manually and are 
registered by nurses on average three times in 24 hours, which basically means one time every 
work-shift. As a result, vital signs are ‘monitored’ via the electronic health record (EHR).
Early warning scores
Clinical deterioration regularly occurs in hospitalized patients, which may lead to life threatening 
events or death.2,3 To assist care givers in the early identification of deteriorating patients at the 
general ward, scores have been developed based on vital signs. These scores are called Early 
Warning Scores (EWS) and were first reported in 1997 by Morgan and associates.4 The Modified 
Early Warning Score (MEWS) is an example of an EWS and is commonly used.5-7 A higher MEWS 
is associated with a worse clinical condition of the patient and an increased number of ICU 
admissions and cardiac arrests.8-10 A recent review shows that the predictive value of EWS is 
high and that use of EWS benefits patient outcome.11 However, significant limitations of EWS 
are also reported. Vital signs underlying the scores are not regularly measured, documented 
or interpreted at the general ward, sometimes due to unfamiliarity with the locally used 
EWS system.12-16 Also, routine measurement of vital signs is subjected to inaccuracy and 
incompleteness.3,17,18 For example, respiratory rate, an important predictor of sepsis and 
mortality,19,20 is often incorrectly measured and underestimated by nurses.21 Furthermore, 
many nurses consider the measurements as time-consuming.21 The intermittent and manual 
measurements of vital signs at the ward harbor serious safety risks.22 Patients may deteriorate 
in between measurements which is unnoticed by nurses. This is particularly the case during 
night hours when they are less attended by nurses.23 A delayed detection of deterioration leads 
to unplanned ICU admissions, which are associated with higher mortality ranging between 
20% and 65%, a longer hospital stay,24-26 and a 60% increase of hospitalization costs.27 More 
frequent measurements such as intensified periodic and continuous monitoring may result in 
earlier detection of significant changes in vital signs, that can predict life threatening events.28 
This is why patients at high risk of deterioration are often admitted to higher care units with 
continuous monitoring of vital signs at admission or immediately after surgery.29 
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Increase in vulnerable groups for deterioration at wards 
The median age of hospitalized patients increases due to an ageing population and more 
elderly patients are eligible for complex medical and surgical treatments.30 Particularly the 
frail older patients may deteriorate more often, suffer from more complications and increased 
mortality associated with hospital admissions.31 There is an increasing desire to monitor these 
patients more intensively regarding vital signs at the general ward, also because of limited high 
care capacity.32, 33
Continuous monitoring and prediction 
Intensified periodic or continuous monitoring at the general ward may be useful to detect 
changes in patients’ vital signs earlier in comparison with discontinuous assessment of an 
EWS. Combined with predictive analytics, early detection followed by early activation of a rapid 
response team (RRT) and early intervention34 potentially leads to improved survival and a 
decrease in hospital length of stay.35 There are more possible advantages of continuous and 
remote monitoring at the general ward. Nurses do not have to enter patients’ room for vital sign 
measurements, which reduces workload. Less disturbances improves patient’s comfort and 
sleep at night, and ultimately can enhance recovery.36-38 Data transmission from the continuous 
monitoring device to the EHR can be automated, reducing human errors of reporting. Patients 
can have better insight in their own medical data, which supports patient participation and 
self-management in hospital care.39 
Wearable devices for continuous monitoring
In contrast with high care units where most patients are monitored lying in bed, continuous 
monitoring of vital signs at the general ward should facilitate patient mobilization. In comparison 
with patients in high and medium care units, patients at the ward more often change posture 
in bed, sit in a chair or walk in or outside their room. These posture changes and mobilization 
demand specific requirements of the monitoring devices. Furthermore, devices have to 
transmit data wirelessly, contain non-invasive and unobtrusive sensors and preferably can be 
worn on clothes or placed directly on the skin of an easily accessible part of the body.40 
Most wearable devices are initially developed by the life style industry for fitness and wellness 
and include smart watches, patches or tattoos.41-43 Some devices are potentially suitable to be 
used in medical practice, particularly those that measure heart rate, respiratory rate, oxygen 
saturation, blood pressure and temperature.43 However, devices have to meet several demands 
for safe and effective introduction in healthcare and have to be approved by regulatory authorities 
for medical devices. Devices have to be reliable and accurate in measuring vital signs in a broad 
range of normal and abnormal values. Important is the property to set individual thresholds 
of vital signs or scores for alarming.40 Many investigators have already claimed reliability and 
accuracy, however, these are proven in healthy volunteers with a normal range of values. 
Furthermore, unbiased reporting is questionable since researchers are often involved in the 
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development of the device.41 Devices should also be able to transmit medical data wireless and 
remotely to a place where care givers can have real-time insight in data. Preferably devices 
are connectable to the EHR system for frequent storage of (aggregated) vital sign data which 
connection needs to be secured for privacy reasons.44 The device characteristics should comply 
with long-term and continuous measurement. Thus, devices need to be comfortable and 
hypo-allergenic, they should be small, flexible and wireless40,44 and have sufficient battery life 
time.36,44 Also, they should be water proof. A high user-friendliness of the wearable device will 
also allow for patients measuring themselves at home or in the hospital with or without remote 
supervision. When given the opportunity to easily collect vital signs at home after discharge 
from hospital, patients obtain more insight in their own health data,45 which may lead to better 
health outcome or behavioral change in chronic diseases.46-49 Even a reduced length of hospital 
stay and decreased costs are possible when patients continue using a wearable device for vital 
sign monitoring after discharge from hospital to home.35,50
A few wearable devices meet the requirements as described above.34,41,51 However, routine use 
of these devices for (continuous) monitoring of vital signs in healthcare, specifically at the 
general ward, is still limited.41 From a healthcare perspective there are several explanations 
for the limited use:
 •   Wearable device has not received approval from regulatory bodies as a medical device 
 •   Wearable device misses important vital sign(s) deemed mandatory for use in patient 
care40
 •   Wearable device has not been tested in patients43,52
 •   Wearable device has not been adopted by patients and their informal and formal care 
givers e.g. nurses52
 •   Wearable device is very expensive and not expected to be (cost)effective41
 •   Wearable device use has not been embraced or funded by healthcare providers, insurance 
companies and policy makers
 •   Adequate software analyzing the data stream in order to reduce false alarming and 
predict clinical deterioration is lacking40,41,44
Wearable devices used in this thesis
ViSi Mobile
The ViSi Mobile (Sotera Wireless, CA, USA) system (Figure 1) has received CE mark and is 
FDA-cleared for continuously monitoring of 5-lead electrocardiogram, heart rate, blood oxygen 
saturation, respiratory rate, skin temperature, and blood pressure (cuff-based and cuff-less on 
beat-to-beat based). Patients can see their own vital signs, which are displayed on a patient-
worn wrist device. ViSi Mobile is able to send all vital sign data to a stand-alone laptop or to a 
server from where care givers have real time insight in patients’ data. The ViSi Mobile can be 
connected with a predictive analytic scoring system and data can be automatically stored in 
the EHR.
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Figure 1 ViSi Mobile system (left) and HealthPatch (right)
HealthPatch
The HealthPatch (Vital Connect, CA, USA; Figure 1) is a fl exible and self-adhesive patch 
containing two ECG electrodes, a battery and a reusable sensor. The HealthPatch has received 
CE mark and is FDA-cleared for continuous measurement of single-lead ECG, heart rate, 
respiratory rate, skin temperature, body posture, fall detection, and activity. Furthermore, the 
patch is able to measure heart rate variability which can be converted into a psychological 
stress percentage. Data can be transmitted to a secured cloud server from where patients and 
care givers have insight in the data e.g. smartphone via an app.
Figure 2 CheckMe
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CheckMe
The CheckMe (Viatom Technology, Shenzhen, People’s Republic of China; Figure 2) can be held 
between patients’ hands and measures one or two lead ECG, body temperature, heart rate, 
oxygen saturation and systolic blood pressure in a cuff less manner based on pulse transit 
time. The device also includes a pedometer and a sleep monitor. Data can be transferred via 
Bluetooth to a mobile device using the CheckMe app.
Main objectives of this thesis
1.  To evaluate the (technical) feasibility and accuracy of continuous monitoring using ViSi 
Mobile and HealthPatch at the internal medicine and surgical ward
 -    Frequency, duration and cause of artifacts in monitoring data by ViSi Mobile and 
HealthPatch
 -    Comparison of accuracy between regular nurse, ViSi Mobile and HealthPatch vital sign 
measurements
 -    Alarming situations identified by ViSi Mobile and HealthPatch particularly during evening 
and nights shifts
2.  To evaluate the using experiences of ViSi Mobile and HealthPatch by patients, relatives, 
nurses and physicians
 -   Positive and negative effects of continuous monitoring at the general ward
 -   Facilitators and barriers for the use of ViSi Mobile and HealthPatch at the general ward
3.  To evaluate the accuracy of self-measurements by patients using the CheckMe in the 
outpatient clinic and at the internal medicine ward for chronic vascular disease e.g. 
hypertension.
Thesis outline
In chapter 2 the initial experiences of continuous monitoring on the surgical and internal 
medicine ward using ViSi Mobile and HealthPatch are collected. In this pilot study the technical 
feasibility of continuous monitoring and the artifacts in data produced by ViSi Mobile and 
HealthPatch are evaluated and vital signs measured by both devices are compared with regular 
nurse measurements. Furthermore, first experiences of patients and nurses are documented.
Chapter 3 describes the user experiences of continuous monitoring using ViSi Mobile and 
HealthPatch by patients, relatives, nurses and physicians from a randomized controlled trial. 
Positive and negative effects, facilitators and barriers are extracted from in-depth semi-
structured interviews, which are held on the surgical and internal medicine ward.
In chapter 4 the accuracy of vital sign data by ViSi Mobile and HealthPatch is compared with 
regular nurse measurements, and alarming events based on ViSi Mobile or HealthPatch data 
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in time between nurse observations are evaluated. Also, the frequency, duration and cause of 
artifacts in data by both devices are studied in more detail.
The performance of the handheld device CheckMe regarding blood pressure measurement is 
evaluated in chapter 5. Blood pressure values of patients on the internal medicine outpatient 
clinic are measured with the CheckMe and data are compared with a validated, oscillometric 
reference blood pressure monitor. Influence of patients’ posture on blood pressure is 
investigated.
Chapter 6 addresses the accuracy of the CheckMe on the internal medicine ward as blood 
pressure self-measurement tool. Self-measurements of patients are analyzed and compared 
with regular nurse measurements and measurements performed by a trained investigator.
In chapter 7, the HealthPatch is tested in a pilot study of health care providers regarding the 
usability of the stress sensor. Continuous stress measurements using heart rate variability 
and ‘stress percentage’ are performed during daily work and comparison is made between 
surgeons and residents and between different work activities. 
Chapter 8 contains the general discussion and future perspectives, chapter 9 the summary in 
English and chapter 10 the summary in Dutch   
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ABSTRACT
Background
Measurement of vital signs in hospitalized patients is necessary to assess the clinical situation 
of the patient. Early warning scores (EWS), such as the modified early warning score (MEWS), 
are generally calculated 3 times a day, but these may not capture early deterioration. A delay 
in diagnosing deterioration is associated with increased mortality. Continuous monitoring with 
wearable devices might detect clinical deterioration at an earlier stage, which allows clinicians 
to take corrective actions.
Objective
In this pilot study, the feasibility of continuous monitoring using the ViSi Mobile (VM; Sotera 
Wireless) and HealthPatch (HP; Vital Connect) was tested, and the experiences of patients and 
nurses were collected. 
Methods
In this feasibility study, 20 patients at the internal medicine and surgical ward were monitored 
with VM and HP simultaneously for 2 to 3 days. Technical problems were analyzed. Vital sign 
measurements by nurses were taken as reference and compared with vital signs measured 
by both devices. Patient and nurse experiences were obtained by semistructured interviews.
Results
In total, 86 out of 120 MEWS measurements were used for the analysis. Vital sign measurements 
by VM and HP were generally consistent with nurse measurements. In 15% (N=13) and 27% 
(N=23) of the VM and HP cases respectively, clinically relevant differences in MEWS were found 
based on inconsistent respiratory rate registrations. Connection failure was recognized as a 
predominant VM artifact (70%). Over 50% of all HP artifacts had an unknown cause, were self-
limiting, and never took longer than 1 hour. The majority of patients, relatives, and nurses were 
positive about VM and HP. 
Conclusions
Both VM and HP are promising for continuously monitoring vital signs in hospitalized patients, 
if the frequency and duration of artifacts are reduced. The devices were well received and 
comfortable for most patients.
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INTRODUCTION
In hospitalized patients, vital signs are measured to assess the clinical situation of the 
patient and to identify clinical deterioration.1 Monitoring of these vital signs is usually done by 
nurses, and includes blood pressure (BP), heart rate (HR), respiratory rate (RR), blood oxygen 
saturation, and core temperature. Early warning scores (EWS) are physiological track-and-
trigger systems, which use a multiparameter or aggregate weighted scoring system that 
assists in detecting physiological changes and thereby identify patients at risk for further 
deterioration.2,3 The modified early warning score (MEWS) is a commonly used and validated 
EWS system (see Supplementary file 1).4-6 A higher MEWS is associated with admissions to the 
intensive care unit (ICU), cardiac arrest, and mortality.7-9 Since the introduction of EWS, a trend 
was seen toward a decrease in unplanned admissions to the ICU and a decrease in hospital 
mortality.10-16 Although the EWS provides relevant data on patients’ health status, the interval 
measurements may not capture early deterioration of vital signs,17 particularly during the night 
when clinical deterioration may remain undetected until the next day.18 This could explain why 
the majority of the unplanned ICU admissions take place between 8 am and 4 pm.19 Unplanned 
ICU admissions are associated with an increased mortality rate, a longer hospital stay,20-22 
and a 60% increase in hospitalization costs.23 Continuous monitoring of vital signs could be a 
useful tool to detect clinical deterioration in an earlier phase, which allows clinicians to take 
corrective interventions, particularly since subtle changes in vital signs often are present 8 to 
24 hours before a life-threatening event such as ICU admission, cardiac arrest, and death.13,24-27 
Nowadays, wearable devices that facilitate remote continuous monitoring of vital signs 
exist.28 These wireless devices could reduce patient discomfort due to fewer measurements 
by nurses,29-31 allow patient mobility,31 and might reduce workload for nurses.30 Moreover, 
wearable devices are promising for safe patient transports between wards, the operating 
room, and the radiology department.32 However, these devices are still underutilized in health 
care, even though they have been shown to be accurate,17,33 and may reduce costs.34 Despite 
many potential advantages, wearable devices may have disadvantages regarding technical 
dysfunction and adverse psychological effects increasing anxiety of patients for disturbances 
of vital signs.33 
Recently, ViSi Mobile (VM; Sotera Wireless) and HealthPatch (HP; Vital Connect), two new 
devices approved by the US Food and Drug Administration (FDA) for wireless remote monitoring 
of vital signs, were introduced in health care. At present, little is known about the feasibility of 
continuous monitoring and experiences of patients and caregivers. The objective of this pilot 
study was to assess the technical feasibility of continuous monitoring with these new devices 
and to evaluate the experiences of patients and nurses with this method of monitoring on the 
general ward. 
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METHODS
Setting and Recruitment
Patients hospitalized in the internal medicine and surgical ward of the Radboud University 
Medical Center were included between December 2014 and March 2015. All consecutively 
admitted patients were approached for participation if they were hospitalized for at least 48 
hours, and MEWS measurements were ordered at least three times a day by their medical 
doctor. Patients had to be 18 years or older and able to speak, read, and understand the local 
language. At the internal medicine ward, both VM and HP were attached to the patient after 
signed informed consent was obtained. At the surgical ward, patients signed informed consent 
before an elective surgical procedure. Both devices were attached to the patients after surgery 
and arrival at the ward. Patients were excluded from further analyses if they unexpectedly 
participated for a duration shorter than 24 hours in the study. To determine the technical 
feasibility and practical usability, the two wearable devices were used to continuously measure 
vital signs in patients, which were compared with regular data collected in the same patients. 
Since a formal power calculation was not feasible due to the lack of preliminary data with these 
monitoring systems, a sample size of 20 was estimated to obtain sufficient data for analysis. 
After reviewing the study protocol, the institutional review board waived the need for formal 
review and approval (number 2014-1434). 
ViSi Mobile
The VM system has received Conformité Européenne (CE) mark and is FDA-cleared for 
continuously monitoring of 3- or 5-lead electrocardiogram (ECG), heart and pulse rate, blood 
oxygen saturation, RR, skin temperature, and BP (cuff-based and cuff-less on beat-to-beat 
basis; Figure 1). All vital signs are displayed on a patient-worn wrist device, which can be 
locked by an authentication code. This wrist device is connected to a thumb sensor, which 
measures blood oxygen saturation and BP. A chest sensor measures RR and skin temperature, 
and is connected with 3 or 5 ECG cables and sensors. In this pilot study, VM was wirelessly 
connected to a stand-alone Toughbook (Panasonic) pre-installed with VM software, from 
where the investigators received real-time insights on patients’ vital signs and where all the 
data were stored. This Toughbook also showed alarms as soon as vital signs dropped out of 
normal ranges. The VM wrist device was powered by rechargeable batteries, which needed to 
be replaced every 12 to 14 hours.
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Figure 1 ViSi Mobile system (left) and HealthPatch (right). 
HealthPatch
The HP consists of a reusable sensor and a disposable adhesive patch with 2 ECG electrodes 
at the bottom of the patch and a reusable sensor (see Figure 1). The HP has received CE 
mark and is FDA-cleared for continuous measurement of single-lead ECG, HR, heart rate 
variability (HRV), RR, skin temperature, body posture, fall detection, and activity. This small and 
lightweight patch can be attached to the patient’s chest, from where the data is transmitted to a 
mobile device (eg, mobile phone, via Bluetooth). Wi-Fi connection facilitates data transmission 
from the mobile device to a secured cloud server. The patch is powered by a coin-cell battery 
that lasts 3 to 4 days. 
Study Procedures
Patients gave verbal and written consent after being informed about the study protocol. 
Demographics including gender, age, reason for admission, and type of surgery were collected. 
At the surgical ward, VM and HP were attached to the patient after surgery and arrival at 
the ward. At the internal medicine ward, both devices were attached to the patient directly 
after signed informed consent was obtained. Vital signs were continuously measured during 
2 or 3 days. This time frame was chosen to obtain enough vital sign data for analysis and to 
allow patients to get familiar with the devices. Nurses measured vital signs three times daily 
according to the protocol. Trained medical students additionally observed time-related vital 
signs monitored by VM at the Toughbook and HP on the cloud server. They marked the time 
points where vital signs were taken by the nurse and manually selected the results for vital 
signs measured by both devices at these time points for comparison. They also registered the 
cause and duration of technical problems and fixed them when necessary. In case of a VM 
alarm, the student warned the nurse. After 2 to 3 days, the enrolled patients and their relatives 
were interviewed about their experiences regarding continuous monitoring and both wearable 
devices. Nurses involved in the care of included patients were interviewed as well.
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Data Collection and Analysis
Technical Feasibility
All registered data from VM and HP were retrieved for analysis in the Statistical Package 
for the Social Sciences version 20.0 (SPSS, Inc). Data of both devices were compared with 
measurements by nurses at the same time points. For each variable, the accepted discrepancy 
between nurse measurements and both devices was determined, which are listed in Table 1. 
These thresholds were defined as the maximum possible discrepancy in vital signs between the 
nurse measurements and both devices that would not lead to a change in medical treatment. 
A difference in MEWS score of 1 point or more between the nurse measurements and both 
devices was defined as a clinically relevant difference. The MEWS scores were calculated using 
vital signs measured by the nurses, VM, and HP. As VM and HP did not measure all required 
vital signs to calculate the MEWS score, such as level of consciousness, these vital signs were 
taken from the electronic health records (EHR). Bland-Altman plots35 were created to assess 
the agreement between MEWS measurements by nurses and corresponding values of VM and 
HP. All artifacts ≥1 minute were analyzed, since we reasoned that artifacts of less than one 
minute would not be clinically relevant for a patient’s situation. An artifact had occurred if no 
or an invalid value was recorded. Since trained medical students were not present all the time 
(primarily not during out-of-office hours), artifacts were divided into two groups, depending on 
the presence of a student.
Table 1 Accepted discrepancies between nurse measurements, ViSi Mobile, and HealthPatch
Vital sign Accepted discrepancy
Heart rate 5 beats/min
Respiratory rate 2 breaths/min
Oxygen saturation 2%
Temperaturea 0.5˚C
Blood pressure 5 mm Hg
MEWS 1
aViSi Mobile and HealthPatch measure skin temperature.
Practical Usability
User experiences were obtained by means of semistructured face-to-face interviews, after the 
patients had used the devices for 2 to 3 days. Patients’ relatives and nurses were also interviewed. 
Interviews lasted approximately 10 minutes and the following topics were discussed: feelings 
of unsafety or safety, user friendliness, adverse events, and detection of clinical deterioration. 
One researcher (MW) performed a thematic content analysis to determine perceived positive 
and negative effects, and facilitators and barriers, which was critically reviewed by a second 
researcher (TB). Perceived positive and negative effects were presented according to the 
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Donabedian framework for the quality of health care,36 which includes three main domains: 
structure, process, and outcome. Facilitators and barriers were divided into four domains: 
characteristics related to the patient, professional, intervention, and context.37 
RESULTS
Demographics
A total of 25 patients were invited, of which 20 participated in the study—10 patients at the 
surgical ward and 10 patients at the internal medicine ward. The other 5 patients refused 
participation because they thought it would be too much of a mental or physical burden (see 
Figure 2). The study population included 13 males and 7 females with a mean age (standard 
deviation, SD) of 49.9 (13.4) years, ranging between 33 and 82 years. At the surgical ward, 
most patients were admitted for an elective gastrointestinal operation. Patients at the internal 
medicine ward were admitted for several conditions such as sepsis, arthritis, and blood 
pressure control. 
Figure 2 Included patients and vital sign measurements.
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Table 2 ViSi Mobile and HealthPatch data in comparison with corresponding nurse measurements.
Vital signs Nurse ViSi Mobile HealthPatch
Mean (SD)j Mean (SD) Mean difference 
(SD) versus nurse
Mean (SD) Mean difference 
(SD) versus nurse
HRf (beats/min) 81.81 (13.12) 81.62 (12.23) −0.20 (5.54) 84.34 (12.24) −1.52c (5.63)
RRg (breaths/min) 17.38 (3.89) 16.20 (4.57) 1.19a (3.43) 18.02 (5.82) −0.64 (4.94)
Saturation (%) 97.00 (96.00  
to 98.00)d
97.00 (95.00  
to 98.00)d
0.10 (1.65) n.a.k n.a.
Temperature (˚C) 37.01 ( 0.60) 33.61(1.25)e 34.16 (1.16)e
BPh, systolic (mm Hg) 127.93 (19.33) 127.49 (18.68) 0.44 (11.99) n.a. n.a.
BP, diastolic (mm Hg) 73.17 (10.25) 81.17 (11.24) −8.00b (9.93) n.a. n.a.
MEWSi 0.99 (1.13) 1.38 (1.30) −0.40a (1.13) 1.59 (1.54) −0.60b (1.22)
aP=.002. bP<.001. cP=.01. dOxygen saturation was reported as median with interquartile range. eSkin 
temperature. fHR: heart rate. gRR: respiratory rate. hBP: blood pressure. iMEWS: modified early warning 
score. jSD: standard deviation. kn.a.: Not applicable.
Technical Feasibility
In total, 120 vital sign measurements by nurses were observed by the trained medical students 
(see Figure 2). In 40 measurements, one or more vital signs were missing. In 6 measurements, 
data were completed by consulting the EHR. As a result, 86 measurements were used for 
further analysis. For the remaining 34 measurements, VM and HP data were lacking (25 
measurements), or vital signs were not documented by nurses (9 measurements). In 8 patients, 
data from the Toughbook was not available for further analysis due to accidental deletion of 
data; in 2 patients, no HP data were saved at the cloud server due to technical failures (eg, WiFi 
failures, disconnection between HP and its mobile device). In total, 742.8 hours of VM data and 
1033.6 hours of HP data were collected; on an average 61.9 hours of VM and 57.5 hours of HP 
data were collected per patient.
Vital signs
Bland-Altman plots showing the mean of the two devices and the differences between the two 
devices (y-axis) with limits of agreement (1.96 SD) are displayed in Figures 3 and 4. Comparing 
the results for vital signs and MEWS score measured by nurses and VM, the mean differences 
were all within range with the predefined accepted discrepancies in Table 1, although wide 
limits of agreement were found (see Table 2). The largest discrepancy in the mean difference 
was found for diastolic BP. In 13 (15%) cases, the MEWS difference between nurse and VM 
was 2 points or higher, indicating important clinical differences between VM and nurse 
measurements (see Table 3). In four cases, this was related to differences in RR alone. In 
the remaining cases, the combination of RR and oxygen saturation, or RR and systolic BP 
caused the difference. Moreover, in six of these cases, VM measured a higher RR than nurses 
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(range: 1-6 breaths/min), and in the four other cases, nurses measured a higher RR than VM 
(difference: 2-6 breaths/min). In the three remaining cases that resulted in a different MEWS, 
there was a difference in systolic BP (difference: 14 mm Hg) or oxygen saturation (difference: 
1%-5%) between VM and the nurse. The mean differences between nurse measurement and 
HP were all in agreement with accepted discrepancies, although wide limits of agreement 
were found (see Table 2). In 23 (27%) cases, MEWS differed 2 or 3 points between HP and nurse 
measurements (see Table 3). In 17 cases, HP measured higher RR compared with nurses. 
In 16 cases, differences were in the range of 3 to 8 breaths/minute. However, in one case, 
nurses measured 16 breaths/minute and HP measured 42 breaths/minute, indicating possible 
measurement errors in HP. In the remaining six cases, nurses measured a higher RR than HP 
(difference: 4-12 breaths/min). 
Artifacts
ViSi Mobile
In total, 306 artifacts were found, with a total time of 121 hours. In 111 (36.3%) of 306 artifacts, 
a trained medical student was present, and 86 of 111 (77.5%) were identified and reported. A 
cause was found in 82 (95.1%) of 86 artifacts. Almost 70% of all reported artifacts were caused 
by connection failure between Toughbook and VM. Other artifact causes were motion of the 
sensors due to patient movements (n=21, 25.6%) and required calibration of blood pressure 
(n=2, 2.3%). Over 74% of all artifacts lasted less than 5 minutes. Almost 20% lasted less than 1 
hour, and approximately 7% lasted longer than 1 hour. 
HealthPatch
In total, 648 artifacts were found in 18 patients, with a total time of 135 hours. More than 50% 
(n=354) of all artifacts lasted less than 1 minute and were excluded from further analysis. 
In the remaining 294 artifacts, a trained medical student was present in 60% (n=176) of the 
artifacts, and identified and reported the artifact in 53 (30%) cases. A cause was found in 24 
(45%) artifacts such as HealthPatch losing skin contact (n=13, 54%), Bluetooth (n=4, 17%) or 
Wi-Fi problems (n=3, 13%), and patients leaving the ward without their mobile device (n=3, 
13%). Around 43% of all artifacts lasted less than 5 minutes. Over 95% of all artifacts lasted 
less than 1 hour. 
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Figure 3 Bland-Altman plots: (a) heart rate (VM and HP), (b) respiratory rate (VM and HP), (c) systolic 
and diastolic blood pressure (VM). Solid lines indicate mean difference and dotted lines indicate limits of 
agreement.
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Figure 4 Bland-Altman plots showing modified early warning score: (a) VM and HP, (b) VM and HP (jittered). 
Solid lines indicate mean difference and dotted lines indicate limits of agreement.
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Table 3  ViSi Mobile and HealthPatch data in comparison with corresponding nurse measurements.
ViSi Mobile HealthPatch
Difference; nurse – VM (%) Difference; nurse - HP (%)
HRa (beats/min) ≤ 5: 71 (82.5) ≤ 5: 65 (75.6)
6-10: 12 (14.0) 6-10: 16 (18.6)
> 10: 3 (3.5) > 10: 5 (5.8)
RRb (breaths/min) ≤ 2:  50 (58.2) ≤ 2: 36 (41.9) 
3-5: 26 (30.2) 3-5: 31 (36.0) 
> 5: 10 (11.6) > 5: 19 (22.1)
Saturation (%) ≤ 2: 76 (88.4) n.a.e
3-4: 9 (10.5) 
≥ 5: 1 (1.1)
BPc systolic (mm Hg) ≤ 5: 36 (41.9) n.a.
6-14: 33 (38.4)
≥ 15: 17 (19.7)
BPc diastolic (mm Hg) ≤ 5: 27 (31.4) n.a.
6-14: 40 (46.5)
15: 19 (22.1)
MEWSd -4: 1 (1.2) -3: 9 (10.5)
-3: 5 (5.8) -2: 11 (12.8)
-2: 4 (4.7) -1: 13 (15.1)
-1: 23 (26.7) 0: 47 (54.7)
0: 40 (46.5) 1: 3 (3.5)
1: 10 (11.6) 2: 2 (2.3)
2: 3 (3.5) 3: 1 (1.2)
aHR: heart rate. bRR: respiratory rate. cBP: blood pressure. dMEWS: modified early warning score. en.a.: 
Not applicable.
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Practical Usability
Evaluations were performed with all 20 patients, 7 relatives, and 4 nurses (see Table 4).
Perceived Positive and Negative Effects
Processes
One positive effect was identified in this dimension. Patients stated that nurses could keep 
an eye on the vital signs from a distance (n=3); this was also mentioned by one relative. No 
negative effects were identified.
Outcomes
Two positive effects were identified in this dimension. Eight patients and 66 relatives mentioned 
increased feelings of safety by being monitored continuously in comparison with the MEWS 
measurements by nurses only. A patient described:
Being monitored continuously is a very pleasant experience; I felt very safe.
 (Translated from Dutch)
Earlier interventions were deemed possible in case of clinical deterioration (n=3). One negative 
effect was identified; one patient complained about having redness and itching while wearing 
the devices. 
Facilitators and Barriers
Intervention
Seven facilitators were identified. Eight patients said they were not aware of the HP while it was 
attached to their chest. Other facilitators included not being restricted by the devices during 
daily activities such as bathing and putting on clothes (n=3), more freedom of movements 
compared with conventional devices (n=2), the small size of the HP (n=1), the good adhesive 
properties of the patches (n=1), and the invisibility of the devices under clothes (n=1). One 
patient described:
I have used a holter monitor at home several times. These devices are much smaller and they 
do not limit mobility to the same extent.
 (Translated from Dutch)
One patient experienced great advantage of having an insight on his own vital signs. One 
barrier was noted 15 times. Patients mentioned that the VM wrist device was big or heavy 
(n=10); patches came off very quick (6 VM; 2 HP); VM had many cables (n=4); and VM had a 
short battery life (n=2).
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Professional
Two facilitators and one barrier were identified in this domain. Two nurses stated that the 
patches did not lose skin contact while washing the patient, and one nurse said that it was very 
easy to attach the devices to the patient. One nurse mentioned that Wi-Fi connection was poor 
between Toughbook and the VM device. 
Additional Findings
During the study, clinical deterioration was detected with the VM in one patient 3 days 
postoperatively after elective colorectal surgery. The device alerted the nurse who cared 
for the patient because he developed a tachycardia and tachypnea. This situation occurred 
between two regular measurements. He underwent relaparotomy after an anastomotic leak 
was confirmed by computer tomography.
Table 4 Users’ experiences 
Nurse Patient Relatives
Perceived positive and negative effects
Processesa
- Nurse could keep eye on vital signs more easily + +
Outcomes
- Feelings of safety + +
- Earlier interventions +
- Adverse events (redness and itching) -
Barriers and facilitators
Intervention
- Not aware of HPb +
- Small size of HP +
- Good adhesive properties +
- Not being restricted during daily activities +
- More freedom of movements +
- Invisibility under clothes +
- Better insight in own vital signs +
- VMc wrist device too big/heavy -
- Patches came of very quickly -
- VM has too many cables -
- Short VM battery life -
Professional
- Good adhesive properties +
- Very easy to attach the devices +
- Bad Wi-Fi connection VM and Toughbook -
aNo positive or negative effects in the “Structure” or “Context” fields were found. bHP: HealthPatch.
cVM: ViSi Mobile
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DISCUSSION
Principal Findings
This study describes a unique approach in which we continuously measured vital signs on the 
ward using two recently released wireless devices. In general, data obtained by these devices 
correlated well with predefined accepted discrepancies and MEWS calculated on the basis of 
these devices correlated to a larger extent. Patients and nurses were mainly positive about the 
two devices. Both VM and HP are promising devices for continuous patient monitoring on the 
general ward. However, the number of artifacts should be reduced and the barriers mentioned 
by the users could be addressed to further improve both devices. 
Vital Signs
The largest discrepancy in mean difference was found in VM diastolic blood pressure, which is 
unlikely to be directly clinically meaningful since it is not a component of the MEWS. Additionally, 
clinical decisions are mainly based on systolic blood pressure and other vital signs. Wide limits 
of agreement were found for almost all vital signs and MEWS. Although more than 70% of all 
MEWS differed 0 or only 1 point between devices and nurse measurements, larger differences 
in MEWS were found in a few cases, which may have important clinical consequences (eg, 
additional diagnostic procedures or change in treatment). In most of these cases, VM and HP 
measured a higher RR when nurses did not. Although most differences between nurse and 
device measurements were small (<5 breaths/min), in one case, difference between nurse and 
HP measurements was large (26 breaths/min). These findings are important as abnormal RR 
has been shown to be an important predictor of cardiac arrest38 and an indicator of sepsis, 
pneumonia and respiratory depression;39 therefore, it could under- or overestimate a clinical 
condition of a patient. Inaccurate RR measurements by nurses could explain the discrepancy. 
Direct measurement of RR is usually done by visually observing chest movement or by 
manual observations. Reproducibility may be limited by significant interobserver variability.40 
Conversely, ECG-derived RR measurements by HP and VM may be inaccurate. In case of HP, 
RR is estimated by ECG using the respiratory sinus arrhythmia method, which derives RR from 
HRV. Since this method has some limitations, an accelerometer was added to measure RR 
more accurately.41 In VM, RR is derived from impedance pneumography, measuring respiratory 
volume and rate through the relationship between respiratory depth and thoracic impedance 
rate.42 ECG-derived RR may not be accurate when there is excessive patient motion or during 
lower respiratory rates.43,44 More research is required to gain a deeper insight in the different 
methods of measuring RR by devices and nurses.
Artifacts
Most reported VM artifacts concerned connectivity failure between VM and Toughbook. This 
was caused by a restricted Wi-Fi connection of approximately 15 meters between VM and 
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Toughbook, which explains why more artifacts were found in mobile patients. These artifacts 
were not deemed relevant since more stable Wi-Fi connections, such as by using multiple 
access points and 5 GHz networks, would be used to implement VM in a hospital setting. This 
would also facilitate continuous monitoring during patient transport between different wards. 
However, it is important to consider that a wireless connection can always fail, thus proper 
backup power and Internet connections are always demanded. Most HP artifacts were of 
unknown cause. However, most artifacts lasted less than one hour and were self-limiting.
Although HP could not measure all vital signs that are currently used to monitor patients and 
to calculate the MEWS, it may still provide more patient data than interval measurements 
by nurses, resulting in a more continuous dataflow and more specific trends. This may be 
of significance, in particular, since literature shows important lack of documentation of vital 
signs before a life-threatening event.27 Besides that, several studies show that HR and RR 
change significantly before ICU transfer, cardiac arrest, and mortality and therefore, HP can 
have a valuable contribution to the prediction of life-threatening events.24,27
Practical Usability
The majority of patients, relatives, and nurses were positive about VM and HP. Whereas HP is 
able to administer vital signs in real time to patient’s mobile phone, VM shows vital signs in 
real time on the wrist device; these devices could therefore increase insight on patient’s health 
status and potentially influence their behaviors.45,46 Although patients mentioned that the VM 
wrist device was heavy and VM consisted of many cables, they were not restricted during daily 
activities or mobility. This is important as hospitalized patients benefit from mobility, resulting 
in increased recovery and reduced risk of complications.47,48 Another benefit of VM and HP 
is that nurses are able to see patients’ vital signs from a distance. A review by Ulrich et al49 
has shown that sleep deprivation in patients is a common problem that is associated with 
hindrance of the healing process and an increase in morbidity and mortality. Using VM and HP, 
patients could continue sleeping during the night and did not have to be disturbed by vital sign 
measurements. 
Possible negative aspects of continuous monitoring should also be taken into consideration. 
Wearable devices generate a large quantity of data each day. The workload of nurses and 
physicians withholds them from inspecting all these data, which means that the predictive 
value of continuous monitoring is lost.17 Validated devices are available to process all these 
data and to send an alert when patient’s vital signs drop out of normal ranges. A large number 
of alerts and even false-positive alerts could cause alarm-fatigue in nurses.17,50 Algorithms 
using machine learning could be utilized to reduce false-positive alarms.51-53 The VM battery 
has a battery life of 12 to 14 hours, which means that nurses have to change batteries twice a 
day. This might outweigh the fact that nurses no longer need to perform the standard MEWS 
measurements three times a day. 
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Comparison With Prior Work
A few studies about continuous monitoring at the general ward have been published. A 
wireless sensor was successfully used in pregnant women in an inpatient obstetric unit, 
which was able to monitor HR, RR, and temperature.30 Recently, the SensiumVitals digital 
patch was tested in hospitalized patients.54 This patch is able to measure HR and RR and was 
compared with a commonly used clinical monitor. A satisfactory agreement, comparable with 
the result in our study, was shown. The drawback of the study design was that the patients 
were monitored for only 2 hours, which prevented the authors from detecting trends in vital 
signs and lowered predictive value. The use of an implantable device for continuous monitoring 
has been described in the ambulatory setting. Abraham et al55 described the use of a wireless 
implantable hemodynamic monitoring system in heart failure patients, which has shown to 
reduce hospitalization. Wireless technology systems in which patients measure vital signs at 
home have been described, such as for patients with chronic obstructive pulmonary disease,56 
patients with hypertension,57 and patients with diabetes mellitus.58,59 These systems were 
often well received by patients and health care providers, showing improvement of blood 
values such as glucose,58,60 patients’ disease management,56,61 and better connection between 
the patient and the health care provider.59 Particularly, the HP might be suitable for home 
monitoring, although its current version lacks the possibility to measure all vital signs. Though 
VM measures all vital signs, its size and cables might demand much from patients to enable 
monitoring at home.
Strength and Limitations
An important strength of the study is that we were able to monitor patients in a clinical setting 
instead of healthy participants in controlled settings. The study had a small sample size, and 
we missed some VM and HP data, particularly since VM data of 8 patients were automatically 
deleted from the Toughbook and could not be used for artifact analysis. This was due to wrong 
Toughbook settings and was changed with support from the manufacturer. The VM vital signs 
observed by students were used for the comparison with nurse measurements, and we were 
therefore able to draw conclusions about the feasibility of both VM and HP. However, data 
saturation in patient, nurse, and relative interviews may not have been reached. Selection 
bias could have occurred as not all patients who were approached did agree to participate. A 
further limitation of VM and HP is that both devices measure skin temperature instead of body 
temperature. Although it is not yet clear whether or not all vital signs are necessary for proper 
clinical judgment of ill patients, an algorithm should be developed to convert skin temperature 
into body temperature. 
Conclusions
The VM and HP are promising devices for wireless continuous patient monitoring in the hospital 
and were very well received by both patients and nurses. The frequency and duration of artifacts 
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should be reduced and the barriers mentioned could be addressed to further improve VM and 
HP. An ongoing follow-up study focuses on the different effects of VM or HP compared with 
routine MEWS measurements on patient comfort and safety and nurse workload, and on early 
detection of deterioration. Future studies should focus on the effect of continuous monitoring 
on clinical outcome.
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SUPLEMENTAL MATERIAL
Supplementary File 1 Modified Early Warning Score.
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ABSTRACT
Background 
Wearable devices are eligible for continuous patient monitoring at the general ward, increasing 
patient safety. Little is known about experiences and expectations of patients and health care 
professionals regarding continuous monitoring with these devices. 
Objective
We sought to identify positive and negative effects, and barriers and facilitators for use of two 
wearable devices: ViSi Mobile (VM; Sotera Wireless) and HealthPatch (HP; Vital Connect).
Methods
In this randomized controlled trial study, 90 patients admitted to the internal medicine 
and surgical wards of a university hospital in the Netherlands were randomly assigned to 
continuous vital sign monitoring using VM or HP, and a control group. User experiences and 
expectations were addressed using semi-structured interviews. Nurses, physician assistants 
and medical doctors were interviewed as well. Interviews were analyzed using thematic content 
analysis. Psychological distress was assessed using State Trait Anxiety Inventory (STAI) and 
Pain Catastrophizing Scale (PCS). The System Usability Scale (SUS) was used to assess the 
usability of both devices. 
Results
Sixty patients, 20 nurses, 3 physician assistants, and 6 medical doctors were interviewed. We 
identified 47 positive and 30 negative effects, and 19 facilitators and 36 barriers for the use 
of VM and HP. Most mentioned topics regarded earlier identification of clinical deterioration, 
increased feelings of safety, and VM lines and electrodes. No differences related to psychological 
distress and usability were found between randomization groups or devices.
Conclusions
Both devices were well received by most patients and healthcare professionals and the 
majority encouraged the idea of monitoring vital signs continuously at the general ward. This 
comprehensive overview of barriers and facilitators of using wireless devices may serve as a 
guide for future researchers, developers and healthcare institutions that consider implementing 
continuous monitoring at the ward.
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INTRODUCTION
Today’s technology is increasingly influencing healthcare.1 Numerous wearable devices such 
as patches, smart watches and even tattoos exist that can register vital signs such as heart 
rate (HR), respiratory rate, oxygen saturation (SpO2), and blood pressure (BP).
2-5 These devices 
are becoming more accurate and reliable,2,6 and are smaller and more user friendly than 
current hospital monitoring devices which may facilitate patients’ mobility and recovery during 
admission.7,8 Additionally the devices can improve health outcomes such as hypertension and 
can be used as diagnostic tool in the identification of several diseases or clinical deterioration 
during admission.2,9-11 
Vital signs of patients at general wards are usually monitored periodically by nurses, primarily 
during daytime.12 Clinical deterioration in between two measuring moments may not always 
be detected and can result in unplanned admission to the intensive care unit (ICU) which is 
associated with longer hospital stay, increased mortality rate13-15 and higher costs.16 Particularly 
during the night, when less medical personnel is available and clinical deterioration may remain 
undetected until the next morning.17 Wearable devices have the opportunity to monitor patients 
more frequently or continuously in order to provide additional information during the periods in 
which patients are not being seen by nurses.4 By implementing continuous monitoring, clinical 
deterioration can be detected in an earlier phase, particularly since changes in vital signs 
are often present 8-24 hours before a life threatening event occurs.18-22 Additional benefits of 
wearable device-based continuous monitoring are a reduced work load in nurses,23 improved 
patient comfort due to fewer vital sign measurements8,24 and safe patient transport between 
wards.25 Besides positive effects of wearable devices, continuous monitoring can lead to false 
alarms, resulting in unnecessary additional diagnostic procedures and possible alarm-fatigue 
in healthcare professionals.26,27
Recently, ViSi Mobile Mobile (VM) and the HealthPatch (HP) entered hospital care. These two 
wearable devices are FDA approved for continuous vital sign monitoring and have shown to 
be as accurate as nurse measurements in admitted patients.6 Several studies describing the 
opportunities of wearable devices, such as VM and HP have been published focused on the 
accuracy of data.11 However, in order to be used for long term monitoring in hospitals, devices 
should be comfortable and user-friendly for both patients and healthcare professionals. 
Besides, they should be willing to use them and see the benefit of these wearable devices 
and of being monitored continuously. A complete overview of experiences and expectations of 
patients regarding continuous monitoring with wearable devices is lacking. This study aims to 
identify experiences of patients, nurses, physician assistants and medical doctors about the 
use of VM and HP in daily practice for continuous monitoring of vital signs at the general ward. 
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METHODS
Setting, participants and sampling
This randomized controlled trial was conducted in an university hospital between April 2015 
and August 2016. The target population consisted of hospitalized patients, nurses, physician 
assistants, and medical doctors at the internal medicine and surgical ward and medical doctors 
from the intensive care unit. All consecutively admitted patients were invited to participate if they 
had to be hospitalized for at least three days. Surgical patients were included when they were 
scheduled for an elective abdominal surgical procedure. Patients were excluded and replaced 
when they were monitored less than 24 hours. A sample size of 90 patients (45 surgical and 
45 internal medicine patients) was estimated to be sufficient to obtain data saturation based 
on our pilot study.6 Patients’ relatives were involved if they attended the interview. We aimed to 
interview all nurses, physician assistants and medical doctors who were involved in the care 
for included patients to obtain a complete overview of user experiences and expectations. The 
institutional review board decided that formal approval was not required after they reviewed 
the study protocol extensively (local CMO number 2015-1717). The study was carried out in 
accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki). 
Wearable devices
VM (Sotera Wireless, CA, USA) is a patient monitoring system developed to enhance patient 
safety and early detection of clinical deterioration at a general ward. VM continuously 
measures five-lead ECG, HR, respiratory rate, SpO2, BP and skin temperature. It transmits 
all data wireless to a platform with Sotera’s analytic software such as desktop PCs or tablet 
PCs from where healthcare professionals have real time insight in patients’ vital sign data. VM 
consists of a wrist device with touch screen display that shows vital signs, a thumb sensor that 
measures SpO2 and BP. Five ECG cables are attached to the patient’s chest, as well as a chest 
sensor that measures skin temperature and respiratory rate. The battery in the wrist device 
has to be changed every 12-16 hours.
The HP (Vital Connect, CA, USA) is a small and lightweight disposable adhesive patch that 
consists of two ECG electrodes and a reusable module, which contains a sensors and a 
Bluetooth transmitter. It contains a battery that has a wear cycle of approximately 3-4 days. 
The patch continuously measures one-lead ECG, HR, respiratory rate, heart rate variability 
(HRV), skin temperature, steps, and body posture.28 The patch is attached to the patient’s chest, 
from where it sends data via Bluetooth to a mobile device where patients can see their own vital 
signs. Data is transmitted to a secured Vital Connect cloud on the Internet via Wi-Fi.
Study procedures and data collection
Patients at the surgical and internal medicine ward provided written informed consent after 
being informed about the study protocol. All interviewed nurses, physician assistants and 
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medical doctors also signed informed consent. Patients were randomly assigned to 1) VM, 2) 
HP or 3) control group (no device) (1:1:1). This was done to equalize individual factors between 
groups and minimize bias. The control group only received the regular nurse measurements. 
They were interviewed about their current experiences and their expectations of continuous 
monitoring, without being influenced by wearing a device. At the internal medicine ward, 
patients were randomized immediately after signing informed consent. Surgical patients 
signed informed consent prior to an elective surgical procedure and were randomized after 
surgery on arrival at the ward. Vital signs were continuously measured for 2-3 days in the 
VM and HP group. Regular vital sign measurements three times a day by nurses continued 
according to the hospital protocol in all patients. To determine psychological distress, all 
patients completed the short version of the State Trait Anxiety Inventory (STAI)29,30 at baseline, 
and on each day of the study period. On day 3, they completed the Pain Catastrophizing Scale 
(PCS), which provided a valid index about the extent to which people catastrophize.31 STAI and 
PCS scores were compared between randomization groups since psychological distress can 
be a confounding factor. Furthermore, this allowed us to assess whether the devices affected 
psychological distress. Additionally, nurses who took care for participating patients and who 
were involved in e.g. attachment of the devices and changing batteries, completed the System 
Usability Scale (SUS),32 which is a reliable tool for assessing usability. At the end of the study, 
patients and their relatives were interviewed face-to-face for approximately 45 minutes by one 
trained investigator. Nurses, physician assistants and medical doctors who were involved in 
the care for included patients were interviewed as well. For each semi-structured interview, 
an interview guide was used that consisted of predetermined themes based on the model 
for implementation of Grol and Wensing33 enriched with findings of a recent pilot study about 
monitoring with similar wearable devices.6 Themes concerned attitude towards continuous 
monitoring and the wearable devices, experiences with both wearables in clinical practice, 
future expectations of the devices, and perception on changes in clinical care using the devices. 
Questions focused on e.g. feelings of safety, user experiences with the devices, expected effect 
of continuous monitoring on patient safety and quality of care, and effect on nurse-patient 
interaction. The interview guide is available on request. The interviews were done by two 
researchers with a (bio)medical background, trained in interviewing.
Analysis
All interviews were audio-recorded and transcribed verbatim. Subsequently, two researchers 
(MW, TB) individually performed a thematic content analysis to determine facilitators and 
barriers, and positive and negative effects.34,35 The researchers discussed the results until 
consensus was reached. The Donabedian framework for the quality of healthcare was used to 
present all positive and negative effects.36 This framework distinguishes structure (context in 
which the care is delivered), process (all actions that make up health care), and outcome (all 
effects on patients’ health). Facilitators and barriers were categorized according to an existing 
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framework concerning determinants of adoption of mobile health.37,38 New determinants 
regarding use of VM and HP were added to the framework. Interviews were analyzed during 
the study and saturation was assessed using histograms, in which all new factors per interview 
were presented. Quotes and striking issues were documented as well. Once data saturation 
was reached, no further interviews were analyzed since it was expected that no new factors 
would be identified. STAI, PCS and SUS scores were analyzed using SPSS package version 20.0 
(SPSS, Inc, Chicago, IL). STAI scores ranged from 6 to 24 and a higher score indicated more 
psychological distress. SUS scores ranged from 0-100 and a score above 68 was considered 
above average.32 
Descriptive statistics were presented as mean with standard deviation (SD). Statistical 
significance between patient groups regarding demographics and PCS was calculated using 
the ANOVA or Pearson’s chi-square test. ANOVA for repeated measures was used to assess 
differences in STAI score between days and randomization groups. An independent-samples 
T-test was used to calculate difference between HP and VM regarding SUS. STAI and SUS 
results were not correlated with the interview results. A p-value less than 0.05 was considered 
significant. 
RESULTS
Demographics
165 patients were invited to participate, 89 patients at the surgical ward and 76 patients at 
the internal medicine ward. At each ward, 58 patients signed informed consent, 45 eventually 
participated in the study. Reasons for refusal were expectation of large mental (N=37) or 
physical burden (N=10) and expected discharge within 24 hours (N=2). At the surgical ward, 
13 patients were excluded due to rescheduling of the surgery (N=5), withdrawal of informed 
consent (N=4), early death (N=2), prolonged ICU stay (N=1) and a delirium (N=1). Reasons to 
exclude patients at the internal medicine ward were monitoring shorter than 24 hours due 
to unexpected discharge (N=11) or physical burden by VM (N=2). No differences were found 
between randomization groups regarding age (p=0.740) and gender (p=0.549). Demographics 
are shown in Table 1. Relatives of 6 patients attended the interview. Six medical doctors (2 
surgeons, 2 internists, 2 intensivists), 3 physicians assistants and 20 nurses were interviewed. 
Questionnaires
Psychological distress
No significant effect between the three randomization groups was found on STAI score (p=0.330) 
and no significant within-subject effect was found in STAI score between days (p=0.780) (Table 
2). Data of surgical and internal medicine patients were calculated separately; no significant 
effect between the randomization groups was found on STAI score (p=0.859 and p=0.170 
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respectively). No significant differences were found between the three randomization groups 
regarding PCS (p=0.573) (Table 2). 
Table 1 Patient demographics. 
ViSi Mobile (n=30) HealthPatch (n=30) Control group (n=30)
Gender
- Male (%) 18 (60.0) 22 (73.3) 20 (66.7)
- Female (%) 12 (40.0) 8 (26.7) 10 (33.3)
Age 63 56 62
(median, min-max) (26-76) (27-88) (34-77)
measurement period (days)
participated in study 3 (1-4) 3 (1-5) 3 (2-3)
(median, min-max)
Reason for admission (%)
- Colorectal disease 8 (26.7) 8 (26.7) 5 (16.7)
    - Malignant 7 8 5
    - Benign 1
- Hepatobiliary disease 5 (16.7) 5 (16.7) 5 (16.7)
    - Malignant 5 2 5
    - Benign 3
- Upper gastrointestinal disease 2 (6.7)
    - Malignant 2
- Neuroendocrine tumors 1 (3.3) 2 (6.7)
- Malignant 1 2
- Herniation 1 (3.3) 1 (3.3) 1 (3.3)
- Hematological diseases 1 (3.3) 2 (6.6)
- Autoimmune diseases 4 (13.3) 2 (6.7)
- Infectious diseases 3 (10.0) 7 (23.3) 6 (20.0)
- Other 9 (30.0) 5 (16.7) 7 (23.3)
Usability
The SUS was filled in by six nurses (3 internal medicine and 3 surgical nurses), one for each 
device. Both devices scored above average, indicating good usability. No significant difference 
was found between VM and HP (mean (SD) 77.9 (18.5) and 82.5 (18.6) respectively; p=0.678). 
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Table 2 State Trait Anxiety Inventory and Pain Catastrophizing Scale.
STAIc baseline STAI +1 STAI +2 STAI +3 PCSd
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
VMa 11.8 (2.7) 11.3 (2.9) 10.6 (2.6) 10.6 (3.0) 14.2 (11.2)
HPb 11.4 (2.7) 11.2 (2.8) 11.5 (2.8) 11.2 (3.3) 15.7 (11.6)
Control 11.0 (3.1) 11.1 (3.1) 11.2 (3.3) 11.7 (3.5) 17.4 (10.9)
aVM, ViSi Mobile; bHP, HealthPatch; cSTAI, State Trait Anxiety Inventory; dPCS, Pain Catastrophizing Scale.
Interview data
Data saturation occurred after 60 patients were interviewed (19 VM group, 21 HP group, 20 
control group), indicating that it was considered unlikely that new factors would be identified 
in additional interviews (Figure 1). All interviews of healthcare professionals were analyzed. A 
total of 33 unique positive effects by patients and 56 positive effects by healthcare professionals, 
and 14 negative effects by patients and 31 negative effects by healthcare professionals were 
identified. Patients reported 13 facilitators and 22 barriers and healthcare professionals 
reported 13 facilitators and 36 barriers.  
Positive effects
In the structure, process and outcome domains, 1, 23 and 23 positive effects were identified 
respectively (Supplementary file 1) by patients, their relatives and healthcare professionals. Six 
patients and two nurses mentioned alarms as positive effect of continuous monitoring using 
wearable devices. A nurse stated:
“We should all receive a mini-Ipad. It can show us patients’ vital signs during our shift and 
will send us an alert in case the vital signs drop outside the normal ranges.” [Nurse ID 4]
Seventeen patients, two relatives and 17 healthcare professionals expected to be able to 
detect clinical deterioration in an earlier phase using continuous monitoring. Five patients, 
three nurses and one medical doctor mentioned that earlier detection can result in earlier 
interventions. Six patients, one relative and five nurses thought that the implementation of 
continuous monitoring can lead to less patient disturbances. Seven patients and 11 healthcare 
professionals thought that continuous monitoring can save time. We asked all nurses how to 
spend the saved time. A nurse mentioned: 
“Just talking to the patient. To have more time for the story of the patient.” [Nurse ID 7]
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Figure 1 Saturation of positive and negative effects and facilitators. X-axis represents patient numbers; 
Y-axis represents each new item per interview that was mentioned by patients.
Other positive effects regarding efficiency in health care were a reduced workload, shorter 
hospital length of stay, prevention of ICU admission, reduced costs and lower amount of 
required nursing staff. A patient described:
“You can stay shorter in the hospital and can go home with a wearable device. They can 
inspect your data in the hospital while you are at home. I would like that, it would feel more 
safe.” [Patient ID 40]
Seventeen patients, one relative and nine healthcare professionals expected increased feelings 
of safety in patients on the general ward. Also, patients’ relatives and nurses mentioned to feel 
safer. A nurse explained:
“Postoperative patients have been monitored continuously at the ICU. Some do feel unsafe 
after return at the general ward because of a lower number of vital sign measurements.” 
[Nurse ID 1]
All nurses and most patients encouraged implementation of wearable devices for continuously 
monitoring of patients. A nurse and a patient mentioned:
“This is the future. We have to deal with it and the sooner we start working with those 
wearable devices, the more profit we will have.” [Nurse ID 16]
“The future.. I think only 30% of the patients will be hospitalized by then. Patients will be 
monitored from home with this kind of smart devices.” [Patient ID 50]
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Negative effects
Twelve and 18 negative effects were identified in the process and outcome domain respectively 
by patients, their relatives and healthcare professionals (Supplementary file 2). One patient and 
five healthcare professionals thought that continuous monitoring can generate an overload of 
information. An internist mentioned:
“Sometimes you just do not want to know, making yourself crazy with too much data. 
Particularly when data does not influence your decision in patient’s treatment.” [Medical 
doctor ID 5]
Particularly nurses at the surgical ward were afraid that their ward would become like an ICU; 
three nurses and one medical doctor thought that this can lead to reluctance for transfer to the 
ICU. The alarm system was mentioned as negative effect by three nurses and three medical 
doctors, leading to false positive alarms, irrelevant alarms and alarm-fatigue. Nine patients, 
one relative and five nurses were afraid that interaction between patient and healthcare 
professionals would be reduced. A patient mentioned:
“You need the confidence from the nurses, I would miss that. However, quantity time might 
become quality time.” [Patient ID 58]
Seven nurses and one medical doctor mentioned that continuous monitoring would cost more 
time and one nurse, one physician assistant and one medical doctor thought it would increase 
work load. A nurse said:
“Maybe it will increase work load. What if you receive an alarm every time a patient falls 
asleep and the oxygen saturation decreases a little bit?” [Nurse ID 6]
Twelve patients, two relatives and two healthcare professionals mentioned that patients can 
become worried by being able to see their own vital signs. A patient explained:
“Some people are very anxious. Like my wife… like she already said: she would overreact. I 
would like to know my vital signs, but she would panic.” [Patient ID 54]
Facilitators
Eight facilitators were found in the domain ‘Factors related to device’ (Supplementary file 3). 
One nurse and one medical doctor mentioned that using continuous monitoring healthcare 
professionals are able to see trends in vital signs. A surgeon stated:
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“Last night we saw a patient with an Early Warning Score of 3 and in the morning it suddenly 
was 13. Using continuous monitoring, we would have been able to see the Early Warning 
Score slowly increasing during the night.” [Medical doctor ID 6] 
Two patients, two nurses and one medical doctor mentioned the small size of the HP. Three 
patients said they thought it was easy to view al vital signs on the VM wrist device or the mobile 
device of the HP. Two patients and one nurse said they think both devices are reliable. 
Three facilitators were found in the domain ‘Individual factors’. Two patients, two nurses and 
two medical doctors thought that continuous monitoring will lead to earlier detection of clinical 
deterioration and two patients mentioned they think that patient safety will be improved. In the 
Human environment domain, eight facilitators were identified. Five patients mentioned that the 
devices were invisible under their clothes and seven patients said they were not aware of the 
device. One patient, two nurses and one medical doctor mentioned fewer actions during vital 
sign measurements as facilitator, such as putting on the upper arm cuff for BP measurements. 
Barriers
In the domain ‘Factors related to the devices’, 22 barriers were identified (Supplementary file 
3). Two patients, three nurses and one medical doctor mentioned the VM battery change as 
barrier. VM wrist device was thought to be too big or heavy by five patients, three nurses and 
one medical doctor. Furthermore, VM cables and the patches and electrodes were mentioned 
as barriers as well. A patient said:
“Yesterday I felt very ill. I noticed that when you do not feel very well, every line, every device is 
just too much.” [Patient ID 40]
Three patients mentioned that devices are not able to measure patient experiences, such as 
pain. A patient described:
“The devices are not able to register pain. When the nurse does not visit me, I cannot tell her I 
am having a headache. The device will not register that.” [Patient ID 55]
Two patients and five nurses said that it is a barrier that the HP is not able to measure all vital 
signs. Furthermore, it was also mentioned that VM and HP both are not able to measure core 
temperature. 
Four barriers were identified in the domain Individual factors. One medical doctor mentioned 
the risk of overtreatment by identifying abnormalities in vital signs that cannot be ignored. One 
medical doctor and one patient said that the VM wrist device is stigmatizing. In the domain 
‘Human environment’, six barriers were identified. Three patients thought it was a burden to 
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carry the HP mobile device. One medical doctor feared that there will be too much attention for 
the vital signs and less attention for the individual patient. One nurse mentioned that patients 
were worried that patches would come off. Four barriers were identified in the Organizational 
environment. Two medical doctors mentioned that nurses do not have adequate training to 
interpret continuous data. Four nurses and one medical doctor thought that there would not 
be enough personnel to monitor all data. 
“At this moment it is not feasible to monitor all patients 24 hours a day and to anticipate 
adequately to clinical deterioration with the amount of nursing staff we have.” [Nurse ID 6]
DISCUSSION
Main findings
In this study we successfully investigated non-ICU patients with a wide spectrum of clinical 
conditions and healthcare professionals regarding their experiences and expectations during 
the use of two wearable devices for continuous monitoring of vital signs. We showed that 
continuous monitoring at the ward was not only well received by patients and their relatives, 
but also by their healthcare professionals. We found that using wearable devices did not affect 
stress levels. The majority of participants favored the use of these devices in daily practice. 
Both patients and healthcare professionals expected that continuous monitoring of vital signs 
would lead to earlier identification of clinical deterioration and to an improvement of quality, 
safety and efficiency in healthcare. 
Our semi-structured interviews revealed a primarily positive attitude towards continuous 
monitoring and both used devices from patients, relatives and healthcare professionals. A 
recent study by Abelson et al. also confirms that surgical patients have a positive attitude 
towards wearable devices and mobile apps and that they are willing to use them.39 Earlier 
detection of clinical deterioration was frequently mentioned by patients and healthcare 
professionals corresponding with findings in a recent review by Cardona-Morrell et al. They 
showed that continuous monitoring of vital signs at the general ward leads to earlier detection 
of clinical deterioration.10 Continuous monitoring can lead to saved time and reduced work 
load for nurses. All nurses mentioned they would use this time for the patient, such as 
mobilization, washing/showering patients, providing information and being a listening ear 
for the patient. This might solve the problem for less nurse-patient interaction, which was 
frequently feared of by patients. Future research should shed light on changes in nurses’ 
workload after implementation of continuous monitoring. One of the most frequently reported 
barriers was the wrist device and cables of VM. Particularly surgical patients mentioned 
that the VM cables were a burden in combination with other lines, such as abdominal drains 
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and urinary catheters. However, patients did not feel restricted during daily activities. This 
is important since early appropriate mobilization improves recovery and reduces the risk 
of complications.40,41 STAI and PCS scores revealed no differences in psychological distress 
between patients in the intervention and control group, indicating that nor the VM or HP caused 
additional stress or reduced stress. According to SUS scores, the ‘larger’ VM wrist device and 
cables did not influence the overall usability of the VM in comparison with the ‘smaller’ HP. It is 
expected that future devices will become smaller while being able to wirelessly monitor all vital 
signs continuously. The amount of data that will become available by continuous monitoring 
was mentioned as a negative effect by healthcare professionals, as it was expected that they 
can never review all data. Big data analytics are available for effective storage and processing 
of large amount of data.42,43 Alarms can alert the nurse when patient’s vital signs drops out of 
normal ranges, resulting in a high number of false-positive or irrelevant alarms or even alarm-
fatigue.27,44 Machine learning algorithms can prevent unnecessary diagnostic procedures and 
overtreatment due to a reduced number of irrelevant and false-positive alarms.45-47  
Other research
Few studies regarding continuous monitoring at the general ward exist. Brown et al. compared 
continuous monitoring using the EarlySense system with intermittent monitoring at a medical-
surgical ward.48 This system includes a flat sensor that is placed under the patient’s bed and 
monitors HR and respiratory rate continuously. They found a reduced number of days at 
the ICU and shorter overall hospital stay due to earlier interventions in patients who were 
monitored continuously. However, the system is not able to monitor other vital signs such as 
BP, SpO2 and temperature and not when patients are out of bed. Using HP and VM, patients are 
able to mobilize throughout the hospital while being monitored continuously for relevant vitals. 
VM measures almost all vital signs, which are required to calculate the MEWS and judge the 
clinical situation of the patient. 
Strengths and limitations
An important strength is that we were able to monitor patients admitted for various reasons 
for a longer period of time in a clinical setting. We collected a large number of semi-structured 
interviews from both patients and healthcare professionals and were able to reach data 
saturation in patients about all pre-defined categories, resulting in a comprehensive overview 
of the positive and negative effects of continuous monitoring and facilitators and barriers 
regarding VM and HP. The control group allowed us to collect current experiences from 
patients that were not yet influenced by using wearable devices. Regarding interviews with 
healthcare providers, data may not have saturated. Selection bias can have occurred since not 
all approached patients signed informed consent, particularly at the surgical ward. However, we 
randomized all patients to VM, HP or a control group and no significant differences were found 
between randomization groups for example gender, which minimized bias. Patients mainly did 
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not agree with participation because they feared the mental or physical burden, particularly 
severely ill patients or patients with psychological distress. No differences were found in 
experienced stress between different randomization groups. Although the STAI questionnaire 
is validated for measuring psychological distress, many other stressful factors can have had 
impact on patients and potentially influence the outcomes (stress prior to surgical procedures 
or complications during hospitalization). 
Future perspectives
Implementation of wearable devices for continuous monitoring is expected to influence health 
care in multiple ways. Patient safety can be improved since trained and experienced personnel 
can be warned during an earlier phase of deterioration and perform early interventions. This 
can prevent unnecessary ICU admission and shorten hospitality stay. Nurses will have to be 
taught how to operate wearable devices and continuous vital sign data at the general ward. 
It is expected that nurses will have more time for other needs of a patient during admission. 
Data transmission via Wi-Fi between device and the EHR should be safe and accurate. 
Potential alarms in vital signs can be processed using predictive analytics and machine 
learning techniques to prevent false positive alarming. Furthermore, patients can benefit from 
continuation of monitoring using the same or comparable wearable devices. Vital signs data 
collected at home can be shared with trained nurses or physicians. With continuous monitoring 
patients can be more actively involved in their own treatment. To stimulate this, the facilitators 
and barriers reported in this study are of great value when planning to implement wearable 
devices at the general ward. 
Conclusion
According to patients and healthcare professionals, VM and HP have great potential for 
continuous monitoring of vital signs at the general ward and almost all encouraged the idea 
of monitoring vital signs continuously at the general ward. The comprehensive overview of 
barriers and facilitators of using wireless devices should be taken into consideration when 
choosing the device for implementing continuous monitoring. Continuous monitoring may 
provide the ability of predictive analytics for clinical deterioration and early interventions. 
Further studies should explore the effect of continuous monitoring on clinical outcomes of 
patients at the general ward. 
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SUPPLEMENTAL MATERIAL
Supplementary file 1 Positive effects.
Patient Group Relatives Nurse PAa MDb
Structure
1. Monitoring patients from a distance 2 HPc/Cod 2
Process
2. Vital sign monitoring 23 18 4 4
2.1 Monitoring patients with high MEWS 1
2.2 Monitoring patients who don’t call for help 1
2.3 More information about patients
    2.3.1 Availability of historical data 4 HP/Co 2 1 1
    2.3.2 Insight in effect of medication 1
    2.3.3 Could assist with differential diagnosis 1
    2.3.4 Trends 1 VMe 5 2 1
    2.3.5 Improved communication between physicians  1 Co
    2.3.6 From home 1 HP
    2.3.7 Not specified 7 VM/HP/Co 3 1
2.4 Alarms 6 VM/HP/Co 2
2.5 Data automatically in EHR 2 1
2.6 More reliable data
    2.6.1 No measuring error between nurses 1 HP
    2.6.2 Measurements at fixed time points 1 HP
    2.6.3 Not specified 1 HP 1
3. Detection of clinical deterioration 22 2 16 2 5
3.1 Earlier detection of abnormal vital signs
    3.1.1 During the night 1 HP
    3.1.2 Not specified 16 VM/HP/Co 2 12 2 3
3.2 Earlier interventions
    3.2.1 Earlier ICU admission 1 1
    3.2.2 Not specified 5 VM/HP 3 1
4. Patient-professional interaction 9 1 12 1
4.1 Less patient disturbances 6 VM/HP/Co 1 5
4.2 More contact between nurse and patient 2 VM 2
4.3 Less actions during MEWS measurements
    4.3.1 More hygiene by not touching the patient 1
    4.3.2 Not specified 1 VM 4 1
5. Increased patient mobility 2 1 2
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Patient Group Relatives Nurse PAa MDb
Outcome
6. Quality and safety 8 10
6.1 Improvement of quality of care 1 Co 3
6.2 Improvement of patient safety 7 VM/HP/Co 7
7. Efficiency in health care 14 17 3 7
7.1 Time saving
    7.1.1 Time for other activities 1 HP 1 1
    7.1.2 Particularly during evening and night shifts 1 1
    7.1.3 Not specified 6 VM/HP/Co 7
7.2 Reduced work load 3 HP 5 1 1
7.3 Shorter hospital length of stay
    7.3.1 Earlier discharge with HP 1 HP
    7.3.2 Shorter ICU length of stay 1
    7.3.3 Not specified 1 1
7.4 Prevention of ICU admission 4
7.5 Reduced costs 2 HP/Co 1
7.6 Less nursing staff needed 1 HP
7.7 Not specified 1
8. Psychosocial domains/well being 24 4 9 1 3
8.1 Feelings of safety patient 17 VM/HP/Co 1 5 1 3
8.2 Feelings of safety nurse 1 Co 1
8.3 Feelings of safety relatives 1 Co 3
8.4 More privacy 1
8.5 More rest in the room 2 HP/Co
8.6 Better sleep at night 3 HP/Co 2
9. Insight in own vital sign monitoring 4 1 2
9.1 Patients are more involved in own treatment 1 Co 1
9.2 To be relieved 2 VM 1
9.3 Specified 1 Co 1
10. No restriction in daily activities 1 HP
aPA, Physician assistant; bMD, Medical doctor; cHP, HealthPatch; dCo, Control group; eVM, ViSi Mobile.
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Supplementary file 2 Negative effects. 
Patient Group Relatives Nurse PAb MDc
Processa
1. Vital sign monitoring 1 12 1 5
1.1 Overkill information
    1.1.1 Things that cannot be ignored 2
    1.1.2 Less attention for vital signs 1
    1.1.3 Not specified 1 HPd 1 1
1.2 More similarities with ICU
    1.2.1 Delayed admission to ICU 3 1
    1.2.2 Not specified 2 1
1.3 Alarms
    1.3.1 False positive alarms, e.g. movements 1 1
    1.3.2 Irrelevant alarms, particularly during night 2 1
    1.3.3 Alarm-fatigue 1
2. Interaction between professionals and patients 9 1 5 1
2.1 Less nurse-patient contact
    2.1.1 Less use of clinical eye 2
    2.1.2 Not specified 9 VMe/HP/Cof 1 3
2.2 More nurse-physician contact 1
3. Reduced patient mobility 1 Co 1
Outcome
4. Efficiency in health care 1 9 1 2
4.1 Costs more time
    4.1.1 More time with computer 4 1
    4.1.2 To connect patients with devices 2
    4.1.3 Interns need more explanations 1
4.2 Increased workload
    4.2.1 More questions from patients 1 1
    4.2.2 Not specified 1
4.3 Unnecessary treatments 1 Co 1
5. Psychosocial domains/well-being 16 3 9 1 1
5.1 Obsessed patient 1 VM 1 5
5.2 Worried patient
    5.2.1 Wrong interpretation of vital signs 1 HP 1 1
    5.2.2 Certain patient groups (e.g. anxiety) 1 VM
    5.2.3 By hearing alarms 1 HP
    5.2.4 That nobody is watching vital signs 1 Co
    5.2.5 Not specified 8 VM/Co 1 1
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Patient Group Relatives Nurse PAb MDc
5.3 Increased feelings of illness 1
5.4 False sense of safety 1 HP 1 1
5.5 Feelings of unsafety 1 Co
5.6 Worried family 1
6. Restriction in daily activities 1 Co
7. Reduced patient empowerment 1 Co
aNo positive or negative effects in the “Structure” field were found; bPA, Physician assistant; cMD, Medical 
doctor; dHP, HealthPatch; eVM, ViSi Mobile; fCo: Control group.
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Supplementary file 3 Facilitators and barriers
Fac Bar Device Patient Nurse PA MD
1. Factors related to devices
1.1 Design and technical concerns
 1.1.1 WiFi connection between VM and Toughbooka 2 VMd 1 1
 1.1.2 Artifacts in dataa 3 VM/HPe 1 1 1
 1.1.3 Data too much/uncleara 2 VM/HP 2
 1.1.4 Able to see trendsa 2 VM/HP 1 1
 1.1.5 Able to see vital signs from a distancea 1 VM/HP 1
 1.1.6 Small sizea 5 HP 2 2 1
 1.1.7 Battery changea 5 VM 2 3
 1.1.8 Wrist devicea
        1.1.8.1 Too big/heavy 9 VM 5 3 1
        1.1.8.2 Not easy to read vital signs 1 VM 1
        1.1.8.3 Light turns on during the night 3 VM 3
        1.1.8.4 Too loose 1 VM 1
        1.1.8.5 Too tight 1 VM 1
 1.1.9 Cablesa 14 VM 8 6
 1.1.10 Patches/electrodesa 16 VM/HP 9 6 1
 1.1.11 No upper arm cuffa 1 VM/HP 1
 1.1.12 Restriction during daily activitiesa 7 VM 2 5
 1.1.13 Alarms (irrelevant/false-positive)a 12 VM/HP 2 7 1 2
1.2 Characteristics of the innovation
 1.2.1 Perceived usefullness
        1.2.1.1 Devices have no clinical eyea 3 VM/HP 1 2
        1.2.1.2  Not able to measure with devices during 
diagnostic proceduresa 
3 VM/HP 1 2
        1.2.1.3  Devices are not able to measure patient 
experience (e.g. pain)a
3 VM/HP 3
 1.2.2 Perceived ease of use
        1.2.2.1 Connecting patientsa 1 2 VM 3
        1.2.2.2  Display/interface (VM wrist device/HP mobile 
device)a
3 VM/HP 3
1.3 System reliability 3 VM/HP 2 1
1.4 Legal issues
1.4.1 Confidentiality – privacy concerns 2 VM/HP 2
1.5 Validity of the resources
1.5.1 Satisfaction about content available (completeness)
       1.5.1.1 Not able to measure all vital signsa 7 HP 2 5
       1.5.1.2  Measures skin temperature instead of core 
temperaturea
1 VM 1
1.5.2 Accuracy 4 2 VM/HP 4 2
1.6 Cost issues 1 VM/HP 1
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2. Individual factors: knowledge, attitude, socio-
demographic characteristics
2.1 Attitude
2.1.1 Agreement with the devices
       2.1.1.1 Time consuming/time saving
2.1.1.1.1 Battery changea 2 VM 2
2.1.1.1.2  Too much data (reviewing all the data take too much 
time)a
2 VM/HP 1 1
       2.1.1.2  Outcome expectancy (use leads to desired 
outcome)
2.1.1.2.1 Earlier detection of abnormal vital signsa 6 VM/HP 2 2 2
2.1.1.2.2 Earlier discharge with HPa 2 VM/HP 1 1
2.1.1.2.3 Improvement of patient safetya 2 VM/HP 2
2.1.1.2.4 Overtreatment of patientsa 1 VM/HP 1
                      2.1.1.3 Motivation/resistance to use
2.1.1.3.1 Wrist device is stigmatizinga       2 VM 1 1
3. Human environment
3.1 Factors associated with patients
3.1.1 Patients’ attitudes and preferences regarding devices
       3.1.1.1 Able to see own vital signsa 3 VM/HP 3
       3.1.1.2 Device invisible under clothesa 5 VM/HP 5
       3.1.1.3 Not aware of devicea 7 VM/HP 7
       3.1.1.4 Extra device with HPa 3 HP 3
       3.1.1.5  Wanted to stop wearing VM, my wrist are not that 
wella
1 VM 1
       3.1.1.6 Short battery lifea 1 VM 1
       3.1.1.7  Increased patient comfort (vitals measured with 
one device)a
1 VM 1
3.1.2 Patient/health professional interaction
                     3.1.2.1 Less attention for patienta 1 VM/HP 1
       3.1.2.2 Less nurse-patient contacta 1 VM/HP 1
       3.1.2.3 Less patient disturbances during the nighta 3 VM/HP 2 1
       3.1.2.4 Less actions during vital sign measurementsa 4 VM/HP 1 2 1
3.1.3 Other factors associated with patients
       3.1.3.1  Patients were worried that patches would come 
offa
1 VM 1
3.2 Factors associated with healthcare providersa
3.2.1 Device localized at chesta 1 HP 1
3.2.2 Feelings of safetya 1 VM/HP 1
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4. Organisational environment
4.1 Internal environment
4.1.1 Work (nature of work)
       4.1.1.1 Time constraints and workload 1 VM/HP 1
4.1.2 Skill – Staff
       4.1.2.1 Staff issues (stability, shortage)
4.1.2.1.1 Not enough personel to monitor all dataa 5 VM/HP 4 1
4.1.3 Organisational factors
       4.1.3.1 Training/lack of or inadequate training
4.1.3.1.1  Nurses are not able to anticipate to deteriorating 
vital signsa
1 VM/HP 1
4.1.3.1.2 Nurses cannot handle fluctuations in vital signsa 1 VM/HP 1
aThese items are added to the Gagnon framework. bPA, Physician assistant; cMD, Medical doctor; dVM, ViSi 
Mobile; eHP, HealthPatch.
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ABSTRACT
Background 
Clinical deterioration regularly occurs in hospitalized patients potentially resulting in life 
threatening events. Early warning scores (EWS), like the Modified Early Warning Score (MEWS), 
assist care givers in assessing patients’ clinical situation, but cannot alert for deterioration 
between measurements. New devices, like the ViSi Mobile (VM) and HealthPatch (HP) allow for 
continuous monitoring and can alert deterioration in an earlier phase. VM and HP were tested 
regarding MEWS calculation compared to nurse measurements, and detection of high MEWS 
in periods between nurse observations.
Methods
This quantitative study was part of a randomized controlled trial. Sixty patients of the surgical 
and internal medicine ward with a minimal expected hospitalization time of three days 
were randomized to VM or HP continuous monitoring in addition to regular nurse MEWS 
measurements for 24–72 h.
Results
Median VM and HP MEWS were higher than nurse measurements (2.7 vs. 1.9 and 1.9 vs. 1.3, 
respectively), predominantly due to respiratory rate measurement differences. During 1282 h 
VM and 1886 h HP monitoring, 71 (14 patients) and 32 (7 patients) high MEWS periods were 
detected during the non-observed periods. Time between VM or HP based high MEWS and next 
regular nurse measurement ranged from 0 to 9 (HP) and 10 (VM) hours.
Conclusions
Both VM and HP are promising for continuous vital sign monitoring and may be more accurate 
than nurses. High MEWS can be detected in hospitalized patients around the clock and clinical 
deterioration at an earlier phase during unobserved periods.
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INTRODUCTION
Hospitalized patients may suffer from clinical deterioration due to their underlying condition 
or adverse events, leading to life threatening events or death.1,2 Frequently, these patients 
require treatment at the Intensive Care Unit (ICU) to prevent further deterioration.3,4 Patients 
transferred from a general ward to an ICU need more resources, have a longer hospital stay 
and are more likely to die.5–7 Earlier identification and treatment of threatening conditions lead 
to lower mortality rates.8,9 To assist care givers in early identification, Early Warning Scores 
(EWS), such as the Modified Early Warning Score (MEWS) have been developed based on an 
aggregated vital sign scores10 and are used to identify patients at risk for further deterioration 
and to deliver faster supportive care.11 However, studies show conflicting results about the 
value of EWS in relation to patient outcomes.12,13 Identification of early deterioration depends 
on the quality and frequency of measurements by nurses.14 The optimal frequency of vital sign 
measurements is unknown,15,16 but should be high enough to detect early changes in vital 
signs prior to life threatening events.14 New developments in technology allow wireless and 
continuous monitoring of vital signs, which may lead to earlier detection of clinical deterioration 
at the general ward.17,18 Additional benefits can be reduced work load for nurses19 and less 
patient disturbances.19–21 In a recent study we demonstrated that continuous monitoring by two 
different wearable devices was as accurate as nurse measurements and both devices were 
well received by patients and nurses.22 In this study the use of ViSi Mobile (VM; Sotera Wireless, 
San Diego, CA, USA) and HealthPatch (HP; Vital Connect, Campbell, CA, USA) was examined 
in a setting of hospitalized non ICU patients. Differences in MEWS results between regular 
periodic measurements by nurses and device measurements were compared, and high MEWS 
periods in between nurses’ measurements were identified.
METHODS
Participants and Setting
This study was part of a randomized controlled trial (RCT) on patient and care giver reported 
outcomes regarding smart devices for continuous monitoring vital signs at the internal 
medicine and surgical ward of the Radboud university medical center in the Netherlands. 
Patients who were 18 years or older and able to speak Dutch were eligible for participation. 
Vital sign measurements had to be ordered for at least three times a day by the care giver 
and expected hospitalization time had to be three days or longer. In case of an unexpected 
admission time of less than 24 h, a patient was excluded. Since a formal power calculation was 
not possible due to lack of preliminary data with these devices, a sample size of 60 patients 
was estimated to obtain sufficient data. In the RCT consisting of three groups, 30 patients 
were controls without continuous monitoring. These were excluded for further analysis. 
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The institutional review board decided that formal ethical review was not required after they 
reviewed the study protocol extensively (local CMO number 2015– 1717), because continuous 
monitoring using both devices did not interfere with regular treatment, privacy of the patients 
was guaranteed and all patients were asked to sign informed consent after they were informed 
about the study.
Wearable devices
ViSi Mobile (VM) is FDA approved and received CE mark for monitoring five vital signs 
continuously.22 The wrist-worn device works with a number of sensors measuring blood pressure 
(BP), heart rate (HR), respiratory rate, blood oxygen saturation (SpO2), skin temperature, and 
5-lead ECG. BP can be measured cuff-less by a thumb sensor after twice daily calibration with 
an upper arm cuff. Vital signs are visible for patients on a wrist device and can be locked by an 
authentication code. In this study all vital signs were transmitted via Wi-Fi to a laptop. Battery 
in the wrist device had to be recharged after 12–16 h. 
The HealthPatch (HP) is a small and lightweight disposable patch, containing two ECG 
electrodes, a reusable sensor and a disposable battery lasting 3–5 days.22 It received FDA 
clearance and CE mark for continuously measuring one-lead ECG, HR, respiratory rate, skin 
temperature, steps, body posture and falls.23 HP can be attached to the patient’s chest from 
where it transmits all data via Bluetooth to a mobile device (iPod or smart phone) and via Wi-Fi 
connection to a secured internet cloud.
Study procedures
Patients gave written informed consent and were randomized for connection with VM or HP. 
Demographics including age, gender, MEWS at day 1, reason for admission and type of surgery 
were registered. At the surgical ward, patients signed informed consent before surgery and 
received VM or HP on arrival at the ward. At the internal medicine ward, patients were connected 
to the VM or HP immediately after signing informed consent. All patients participated between 
24–72 h and they received regular MEWS measurements by nurses. Nurses were formally 
blinded for the device results; they had no insight in the device data during their regular 
measurement moments. The VM data collector, a preconfigured Panasonic Toughbook, was 
set at the nurse’ post and showed alarms when vital signs fell out of normal ranges. Normal 
ranges were configured per individual patient based on current situation and clinical history. 
Technical issues, such as connectivity failures, were registered and repaired.
Data collection and analysis
Registered data were retrieved from the Toughbook (VM) and the Vital Connect secured cloud 
server (HP) for analysis. Nurse measurements were extracted from the Electronic Health 
Record (EHR) for the period of inclusion. Nurse measurements with missing vital signs, 
except oxygen administration and AVPU (Level of consciousness. A: Alert; V: Verbal; P: Pain; U: 
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Unresponsive), were excluded. Artefacts in VM and HP data, defined as no or an invalid value 
for more than one minute, were retrospectively determined and excluded.
Device data versus nurse measurements
Mean values for each vital sign obtained by either VM or HP were calculated from a five minute 
period of continuous registration prior to each nurse measurement and was compared to the 
nurses’ results. Oxygen administration and AVPU were imputed as 0 l/min and as ‘Alert’ in case 
of a missing value in the EHR assuming that a deviating value would have been documented. 
Vital signs outside physiological realistic ranges defined as SpO2 50–100%, respiratory rate 
2– 50 breaths/min, HF 20–250 beats/min, temperature 32–42 °C, systolic BP 50–300 mmHg, 
were considered measuring errors and excluded. Because VM measures 5 vital signs (HR, 
respiratory rate, SpO2, BP, skin temperature) and HP 3 (HR, respiratory rate, skin temperature), 
we introduced three variants of the MEWS calculation, to be able to compare VM and HP based 
MEWS with nurses’ MEWS: (1) a regular MEWS-VII (all seven parameters were used in the 
calculation); (2) MEWS-IV based on SpO2, HR, respiratory rate and systolic BP, measured by 
VM; (3) MEWS-II based on HR and respiratory rate which were measured in all groups. Vital 
signs not captured by VM or HP were taken from nurses’ measurements to complete the MEWS 
calculation in all situations. Since VM and HP both are not able to measure core temperature, 
these measurements were taken from the EHR.
High MEWS measurements by VM and HP between periodical nurse measurements
For every 30 minutes of continuous VM and HP data, a mean or median value was calculated 
for each vital sign and the MEWS. In case of HP, the value of BP and SpO2 were taken from the 
periodic nurse measurement prior to the device measurement. A high MEWS was defined as a 
calculated MEWS ≥ 6. In case of more than one consecutive MEWS ≥ 6 during a non-observed 
period by nurses, only the first high MEWS during such a non-observed period was counted.
Statistical analysis
All analyses were performed using SPSS 20.0 (SPSS, Inc, Chicago, IL). Descriptive statistics are 
presented as mean with standard deviation (SD) or median with interquartile range, depending 
on skewness of data distribution. To test for skewness, the Shapiro-Wilk test was used. Bland–
Altman plots, showing mean differences with corresponding limits of agreement, were created 
to assess the agreement between vital signs measured by nurses and both devices. Selection 
bias between groups regarding age and MEWS at time of admission was analyzed using 
Student’s t-test (normally distributed data) or Mann–Whitney U test (non-normally distributed 
data). The Chi-Square test was used to test for selection bias regarding gender. A P-value 
below 0.05 was considered significant.
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RESULTS
Demographics
At the surgical ward, 59 patients were informed about the study (Supplementary file 1). Thirty-
nine patients signed informed consent, of whom 30 participated. Nine patients were excluded 
because the surgical procedure was re-scheduled (N = 1), patient withdrew consent (N = 4), 
patient deceased (N = 2), ICU stay was extended (N = 1), or patient had a major immediate 
postoperative complication (N = 1). Twenty patients refused because they expected a mentally 
(N = 16) or physically (N = 4) burden. At the internal medicine ward, 46 patients were informed. 
Thirty-six patients signed informed consent, of whom 30 participated. Six patients were 
excluded because their admission time appeared shorter than 24 h (N = 4), or the use of VM 
was deemed physically heavy (N = 2). Ten patients refused participation because they expected 
mental (N = 7) or physical (N = 2) burden or discharge within 24 h (N = 1). Demographics are 
shown in Table 1. No differences were found between the VM and HP groups regarding age (p = 
0.520), gender (p = 0.273), or median MEWS at time of admission (p = 0.217).
Device data versus nurse measurements
In total, 1282 h of VM and 1886 h of HP data were recorded, on average 49 h of VM and 63 h of HP data 
per patient. The amount of missing VM data was 10.1 percent (129 h), mainly due to connection 
failures and errors in data storage. 8.4 percent (158 h) of HP data was missing due to connection 
failures or unknown cause. The removed artifacts were mainly due to connection failures 
and errors in data storage, and would have led to so called ‘blue alarms’. These blue 
alarms indicate technical issues and are strongly reduced in an ongoing study in which 
we were able to connect ViSi Mobile to the hospital wide-range Wi-Fi system (instead 
of the Toughbook). ‘Red alarms’ are alarms indicating change in vital signs and alert 
nurses. In this study, the blue alarm did not affect any reported result. In total, 150 
MEWS measurements were performed by nurses during the time the VM was connected 
to patients. Of these measurements, 113 (75%) were used for further analysis and 25
percent could not be calculated due to missing vital signs. In the HP group, 199 of the 206 (96%) 
MEWS measurements by nurses were used. Table 2 shows the absolute values and contribution to 
the MEWS per vital sign. All MEWS IV and II values corresponded well with nurses’ MEWS. Median 
MEWS measured by VM and HP were higher than nurses’ MEWS. Compared to nurse 
measurements, VM SpO2 and respiratory rate and HP respiratory rate measurements 
contributed more to the MEWS due to higher variability in respiratory rate measurements by 
both devices (Table 3; Supplementary file 2).
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Table 1 Patient demographics. 
Demographics ViSi Mobile (n=30) HealthPatch (n=30)
Gender
- Male (%) 18 (60.0) 22 (73.3)
- Female (%) 12 (40.0) 8 (26.7)
Median age 63 56
(min-max) (26-76) (27-88)
Median time  
participated in study 3 3
(min-max; in days) (1-4) (1-5)
Median MEWS at day 1* 0 (0-1) 1 (0-2)
- Median saturation 97 (96-98) 98 (96-99)
- Median respiratory rate 16 (16-18) 16 (16-18)
- Median heart rate 83 (74-97) 82 (72-98)
- Median systolic blood pressure 139 (123-159) 138 (126-148)
- Median core temperature 37.3 (36.7-37.6) 37.2 (36.7-37.8)
Reason for admission (%)
- Colorectal disease 8 (26.7) 8 (26.7)
    - Malignant 7 8
    - Benign 1
- Hepatobiliary disease 5 (16.7) 5 (16.7)
    - Malignant 5 2
    - Benign 3
- Neuroendocrine tumors 1 (3.3)
- Malignant 1
- Herniation 1 (3.3) 1 (3.3)
- Hematological diseases 1 (3.3)
- Autoimmune diseases 4 (13.3) 2 (6.7)
- Infectious diseases 3 (10.0) 7 (23.3)
- Other 9 (30.0) 5 (16.7)
MEWS = Modified Early Warning Score.
*First MEWS measurement determined at time of admission. 
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Table 2 Vital signs and calculated MEWS VII, IV and II in patients with VM or HP, compared to nurses’ 
measurements.
Nurse  MEWSa ViSi Mobile MEWS
Saturation (%) 97 (95 – 98) 0.4 95.6 (94.0 – 97.1) 0.7
Respiratory rate (breaths/min) 16 (16 – 16) 0.1 15.7 (12.9 – 18.1) 0.4
Heart rate (beats/min) 82 (72 – 90.5) 0.3 79.9 (70.6 – 91.1) 0.3
Systolic BP (mmHg) 123 (106 – 140.5) 0.6 117.7 (103.0 – 134.9) 0.7
MEWS-II 0.4 0.8
MEWS-IV 1.4 2.1
MEWS-VII 1.9 2.7c
Nurse  MEWSa HealthPatch MEWS
Saturation (%) 96 (96 – 98) 0.3
Respiratory rate (breaths/min) 16 (16 – 18) 0.1 18.6 (16.5 – 21.3) 0.7
Heart rate (beats/min) 84 (73 – 91) 0.3 83.8 (74.4 – 92.0) 0.3
Systolic BP (mmHg) 130 (118 – 145) 0.2
MEWS-II 0.4 1.0
MEWS-IV 0.9 1.6b
MEWS-VII 1.3 1.9c
BP = Blood pressure. MEWS = Modified Early Warning Score. 
aPartial score of total MEWS. bCompleted with saturation and systolic blood pressure from concurring nurse 
measurement. cCompleted with oxygen administration, AVPU score and temperature from concurring 
nurse measurement. 
Table 3 Differences in vital signs and calculated Modified Early Warning Score between nurses and patients 
with ViSi Mobile or HealthPatch.
Vital sign Nurse – ViSi Mobile Nurse - HealthPatch
Mean difference ± SD Mean difference ± SD
Saturation (%) 0.94 ± 2.65a -
Respiratory rate (breaths/min) 0.84 ± 3.43a,b -1.94 ± 3.56a,b
Heart rate (beats/min) 0.69 ± 9.27 -1.00 ± 6.18a
BP systolic (mm Hg) 5.42 ± 14.27a -
BP diastolic (mm Hg) -5.57 ± 9.80a -
Temperature (˚C) 2.96 ± 1.13a,b,c 2.76 ± 0.89a,b,c
MEWS II -0.38 ± 0.89a -0.65 ± 1.14a
MEWS IV -0.80 ± 1.64a -0.65 ± 1.14a
MEWS VII -0.80 ± 1.64a -0.65 ± 1.14a
SD = Standard deviation. BP = Blood pressure. MEWS = Modified Early Warnings Scores.
aSignificant one-sample T-test (p < .05). bSignificant linear regression (proportional difference) (p < .05).
cCore temperature vs. skin temperature.
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High MEWS measured by VM and HP in between nurse measurements
Fig. 1 shows the number of extra MEWS measured by VM and HP during non-observed periods 
by nurses: 71 in 14 VM patients and 32 in 7 HP patients. Time between high MEWS measured by 
a device and next regular MEWS measurement by a nurse is depicted in Fig. 2. Delay between 
these measurements ranged from 0 up to 10 h. In 57 of 71 (80%) VM and 30 of 32 (94%) HP 
cases of high MEWS, the consecutive MEWS calculated by nurses was not alarming (MEWS 
< 6). Thirty-four times (48%) with VM and 14 times (44%) with HP, the high MEWS occurred 
between 6 PM–8 AM.
.
Figure 1 Number of extra MEWS measured by ViSi Mobile and HealthPatch during non-observed periods 
by nurses’.
MEWS = Modified Early Warning Score. 
DISCUSSION
Main findings
VM and HP measurements resulted in higher MEWS compared to observations by nurses, 
due to higher median and more variable respiratory rate measurements registered by both 
devices. Over 100 periods of high MEWS, based on continuous device measurements, were 
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found during unobserved periods, half of them during evening and night shifts, indicating 
missed potentially alarming situations. Regarding high MEWS, delay before the next regular 
nurse MEWS measurement was up to 10 h.
Figure 2 Time between high MEWS measured by a device and next regular MEWS measurement by a 
nurse. The X axis depicts the hour of the day; the Y axis depicts the percentage of nurse measurements 
with their delay (see box).
Discrepancies in respiratory rate measurements
Both devices measured higher MEWS values compared to nurses’ measurements due to more 
variable respiratory rate measurements. Differences in median respiratory rate measurements 
between devices and nurses’ measurements have been found in previous studies.19,24 These 
differences are relevant since respiratory rate is an important predictor for severe complications, 
such as sepsis25 and cardiac arrest.26 Despite different methods to measure respiratory rate by 
the devices (e.g. heart rate variability plus accelerometer, versus impedance pneumography), 
the results did not differ between ViSi Mobile and HealthPatch. Respiratory rate seems difficult 
to measure accurately with an inter-observer variation up to 35%.27 Visual chest movements 
should be observed for 1 min to calculate respiratory rate, but is often done for only 15 s, which 
may result in inaccurate measurements.15 In this study, most nurses calculated respiratory rate 
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from a 15 s observation or, in some cases, by just estimating the number of chest movements, 
resulting in a median respiratory rate of 16 breaths/min, with a very small interquartile range 
of 16–18 breaths/min. Inaccurate respiratory rate measurement by nurses potentially lead to 
underestimation of the patients’ clinical condition and can be improved by monitoring patients 
using these devices.
High MEWS measurements
The overall intention is detecting high MEWS earlier than measured by nurses in order to 
improve the timeliness of clinical actions (“true positives”), and do so without unnecessarily 
alarming too many (“false positives”). In this study we did not focus on clinical end-points. 
Many high MEWS were found in patients based on VM or HP without care givers being aware 
of these potentially alarming and unsafe situations. In three patients in this study, nurses 
were alarmed by VM between two regular nurse measurements and warned a physician. 
The patients were later diagnosed with a pneumonia, atrial fibrillation and an anastomotic 
leakage. Almost 50% of all high MEWS calculated on VM and HP measurements occurred 
during evenings and nights, when patients are less attended and more vulnerable to unnoticed 
deterioration.28 High MEWS could also be generated due to physiological noctural changes 
in vital signs, such as lower BP and respiratory rate.29 Potential drawbacks of these ‘false-
positive’ alarms are increased work load and alarm-fatigue.30–32 Algorithms based on machine 
learning can reduce these false alarms.33–35 The effect of these high MEWS on clinical outcome 
and nurses’ workload and alarm fatigue will be further explored in ongoing studies.
Previous research
Cardona-Morrell et al. showed that continuous monitoring of vital signs enabled the detection 
of clinical deterioration in an earlier phase than intermittent measurements.17 The frequency 
of the Rapid Response Teams (RRT) activations increased, and complete and timely vital sign 
documentation improved. The effects on clinical outcome, such as ICU transfers and length 
of stay were less evident. Most studies had small sample sizes and a non-randomized design. 
We randomized patients to reduce the risk of selection bias. In a multicenter study using an 
electronic automated system, an increase in RRT calls, improved survival and a decrease in 
length of stay was demonstrated, and time to complete and record vital signs was reduced.36 
The monitors in this study contained cables reducing patient mobility. Also, monitors could not 
measure respiratory rate, meaning additional nurse measurements, documentation and likely 
underestimation of the EWS.
Limitations
Selection bias may have occurred because one third of all patients refused to participate, 
particularly at the surgical ward and mainly due to negative expectations regarding the 
VM device. Since VM and HP do not measure all vital signs needed to calculate the MEWS, 
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registrations of nurses were used with potential to be inaccurate or missing. It is unknown 
whether all vital signs are necessary for proper clinical judgment. Other EWS, such as the 
standardized early warning score, reduce patient mortality without scoring oxygen administra-
tion.37 Literature shows that HR and respiratory rate change significantly before cardiac 
arrest and mortality, indicating that HP derived data may be enough to predict life threatening 
events.1,2 Both devices measure skin temperature, which is recommended to be converted to 
core temperature for clinical use. The accuracy, however, should be questioned particularly in 
certain disease circumstances such as shock. For this reason we took nurse core temperature 
measurements in the VM and HP calculations of the MEWS. The potential of skin temperature 
for use in prediction of clinical deterioration will be further explored in future studies. VM 
artefacts mostly concerned connectivity failures between VM and its Toughbook due to a 
restricted Wi-Fi connection of 15 meters. Most artefacts were found in patients who were able 
to move around. With routine and scaled up use in a hospital, VM is connected with the hospital 
Wi-Fi system which reduces the number of artefacts and can provide safe transfer between 
wards or during diagnostic procedures, such as a CT scan.
Impact and future research
Earlier identification of clinical deterioration with continuous monitoring may prevent serious 
adverse events and reduce mortality at the general ward and during transport38 and hospital 
costs.6,39 Continuous monitoring may improve patient wellbeing by reducing sleep disturbances 
due to nurse measurements.40-42 Further studies should focus on the clinical and socioeconomic 
outcomes of continuous monitoring with these wearable devices and the reduction of nurse 
workload. The nature and severity of alarming situations have to be explored.
Conclusions
Both VM and HP are promising for continuous vital signs monitoring at the general ward. 
Both measure respiratory rate more accurately than nurses. High MEWS can be detected in 
hospitalized patients around the clock and detect clinical deterioration in unobserved periods 
at an earlier phase. The availability of continuous monitoring may pave the way for adequate 
predicting upcoming clinical deterioration and early interventions.
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SUPPLEMENTAL MATERIAL 
Supplementary file 1 Flowchart of patients’ recruitment and inclusion in the study. Number of Modified 
Early Warning Scores performed by nurses and calculated by ViSi Mobile and HealthPatch. Duration of 
recording data and missing periods with median and ranges. 
MEWS = Modified Early Warning Score. 
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Supplementary file 2 Bland-Altman plot showing respiratory rate.
Supplementary file 2 Bland-Altman plot showing respiratory rate.
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ABSTRACT
Background
Cuffless blood pressure (BP) monitoring devices, based on pulse transit time, are being 
developed as an easy-to-use, more convenient, fast, and relatively cheap alternative to 
conventional BP measuring devices based on cuff occlusion. Thereby they may provide a great 
alternative to BP self-measurement.
Objective
The objective of our study was to evaluate the performance of the first release of the Checkme 
Health Monitor (Viatom Technology), a cuffless BP monitor, in a real-life setting. Furthermore, 
we wanted to investigate whether the posture of the volunteer and the position of the device 
relative to the heart level would influence its outcomes.
Methods
Study volunteers fell into 3 BP ranges: high (>160 mmHg), normal (130–160 mmHg), and 
low (<130 mmHg). All requirements for test environment, observer qualification, volunteer 
recruitment, and BP measurements were met according to the European Society of 
Hypertension International Protocol (ESH-IP) for the validation of BP measurement devices. 
After calibrating the Checkme device, we measured systolic BP with Checkme and a validated, 
oscillometric reference BP monitor (RM). Measurements were performed in randomized order 
both in supine and in sitting position, and with Checkme at and above heart level.
Results
We recruited 52 volunteers, of whom we excluded 15 (12 due to calibration failure with 
Checkme, 3 due to a variety of reasons). The remaining 37 volunteers were divided into low 
(n=14), medium (n=13), and high (n=10) BP ranges. There were 18 men and 19 women, with a 
mean age of 54.1 (SD 14.5) years, and mean recruitment systolic BP of 141.7 (SD 24.7) mmHg. 
BP results obtained by RM and Checkme correlated well. In the supine position, the difference 
between the RM and Checkme was >5 mmHg in 17 of 37 volunteers (46%), of whom 9 of 37 
(24%) had a difference >10 mmHg and 5 of 37 (14%) had a difference >15 mmHg.
Conclusions
BP obtained with Checkme correlated well with RM BP, particularly in the position (supine) 
in which the device was calibrated. These preliminary results are promising for conducting 
further research on cuffless BP measurement in the clinical and outpatient settings.
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INTRODUCTION
Noninvasive blood pressure (BP) monitors based on cuff occlusion are used widely in and 
outside of care facilities. These devices measure systolic (SBP) and diastolic blood pressure 
(DBP) by auscultation1 or oscillometry.2 Disadvantages of these measurements are discomfort 
for the patient because of painful cuff inflation, which may influence BP outcome, and the 
impossibility of continuous or semicontinuous BP monitoring due to the necessity of cuff 
inflation and deflation. Measurements can also vary between users, for example, patients or 
health care workers, due to interindividual differences in use. Although self-measurement of BP 
using noninvasive BP monitors has been shown to produce significantly greater BP reduction 
in patients with hypertension than standard care using clinic-based BP measurements,3 it 
is not common practice because it is time consuming and has high overall costs because of 
expensive equipment and technologies.4
To overcome the disadvantages of BP measurements based on cuff occlusion and to provide 
easy-to-use devices for reliable self-measurement, pocket-sized BP monitoring devices 
without the need of a pressure cuff have been developed and are entering the consumer 
market. The majority of the cuffless devices indirectly measure BP by determining pulse 
transit time, the time interval required for a pressure wave in the arterial tree to travel between 
2 sites (ie, a proximal and a distal point). Pulse transit time is closely related to BP via arterial 
compliance. Not only are these devices able to measure BP quickly and conveniently, but some 
of them also measure other modalities such as pulse rate, oxygenation, respiratory rate, and 
skin temperature. Furthermore, with respect to BP measurement, correct cuff size and cuff 
position are no longer important issues to take into account for obtaining reliable results. 
Altogether, these new cuffless devices could be an excellent alternative to BP measuring 
devices based on cuff occlusion, especially for the purpose of self-measurement.
The Checkme Health Monitor (Viatom Technology, Shenzen, People’s Republic of China) is a 
newly released Conformité Européenne-approved cuffless BP monitoring device. Checkme is 
a IIa category medical device compliant with directive 93/42/European Economic Community. 
As it is aimed at the consumer market, it has been defined as a screening device for primary 
medical checking and not for diagnostic use. However, for its use in a clinical setting, especially 
during monitoring of hypertension treatment, the device’s accuracy in persons with BPs outside 
the normal range has to be determined as well.
To ensure the accuracy of new BP monitoring devices, several protocols have been established, 
such as the European Society of Hypertension International Protocol (ESH-IP) revision 20105 
and protocols of the Association for the Advancement of Medical Instrumentation.6,7 However, 
a single unified protocol for all types of BP monitoring devices is still under development. 
For example, the ESH-IP and Association for the Advancement of Medical Instrumentation 
protocols stipulate the use of a mercury sphygmomanometer as the reference device, whereas 
the International Organization for Standardization protocol allows use of any type of reference 
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manometer, as long as it meets the accuracy requirement. Furthermore, the protocols that 
have been developed for validating noninvasive BP devices are designed primarily for monitors 
that are intrinsically able to give absolute BP readings in a single measurement.
Other category devices, such as Checkme, require patient-specific calibration by a secondary 
measurement method or device before they can give absolute BP readings. A protocol for 
validating such a monitor must include provisions to assess the monitor’s accuracy in tracking 
intrapatient BP changes, relative to the calibrated level, after a patient-specific calibration or 
between calibrations.8
Another issue in daily practice is that oscillometric devices for the noninvasive estimation of BP 
have progressively become the clinical standard because of the need to train staff in determining 
BP by auscultation, cost, and the banning of mercury in many states and countries.2 Therefore, 
it is conceivable that new devices are being evaluated in comparison with the easy-to-use 
automated oscillometric BP devices used in daily practice.
Finally, with classic BP devices, a correct BP can only be determined with the detection point 
(eg, the arm) at heart level. Because of the assumed method of BP measuring with cuffless 
devices, it is still unclear whether the device’s position relative to the heart may influence the 
results of the measurement.
The aim of this study was to evaluate the performance of the first release of the Checkme 
cuffless BP monitor in a real-life patient setting. To this purpose, we compared Checkme BP 
measurements with measurements from a validated oscillometric reference BP monitor (RM) 
according to ESH-IP requirements. Our second aim was to investigate whether the posture of 
the volunteer and the position of the device relative to the heart level would affect outcomes.
METHODS
Checkme
Checkme is a cuffless BP monitoring device, which only determines SBP. It can be used both 
in clinical settings and for self-measurement (Figure 1).
This biometrical device can also measure skin temperature, heart rate, oxygen saturation, 
and 1-lead electrocardiogram, and it can be used as a sleep monitor. Before being able to 
measure SBP with Checkme, a personal profile containing sex, age, weight, and height has 
to be created, and the device has to be calibrated with an RM. Calibration is performed by 
simultaneously measuring SBP with Checkme and with RM and entering the SBP of the RM 
into Checkme after each measurement. After both calibration measurements, the Checkme is 
ready to use. SBP, heart rate, and oxygen saturation can then be measured by putting the right 
index finger beneath the lid on top, the right thumb on the metal plate on front, and the right 
middle finger on the metal plate on the back. Simultaneously, the metal plate on the left side 
of the device has to be pressed against the palm of the left hand (Figure 2, Figure 3).
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Figure 1 Checkme Health Monitor (Viatom Technology) device.
Figure 2 Checkme position during measurement (front).
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Figure 3 Checkme position during measurement (back).
Checkme has to be held still at heart level during a measurement. Performing one measurement 
takes about 20 seconds. To evaluate the result, data can be transferred via Bluetooth to a 
mobile phone or tablet (supported operating systems are iOS or Android) with the Checkme 
app (Figure 4). Details by which the Checkme measures BP have not been described in the 
public domain.
Reference Device
We used the validated Vital Signs Monitor 300 series (Welch Allyn, Skaneateles Falls, NY, USA) 
as RM. This automatic device measures SBP and DBP in the upper arm by oscillometry. The 
normal adult cuff size is suitable for people with an arm circumference of 25.3–34.4 cm. We 
used the small adult cuff when arm circumference was lower (range 20.0–27.0 cm) and the 
large adult cuff when arm circumference was higher (range 40.7–55.0 cm).
Familiarization
Before the validation procedure, we took a multiple series of test measurements using the 
Checkme and RM to familiarize ourselves with the devices. To test the study procedure and 
familiarize ourselves with it, we measured 2 volunteers accordingly. We encountered no 
problems. Experienced technicians of the Radboud University Medical Center maintained and 
calibrated the RM according to the manufacturer’s protocol.
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Figure 4 The Checkme app, showing heart rate (HR), electrocardiogram (ECG), and oxygen saturation 
(SpO2).
Recruitment
We recruited study volunteers from patients who visited the hypertension outpatient services 
of the Radboud University Medical Center Department of Internal Medicine. To cover inclusion 
in all BP categories in this study, we also recruited patients with hypertension admitted to the 
hospital (highest BP range) and healthy employees (lowest BP range). We stopped recruitment 
after obtaining valid measurements of 37 volunteers with baseline BP measurements in the 
required ranges. Exclusion criteria were cardiac arrhythmias, upper-arm circumference 
outside the cuff range, and age <25 years. Information on age, sex, and use of antihypertension 
medication was collected and height, body weight, and arm circumference were measured. All 
volunteers gave written informed consent. The institutional review board gave permission for 
this study (Medical Research Ethics Committee CMO no. 2015-1717).
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Protocol
This study followed the ESH-IP requirements for test environment, observer qualification, 
volunteer recruitment, and BP measurements for the validation of BP measurement devices.5 
Because device readings are digital, 1 researcher performed all measurements. In addition 
to the ESH-IP requirements, we took measurements in different positions to establish the 
influence of posture on device readings.
Each volunteer was seen individually in a quiet, temperature-controlled room. Appropriate cuff 
size (in the case of RM) was chosen based on upper-arm circumference. For each individual 
volunteer, a new profile was created on the Checkme device, with input of sex, date of birth, 
height, and weight. Volunteers were given oral instructions regarding proper use of the 
Checkme device before measurements were taken. 
Baseline measurements were performed with the volunteer in the supine position after resting 
for 10 minutes. BP was measured 3 times at the right upper arm with the RM. The mean of 
the last 2 values was used as the baseline value, on the basis of which volunteers were divided 
into 1 of 3 BP categories: high (SBP >160 mmHg), normal (SBP ≥130 and ≤160 mmHg), or low 
(SBP <130 mmHg) BP, according to ESH-IP, with at least 10 volunteers in each BP category.
Next, we calibrated the Checkme device with the volunteer in the supine position with hands 
resting on the lower abdomen. The last measured baseline SBP with the RM was used as the 
input value for calibration. After calibration, we randomized the order of measurements. In the 
first series of measurements, BP was measured in the supine position with Checkme at heart 
level (arms resting on lower abdomen), Checkme above heart level (arms stretched above the 
head at a 90° angle with the body), and the RM (right upper arm) according to the randomization 
order. After the first series of measurements in the supine position, volunteers were asked to 
sit up. After 5 minutes of rest, the volunteer’s BP was again measured in random order with the 
Checkme at heart level and RM, both in the upright position. All of the above measurements 
were executed 3 times successively. According to ESH-IP, the interval between consecutive 
measurements was between 30 and 60 seconds. Failed measurements were repeated up to a 
maximum of 3 times.
Statistical Analysis
All statistic calculations were performed with IBM SPSS version 20 (IBM Corporation). To 
evaluate the influence of the volunteer’s position on the device readings, we compared the 
means of 3 consecutive measurements with a device in the supine or sitting position by paired 
samples t -test. A difference with P<.05 was considered to be significant.
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RESULTS
We excluded 15 of 52 recruited volunteers: 12 due to repeated BP calibration failures with 
Checkme, 2 because they appeared to have low BP (SBP <130 mmHg) with already sufficient 
data, and 1 who declined to continue after inclusion. None of the volunteers had arrhythmias. 
In <3% of all measurements, BP had to be measured again due to failure during the first 
attempt of both the RM and the Checkme readings.
Study Population
Of the 37 volunteers who completed the study, 14 were in the low range (SBP <130 mmHg), 13 were 
in the medium range (SBP between 130 and 160 mmHg), and 10 were in the high range (SBP >160 
mmHg). Table 1 shows their baseline characteristics. There were 18 men and 19 women with a 
mean age of 54.1 (SD 14.5) years. The mean baseline SBP was 141.7 (SD 24.7) mmHg. For 31 of the 
37 volunteers (84%) we used the normal cuff size of the RM. Due to an arm circumference above 
than normal range, the remaining 6 volunteers (16%) required the large cuff.
Table 1 Study population characteristics.
Characteristics All volunteers (n=37)
Male:female 18:19
Age in years, mean (SD) 54.1 (14.5)
White, n (%) 36 (97)
Black, n (%) 1 (3)
Height in m, mean (SD) 172.2 (7.5)
Weight in kg, mean (SD) 83.3 (18.4)
Use of blood pressure-lowering drugs, n (%) 22 (60)
Normal cuff size, n (%) 31 (84)
Baseline systolic blood pressure in mmHg, mean (SD) 141.7 (24.7)
Feasibility
In 22 of 52 volunteers (42%), calibration with Checkme failed the first time (error message: 
“unstable measure, calibration failed”). We repeated the procedure up to a maximum of 5 
times. In 5 of 52 volunteers (10%), calibration succeeded after the second attempt, in 4 (8%) 
after the third attempt, and in 1 (2%) after the fifth attempt. Calibration continued to fail in 12 
of 52 volunteers (23%), whereupon they were excluded from further measurements. In 2 of 37 
volunteers who completed the study, the SBP measurement could not be determined in the 
upright position.
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Comparing BP Results (Primary Aim)
Table 2 shows the BP results for RM and Checkme. Table 3 shows the proportion of patients 
with differences between RM and Checkme of >5, >10, and >15 mmHg. We constructed Bland-
Altman scatter plots of BP differences between RM and Checkme against the mean BP of 
the RM and Checkme in the supine (Figure 5) and upright positions (Figure 6). BP results 
correlated with the position of Checkme relative to the heart level.
Table 2 Systolic blood pressure measurements (mmHg) taken by the reference monitor and Checkme in 
the supine and upright positions.
Volunteers’ position Meana SD Range (min; max)a
Supine position
Reference monitor 136.6 21.8 84.7 (106.3; 191.0)
CheckMe at heart level 138.4 25.2 94.5 (94.5; 189.0)
CheckMe above heart 130.7b 27.7 101.0 (86.0; 187.0)
Upright position
Reference monitor 139.2 22.3 100.7 (102.3; 203.0)
Checkme at heart level 136.6c 25.9 87.7 (102.3; 190.0)
aThe average or range of 3 consecutive blood pressure measurements. bP<.001 compared with Checkme 
at heart level. cP=.01 compared with Checkme at heart level in the supine position.
Influence of Posture on the Device Readings (Secondary Aim)
Table 2 summarizes the results of the SBP measurements obtained with RM and Checkme in 
the various positions. In the supine position, SBP measured with Checkme above heart level 
was significantly lower than SBP measured supine at heart level. SBP obtained with Checkme 
in the upright position was significantly lower than in the supine position, in which the device 
is just above heart level. Table 3 summarizes differences in SBP readings between RM and 
Checkme in both the supine and upright positions. The SBP measurement with Checkme in 
the upright position was significantly lower than the SBP measurement with Checkme in the 
supine position.
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Table 3 Differences in systolic blood pressure readings between the reference monitor and Checkme in 
various postures and the proportion of volunteers with differences >5, >10, and >15 mmHg between the 
reference monitor and Checkme.
Reading differences Supine at heart level (n=37) Upright at heart level (n=35)
Difference between the devices (mm Hg)
Mean (SD) –1.8 (8.5) 2.6 (12.1)a
Min; max of range –19.3; 18.2 –35.5; 20.3
Degree of difference
>5 mmHg, n (%) 17 (46) 23 (66)
>10 mmHg, n (%) 9 (24) 15 (43)
>15 mmHg, n (%) 5 (14) 6 (17)
aP=.02 compared with measurements in the supine position.
DISCUSSION
The results of this comparative study show that the first version of the Checkme device yields 
BP results that are to a large extend comparable with BPs obtained by a validated oscillometric 
BP monitor. We observed this for a predefined wide range of BP levels under well-controlled 
circumstances. Furthermore, BP results correlated with the position of Checkme relative to 
the heart level. Compared with a reference BP, Checkme recorded a higher BP below heart 
level and a lower BP above heart level. 
Due to the lack of a uniform international protocol that includes provisions to assess 
intrapatient BP changes relative to the calibrated level, it was not possible to conduct a formal 
device validation study. As the Checkme requires patient-specific calibration by a secondary 
measurement device before it can measure absolute BP, we consider such a protocol to be 
necessary.
The strength of this study is that it met all ESH-IP requirements for test environment, observer 
qualification, volunteer recruitment, and BP measurements. Measurements were conducted 
in a quiet, temperature-controlled room and the manufacturer’s guidelines on use of the test 
device were followed. Furthermore, we used a validated RM device and randomized the order 
of measurements with Checkme and RM to eliminate the influence of changes in BP over time 
on the study results.
Checkme is one of the first cuffless devices to be launched, indicating that cuffless BP 
measurement is in its infancy. Notably, Checkme has outgrown its developmental phase. As the 
technique of cuffless devices is continuously being improved, future generations of Checkme 
may be even more suitable for measuring BP in the clinic.
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Figure 5 Bland-Altman plot of the difference in systolic blood pressure readings between the reference 
monitor (RM) and the Checkme Health Monitor (at heart level) in the supine position.
One disadvantage of Checkme is the inability to measure DBP, because DBP can be used 
to calculate pulse pressure and adds to the overall cardiovascular risk profile. Based on the 
underlying method of measuring, a subsequent version of Checkme may expected to have 
this ability. Another issue with the Checkme version used in this study was the inability to 
calibrate the device in a substantial number of volunteers. Repeated attempts to calibrate 
Checkme after warming volunteers’ hands and further instructing them to hold still or change 
their position were not effective in some of them and thus further BP measurements were not 
possible. According to the manufacturer, a new software release has resolved this problem.
Ideally, Checkme is calibrated by taking simultaneous BP measurement with the RM. In this 
study, we calibrated Checkme after baseline measurements with the RM. However, as the time 
interval between taking the 2 measurements was a maximum 2 minutes (depending on the 
number of attempts during calibration), we can assume that BP had not significantly altered. 
Calibration parameter stability over longer periods of time has yet to be established in further
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Figure 6 Bland-Altman plot of the difference in systolic blood pressure readings between the reference 
monitor (RM) and the Checkme Health Monitor (at heart level) in the upright position 
research. After the completion of this study, Viatom updated the Checkme software to reduce 
calibration failures and has provided additional instructions for positioning Checkme against a 
lower limb during the calibration measurements. Therefore, the process of calibration can be 
expected to be more successful in future studies.
Checkme’s BP measuring algorithm has not been made public, probably for commercial reasons. 
Most cuffl ess devices measure BP indirectly by determining pulse transit time, the time interval 
required for a pressure wave in the arterial tree to travel between 2 sites (ie, a proximal and a 
distal point). Pulse transit time is closely related to BP via arterial compliance. For example, if 
arterial BP increases, arterial wall tension will increase. Subsequently, arterial compliance and 
pulse transit time will decrease.9 Most cuffl ess devices calculate pulse transit time by using the 
electrocardiogram as the proximal timing reference and the arterial waveform in an extremity as 
the distal reference.10 Recent research has shown a signifi cant relationship between BP measured 
with pulse transit time and BP measured with conventional devices based on cuff occlusion.11-13
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Differences in BP depending on posture and position of the device suggest that cuffless BP 
measurement by Checkme, and probably in general, is influenced by the position of the device 
relative to heart level. This may suggest an inherent error in Checkme’s algorithm when BP is 
measured in a position other than that indicated by the manufacturer. Therefore, it is important 
that future users of Checkme conduct all measurements in the position stipulated in the user 
manual. Furthermore, we observed 1 outlier (with SBP difference between RM and Checkme 
>40 mmHg), which we could explain.
If Checkme will be able to fulfill formal international validation protocol requirements, which 
include provisions to assess the monitor’s accuracy in tracking intrapatient BP changes relative 
to the calibrated level, after a patient-specific calibration or between calibrations, we expect 
increased use of this device. Especially promising is such devices’ ability to measure BP faster 
and more conveniently than conventional BP monitoring devices based on cuff occlusion. This 
implies not only that BP can be measured more efficiently in the clinic, but also that patients 
can easily self-monitor their BP at home. Because self-measurement of BP has been shown 
to have a positive effect on reducing BP,3 this easy-to-use BP device will probably find a place 
in the management of hypertension. The low costs of cuffless devices relative to cuff occlusion 
devices will also contribute to their implementation in and outside the clinic.
We believe the market of wearable BP sensors will develop in the areas of self-measurement 
and remote monitoring. In this context, device validation may be accelerated if development of 
techniques, calculation, and feedback on the basis of clinical data would take place in an open 
source environment.
CONCLUSION
Checkme SBP correlated well with reference SBP, in particular in the supine position. Although 
we did not perform a formal validation study at this preliminary stage, these preliminary results 
are most promising and warrant further research on cuffless BP measurement in the hospital, 
the clinic, and at home.
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ABSTRACT
Background
Vital sign measurements in hospitalized patients by nurses are time consuming and prone 
to operational errors. The Checkme, a smart all-in-one device capable of measuring vital 
signs, could improve daily patient monitoring by reducing measurement time, inter-observer 
variability, and incorrect inputs in the Electronic Health Record (EHR). We evaluated the 
accuracy of self measurements by patient using the Checkme in comparison with gold standard 
and nurse measurements.
Methods and findings
This prospective comparative study was conducted at the Internal Medicine ward of an academic 
hospital in the Netherlands. Fifty non-critically ill patients were enrolled in the study. Time-
related measurement sessions were conducted on consecutive patients in a randomized order: 
vital sign measurement in duplicate by a well-trained investigator (gold standard), a Checkme 
measurement by the patient, and a routine vital sign measurement by a nurse. In 41 patients 
(82%), initial calibration of the Checkme was successful and results were eligible for analysis. 
In total, 69 sessions were conducted for these 41 patients. The temperature results recorded 
by the patient with the Checkme differed significantly from the gold standard core temperature 
measurements (mean difference -0.7± 0.6). Obtained differences in vital signs and calculated 
Modified Early Warning Score (MEWS) were small and were in range with predefined accepted 
discrepancies.
Conclusions
Patient-calculated MEWS using the Checkme, nurse measurements, and gold standard 
measurements all correlated well, and the small differences observed between modalities 
would not have affected clinical decision making. Using the Checkme, patients in a general 
medical ward setting are able to measure their own vital signs easily and accurately by 
themselves. This could be time saving for nurses and prevent errors due to manually entering 
data in the EHR.
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INTRODUCTION
The Early Warning Score (EWS) was developed in the United Kingdom in 1997.1 The EWS is a 
physiological scoring system that assists caregivers in detecting physiological changes and 
clinical deterioration in hospitalized non-critically ill patients.2,3 Since then, the EWS has been 
modified, which has resulted in the now commonly-used Modified Early Warning Score (MEWS). 
The MEWS includes systolic blood pressure (BP, mmHg), heart rate (HR, beats per minute), 
respiratory rate (RR, breaths per minute), temperature (Celsius), oxygen saturation (SpO2, %), 
amount of administrated oxygen (L/min), and the AVPU (Alert, responsive to Verbal stimulation, 
responsive to Painful stimulation and Unresponsive).4–6 A higher MEWS is associated with more 
ICU admissions and increased mortality.7–9 Generally, the MEWS is determined for each patient 
at least three times per day to provide a general assessment of their clinical condition during 
hospitalization.
Although early warning scoring has been widely adopted and aims to create a safe, controlled 
situation, several issues have been raised about its practicability and efficacy. Measuring vital 
signs is time consuming, and frequently results in incomplete data input.4,10 A complete MEWS 
calculation takes approximately six minutes in total when accounting for measurements with 
several devices, data processing, and calculation of the MEWS. Inter-observer variation in 
measurements may exist, leading to a different MEWS in identical situations.11 Further, results 
of the measurements are frequently entered in the Electronic Health Record (EHR) manually, 
and are therefore prone to mistakes.12,13 Finally, there is often no automatic alarm produced by 
the EHR to trigger a nurse to a higher level of surveillance or to call the Rapid Response Team 
(RRT). This makes MEWS monitoring rather subjective, and dependent on care professionals 
who may react differently to comparable situations.
The Checkme Pro Health Monitor™ (Viatom Technology, Shenzhen, People’s Republic of 
China) is a newly released Conformite´ Européenne (CE)-approved smart all-in-one device, 
which measures four of the five MEWS vital signs in less than 25 seconds (Figure 1) and can 
easily be handled by patients. Given its capabilities, the Checkme could represent a significant 
improvement in daily patient monitoring given its potential to reduce measurement time, inter-
observer variability, and incorrect EHR inputs, without increasing costs. Moreover, the device 
enables patients to measure vital signs themselves, providing them greater insight into their 
health situation and increases patient empowerment in an in-hospital setting. Recent research 
showed promising results for BP measurements using the Checkme, however, evidence for its 
performance for other vital signs is limited.14
In this prospective comparative study, we evaluated the Checkme for accuracy in assessing the 
individual vital signs used to calculate the MEWS in hospitalized non-critically ill patients on an 
Internal Medicine ward. Vital signs and calculated MEWS based on patient-operated Checkme 
measurements were compared with vital signs and calculated MEWS obtained by nurses and 
by a well-trained investigator (gold standard).
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METHODS
Setting and participants
Participants in this study were consecutive patients admitted to the General Internal Medicine 
ward of the Radboud University Medical Centre between March 2016 and May 2016. Patients 
were included if they were in a stable clinical condition, aged 18–75 years, mentally competent 
and able to understand instructions, and able to provide written informed consent. After 
reviewing the study protocol, the institutional review board waived the need for formal review 
and approval (local Ethical Committee Number 2016–2519).
The Checkme
The study device, the Checkme, measures one or two lead ECG, body temperature, heart rate 
(HR), SpO2 and systolic blood pressure (BP) in a cuffless manner based on pulse transit time. 
The device also includes a pedometer and a sleep monitor. The Checkme has a “Daily Check” 
measuring mode, which measures all vital signs in less than 25 seconds. Before being able 
to conduct measurements with Checkme, a personal profile inclusive of gender, age, weight, 
and height is created on the device, and the systolic BP is calibrated once. This calibration is 
performed by measuring systolic BP simultaneously with a reference device, and by entering 
the reference systolic BP into Checkme. Systolic BP, HR, and SpO2 can then be measured by 
placing the right index finger beneath the lid on top of the device, the right thumb on the metal 
plate in the front, and the right middle finger on the metal plate on the back. Simultaneously, 
the metal plate on the left side of the device is then pressed against the palm of the left hand 
(Figure 1). Temperature can be measured separately via a sensor pressed against the forehead. 
The Checkme is not able to measure diastolic BP, RR or AVPU. To evaluate the results, data 
can be transferred via Bluetooth to a mobile phone or iOS/Android tablet with the Checkme 
app.
Study procedures
After written informed consent was obtained, four measurement sessions were conducted in 
randomized order: a gold standard measurement in duplicate by a well-trained investigator, a 
measurement with the Checkme by the patient, and a regular vital sign measurement taken 
by a nurse. The gold standard measurements were performed to check for intra-observer 
variability. To obtain an accurate MEWS calculation from mixed data input, the investigator 
measurements were always carried out shortly before or after the Checkme measurement. 
The measurement sessions were conducted in the morning (6:30 AM), afternoon (2:00 PM) or 
evening (8:00 PM), always as close as possible to a regular nurse measurement, within a maximal 
time window of 30 minutes for all measurements. All measurements were done in the supine 
position in bed with patients in stable clinical condition. Patients were not allowed to leave their 
beds during the measurements. The investigator was blinded to the nurse’s measurement 
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Figure 1 Viatom Checkme held in measuring position.
results to avoid confounding. Measured vital signs were HR, systolic BP, temperature, RR, 
SpO2, oxygen administration, and AVPU. A MEWS calculation was then performed according to 
established protocol. Gold standard and nurse vital signs were measured using an automated 
BP measuring device (Dinamap, GE Healthcare, Germany), a pulse oximeter (Dinamap, GE 
Healthcare, Germany) and a tympanic thermometer (Genius 2, Medtronic, USA). The BP 
calibration of the Checkme was conducted as a separate measurement in the morning, using 
the same Dinamap blood pressure measuring device. Following a calibration attempt, the device 
would display either “calibration succeed”, “calibration failed”, or “unstable measurement”. If 
the calibration failed or was unstable on three consecutive attempts, the patient was excluded 
from the study. Because the RR and AVPU cannot be measured with the Checkme, the values 
of the repeated investigator’s measurements were used for MEWS calculation in conjunction 
with Checkme vital signs.
Methods of analysis
Statistical analysis was performed using Statistical Package for the Social Sciences (IBM SPSS 
Statistics version 20.0, SPSS inc., Chicago, Illinois, USA). The vital signs were described using 
mean with standard deviation (SD). Bland-Altman plots were created to assess intra-observer 
variability and differences in vital signs and calculated MEWS measured by the investigator, 
529563-L-bw-Weenk
Processed on: 11-3-2019 PDF page: 116
Chapter 6
116
the nurse, and the patient (Checkme). In the plot, every data point represents the difference 
between two measurement methods. The solid line represents the mean difference, and the 
dotted lines represent the limits of agreement (1.96 SD). A one-sample t-test was performed 
on the difference between two measuring methods. A p-value < 0.05 was considered to be 
significant. For each vital sign, the clinically acceptable discrepancy between the three 
methods of measurements was predetermined. Clinically relevant differences were considered 
as follows: 5+ beats/min (HR); 5+ mm Hg (systolic BP); 0.5+˚C (temperature); 2+ breaths/min 
(RR); 2+ % SpO2. A difference in MEWS score of 1 point or more between different measurement 
sets was additionally considered to be clinically relevant.
RESULTS
Study population
Fifty consecutive patients were included in the study for at least one set of vital sign 
measurements and MEWS calculations. Patients’ demographics and results of the Checkme 
calibrations are depicted in Table 1. In 41 of 50 patients (82%), initial calibration of the 
Checkme was successful and results were eligible for analysis. Two sets of measurements 
were performed in the morning (6:30 AM), 49 sets in the afternoon (2:00 PM) and 18 sets in 
the evening (8:00 PM). This resulted in a total of 69 measurement sets in 41 patients. Nine 
measurements performed by nurses (13.0%) were not complete (vital sign missing or not 
correctly entered in the EHR).
Table 1 Demographics of study population and results of calibration procedure.
Total Men Women
Gender (%) 50 (100.0) 31 (62.0) 19 (38.0)
Age (years) 56.7 ± 15.8 58.7 ± 14.0 53.4 ± 17.8
Weight (kg) 79.5 ± 18.8 84.0 ± 16.5 72.2 ± 20.5
Length (cm) 171.9 ± 26.7 180.0 ± 7.1 158.7 ± 39.5
Calibration of Checkme
Successful calibration (%) 41 (82.0) 25 (80.6) 16 (84.2)
Number of successful attempts (%) 1 30 (73.2) 18 (72.0) 12 (75.0)
2 7 (17.1) 6 (24.0) 1 (6.2)
3 4 (9.7) 1 (4.0) 3 (18.8)
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General results
Patient measurements using the Checkme took approximately 30 seconds per patient, and 
an additional 6–7 minutes were needed to calibrate the device. A successful first attempt BP 
calibration was obtained in 30 (73.2%) patients (Table 1). Repeated calibration attempts were 
needed in the other patients, and calibration eventually failed in 9 patients. Most failures were 
presumed to be due to shivering or cold hands. Calibration failure was not found to correlate 
with patient gender, age, or weight.
Intra-observer variability
Table 2 depicts the vital signs and MEWS obtained via the well-trained investigator (gold 
standard) and the mean values of these measures in duplicate. Intra-observer variability was 
found to be significant for temperature measurements; measurements for other parameters 
were comparable for both attempts. Depending on the vital sign, 67.7 to 98.5% of the obtained 
results were less than the predefined clinically relevant differences. Sixty-two (91.1%) calculated 
MEWS measurements fell within the predefined limits of agreement.
Differences in vital signs
Table 2 depicts the results of vital signs measured by nurses and patients (Checkme) in 
comparison with the gold standard. Data were equally distributed, and all mean differences 
were less the predefined clinically relevant limits for acceptable differences. Compared with 
the gold standard, the vital sign measurements recorded by the nurse showed a slightly but 
significantly higher temperature. Measurements of RR were additionally found to be somewhat 
discordant, with 14 (24.1%) of all measurements differing by 3–4 breaths/min and 17 (29.3%) of 
all measurements differing more than 5 breaths/min. Figure 2 shows the Bland-Altman plots 
of nurse and gold standard measurements.
Figure 3 shows the Bland-Altman plots for Checkme in comparison with the gold standard. The 
results recorded by the Checkme for HR and SpO2 were largely in line with the gold standard 
measurements. Checkme temperature readings did differ significantly from the gold standard 
for temperature, with 17 (25.7%) of all measurements differing more than 1.0 ˚C from the 
gold standard. Further, for systolic BP, 17 (25.0%) of all measurements differed by more than 
15 mmHg. Mean differences for all vital signs were, however, within the predefined limits of 
agreement.
Differences in calculated MEWS
MEWS calculations on the basis of vital signs obtained by the gold standard measurements 
differed significantly from the MEWS based on nurse measurements, but were comparable to 
the MEWS derived from Checkme measurements. Compared with gold standard MEWS, the 
nurses’ MEWS differed by two points or more in 15 (25.8%) cases. By contrast, in 10 (15.4%) 
cases MEWS differed two points or more between gold standard MEWS and Checkme. Most
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Figure 2 Bland-Altman plots of nurse and gold standard results.
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MEWS calculations differed by 0–1 points between two methods. Mean differences of 
calculated MEWS were in range with the predefined accepted discrepancies. Three of 69 MEWS 
calculations by gold standard and nurses fell outside the limits of agreement (Figure 2). Bland-
Altman plots are shown in Figure 3.
Other
Patients reported their experiences about the use of the Checkme. In general, they found the 
device to be user-friendly, and described being able to measure their own vital signs with ease. 
Some elderly patients experienced difficulty holding the device firmly during measurement.
DISCUSSION
For the first time, the Checkme all-in-one device was tested in clinical practice in a significant 
number of hospitalized non-critically ill Internal Medicine patients to determine 4 of 5 vital 
signs necessary for early warning scoring. This study shows that after initial calibration of the 
Checkme to measure systolic BP, patients were able to easily and reliably measure their own 
vital signs. The results obtained by the Checkme were, to a large extent, comparable to the 
measurements obtained by nurses and by those of a gold-standard well-trained investigator. 
Measurement differences had a minimal effect on the aggregated MEWS.
Intra-observer variability between investigator measurements was low, supporting the use of 
this measurement as a “gold standard”. The differences in measured temperature between 
investigator measurements and between investigators’ and nurses’ measurements can be 
explained by the measuring error of 0.1˚C of the tympanic thermometer used.15 Significant 
differences for temperature were found between Checkme and the tympanic thermometer. 
Tympanic thermometers are often used in hospitalized patients, although the accuracy of 
tympanic temperature measurements for core body temperature measurement in the literature 
is mixed.16–18 Checkme is able to measure infrared body temperature on the forehead and was 
recently validated.19 A recent review by Geijer et al. showed that these methods of infrared 
body temperature measurement are not as accurate as invasive methods, but are comparable 
to tympanic thermometers.20 Although absolute Checkme temperature measurements will 
be lower than core temperature measurements, the device is able to accurately monitor 
temperature changes in patients, which is often the primary finding of clinical interest.16
Although more extensive differences were found for systolic BP measurements between gold 
standard and Checkme, these were not statistically significant. Checkme is able to measure BP 
without cuffs using pulse transit time, which is closely related to BP via cuff based methods and 
arterial compliance.21–23 Although a validation study has yet to be published, BP measurement 
by the Checkme has been shown to be reliable and accurate in an earlier study.14 Additionally, 
BP differences in our study had a minimal effect on differences in calculated MEWS, without 
529563-L-bw-Weenk
Processed on: 11-3-2019 PDF page: 121
Smart all-in-one device to measure vital signs
121
6
Figure 3 Bland-Altman plots of Checkme and gold standard results.
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important clinical consequences. Although the measurements were randomized, the gold 
standard and Checkme measurements were always undertaken directly after one another, 
whereas the nurse measurements sometimes had a time difference of 5 to 30 minutes 
before or after the other measurements. This could explain the differences between nurses’ 
and gold standard RR measurements. Inaccurate RR measurements by nurses and limited 
reproducibility as evidenced by significant inter-observer variability could further explain this 
discrepancy.24 
The calculated MEWS derived from Checkme values corresponded more closely with the gold 
standard MEWS than did the MEWS calculated by nurses’ measurements. The predominance of 
MEWS calculations by Checkme differed by one point or less from MEWS calculations obtained 
via the gold standard. Such differences had no important consequences for nurses’ actions, 
such as increased frequency of vital sign measurements, additional diagnostic procedures, or 
rapid response team calls.
An additional important underlying finding in this study is that conscious and non-critically 
ill patients were able to measure their own vital signs easily and in an accurate and reliable 
way when compared to nurses. Furthermore, the Checkme measurements by the patient took 
less time after BP was calibrated successfully, and patient comfort was enhanced by avoiding 
the need for cuff BP measurements. It is unknown whether the Checkme data would be more 
accurate if the nurse had performed the measurements using the device, as this was not the 
focus of our study.
There may be additional benefits to patient self-monitoring of vital signs. For example, in the 
home setting, patient self monitoring of BP has been shown to have a positive effect on BP 
regulation,25 and improves patients’ insight into their own health status and recovery.26 Early 
experience with a device continuously monitoring vital signs resulted in increased interest in 
health data by patients on the internal and surgical ward (unpublished own data).
One drawback of the Checkme is the troublesome calibration of the BP measurement in 
approximately one-fifth of our patients. Our research group evaluated the performance of the 
BP monitor of the Checkme and also studied whether the position of the device influenced the 
outcome.14 Twenty-five percent of the participants experienced difficulties during calibration 
in supine position. This percentage is higher, by contrast, than the 18 percent of patients in 
our study in whom most calibration difficulties were presumed to be due to shivering or cold 
hands. The troublesome calibration could limit home monitoring of vital signs by patients. 
It is expected that the next version of the Checkme will have a more simplified calibration 
procedure. Until then, the calibration procedure could be performed by trained physicians or 
nurses at the outpatient clinic, while the patient receives instructions about the use of the 
Checkme. Also, a trained physician or nurse will be availabe for patients in case of technical 
problems using the Checkme at home.
A strength of this study is the comparison of three measurement methods by an investigator, a 
nurse, and a patient, with blinding for the results of measurements. It is additionally important 
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that we measured admitted patients in a clinical setting instead of healthy participants in a 
controlled setting. Time between gold standard and nurse measurements was mostly less 
than 10 minutes but could be 30 minutes. We cannot rule out slight changes in vital functions 
in a period of 30 minutes, however, due to the random order, the rigid protocol of nurse 
measurements in a patient group that is stable on the ward, comparison and interpretation 
of results seems justified. A limitation is that the Checkme is not able to measure diastolic 
BP and RR; RR is frequently used to inform clinical judgement in hospitalized patients.27 
Importantly, the next version of the Checkme will have the ability to measure RR. MEWS also 
includes oxygen administration and AVPU, which cannot be measured by the Checkme. Other 
EWS, such as the standardised early warning score, do not include oxygen admission but have 
still been shown to decrease inpatient mortality.28 It could be possible that not all vital signs 
have a predictive value for clinical deterioration in different patient groups. Finally, critically 
ill or confused patients are not able to measure their own vital signs using the Checkme. 
Although the benefit of patients measuring their own vital signs is not attainable in this patient 
population, vital signs could still be collected reliably by nurses using the Checkme.
Future clinical research should focus on the use of Checkme and similar devices to predict 
clinical deterioration in various clinical settings, as well as patients’ and caregivers’ experiences 
using all-in-one devices. Furthermore, more frequent measurements and connections to 
hospital’s EHR, including automated alarming, may further increase patient safety during 
admission through earlier detection of clinical deterioration. The Checkme is suitable for 
home monitoring and is able to send all data to secured platforms via telemonitoring. Vital 
sign data could be used to optimize a patient’s home health or to identify underlying diseases 
such as atrial fibrillation prior to hospitalization and surgical procedures. It is expected that 
prehabilitated patients recover faster and with a lower complication rate postoperatively.29 
Cardiac patients could use the Checkme at home for 24-hour ECG registration and analysis, 
benefitting from a more comfortable method of monitoring than current holter monitors as 
well as from enhanced insight into their own health data.
In summary, our study demonstrates that patients in a general medical ward setting are able 
to measure their own vital signs easily and accurately by themselves, with comparable or even 
potentially superior accuracy to current nurse measurements. This could be time saving for 
nurses and prevent errors due to manually entering data in the EHR. While the rate of BP 
calibration failures limits Checkme applicability in certain patients at this time, it is anticipated 
that forthcoming versions of this device will address this shortcoming.
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ABSTRACT
Background
Stress may negatively affect surgeons’ performance during surgical procedures, jeopardizing 
patient safety. For measuring stress, complex methods are used that cannot record stress real 
time. This study reports stress measurements in surgeons and residents using a novel patch 
sensor to identify activities and risk factors of stress.
Methods
In this explorative study, surgeons and residents wore the HealthPatch™ during all daily 
activities for 2-3 days. The patch recorded heart rate variability (HRV), and real time stress 
percentage using a validated algorithm of heart rate (HR) and HRV. The patch was compared 
with self perceived stress reporting using STAI.
Results
A significant increase in HRV and stress percentage was shown in twenty surgeons and 
residents during surgery in comparison with other activities. Consultants showed lower stress 
levels while operating compared to fellows and residents. Stress according to the patch did not 
correlate with STAI outcome.
Conclusions
Continuous stress monitoring using a wearable sensor patch reveals relevant data on actual 
stress of surgeons and residents. Stress was highest performing an operation, particularly in 
fellows and residents.
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INTRODUCTION
Surgery is a stressful profession.1 Long and continuous working hours, high workload, dealing 
with life and death,1 and technically challenging procedures2 are common contributors to stress 
in surgeons and surgical residents. Chronic stress can lead to relational issues, depression, 
and burnout,3-5 and also increases the risk of cardiovascular disease and decreases life 
expectancy.6-9
Surgeons and residents spend a large part of their time in the operating room. Stress can 
both positively and negatively affect surgeon’s performance in the operating room. While 
moderate levels of stress are necessary to improve alertness, focus, efficiency of action 
and thus overall performance (‘good stress’),10 excessive and long lasting stress is known to 
compromise technical11-13 and non-technical skills (‘bad stress’).13 During surgical procedures, 
excessive levels of stress are mainly caused by technical problems, complexity of the 
procedure, equipment failures, patient complications, interruptions, and high workload.10,14,15 
During laparoscopic procedures, stress is associated with a prolonged operation time,11,12 
poorer motion efficiency, and an increased number of errors.12,16 Excessive levels of stress also 
impair non-technical skills such as communication,10,17,18 teamwork, judgment, and decision 
making.10,17 Loss of these abilities is associated with undesirable events in the operating room 
and could compromise patient safety.13-15,18-22
Research of surgical stress has been focused on the operating room environment and stress 
has rarely been studied during other activities.23,24 However, ward rounds and seeing patients 
in the Emergency Room, the Intensive Care Unit and outpatient clinic may also elicit stress, of 
which the consequences for the quality of work are unknown.
Heart rate (HR), heart rate variability (HRV), skin conductance, eye blinks, and salivary cortisol13 
are objective markers for stress response. HRV in particular has shown to be a reliable and 
more time related measure for stress than the other markers.25 Several studies showed 
changes in HRV recordings in surgeons during surgical procedures, indicating an increase in 
intra-operative stress.24,26-31 Qualitative measurement of stress is commonly by self-reporting 
questionnaires, such as the State Trait Anxiety Inventory (STAI).32 Arora et al.33 developed a 
method to measure surgeons’ stress during surgical procedures using the so-called Imperial 
Stress Assessment Tool (ISAT). By combining heart rate, salivary cortisol and STAI data, they 
were able to measure intraoperative stress in a reliable and valid manner. Drawbacks of this 
tool are the complexity, the time consuming and expensive cortisol analyses, and the inability 
to obtain real-time stress levels and for a longer period.
Recently, wearable sensors became available for use in healthcare, which can continuously 
measure vital signs such as HR in an easy and reliable way. The HealthPatch™ (Vital Connect, 
Campbell, CA, USA) is a small, lightweight and comfortable patch, which is attached to the 
chest. The patch is unique in measuring stress continuously and depicting stress real time, 
using a validated algorithm that computes stress as a combination of HRV and HR.34,35 Because 
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of these features the patch has potential to be used in training situations and to assess chronic 
stress.
An exploratory study was conducted determining the value of the patch in continuously measuring 
stress levels in surgeons and surgical residents during all work activities in comparison to usual 
self perceived stress scoring. Important objective was to evaluate to what extent demographic 
and surgical factors, surgical experience level in particular, affect this stress.
METHODS
Participants
Consultants, fellows and residents were recruited from the surgical department of the 
Radboud university medical center in the Netherlands between July 2014 and December 2014. 
A sample size calculation was not deemed necessary because of the exploratory nature of this 
study. Demographics including gender, age, level of surgical experience and concurrent use 
of medication affecting heart rate were noted. Participants gave verbal consent after being 
informed about the study and the anonymous reporting of data. After reviewing the study 
protocol, the institutional review board waived the need for formal review and approval (2014-
1603). 
Patch details
The HealthPatch™ is a flexible self-adhesive patch containing two ECG electrodes and a battery 
(Figure 1). The patch is validated to measure nine items: single-lead ECG, HR, HRV, stress level 
in percentage, respiratory rate, skin temperature, body posture, activity and steps. Patch data 
are streamed to a smart phone via Bluetooth, from where they are transmitted to a secured 
online cloud for storage. Data can be downloaded from the individual accounts for analysis.
Procedure
Participants wore the patch for at least 48 h. In the morning of the first day, the patch was 
attached to the participant’s chest and a connection was established between the patch and a 
smart phone via Bluetooth. Baseline patch data and STAI score were collected during 15 min 
of rest in which participants were instructed to sit comfortably, not performing any physical 
activity, not reading or speaking. Thereafter, data were continuously collected during all daily 
work activities for the next 48-72 h. Participants filled out the STAI before and immediately after 
each surgical procedure, not before and after other activities. This was decided because the 
other daily activities are more heterogeneous and more frequent e.g. administrative activity. 
All participants kept a personal logbook in which they documented the type and time of daily 
activities and also physical activity (e.g. running, taking stairs). At the end of each working 
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day one researcher (MW) debriefed participants with help of the personal logbook. Technical 
failures and side effects of the HealthPatch were documented.
Figure 1 HealthPatch™.
Stress measurements
HRV
The smart patch measures HRV, which is defined as the variation in time interval between 
heart beats (R-R interval). The R-R interval is the time between the peaks of two consecutive 
QRS complexes as recorded by the 125 Hz ECG.36 According to the recommendations of the 
Task Force of the European Society of Cardiology and the North American Society of Pacing and 
Electrophysiology,37 subsequent intervals of five minutes were used for automatic calculation 
of the HRV by the patch. This was done by using time domain and frequency domain analyses. 
For time domain, the standard deviation of the interval between two heart beats (SDNN) and 
square root of the mean R-R interval (RMSSD) were used as parameters reflecting HRV. 
Low SDNN or RMSSD indicate stress.38 In the frequency domain, Fourier transformation 
was used by the patch to calculate the power spectral density. Three main spectral densities 
were distinguished: the very low frequency (VLF) component (0-0.04 Hz), the low frequency 
(LF) component (0.04-0.15 Hz) and the high frequency (HF) component (0.15-0.40 Hz). LF 
and HF represent two branches of the autonomic nervous system; LF is expected to be a 
marker of sympathetic modulation with some parasympathetic act and HF is a marker of 
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vagal modulation.39,40 Stress is accompanied by an increase of sympathetic activity, resulting 
in an increase in LF and a decrease in HF.38,40 The LF/HF ratio was calculated separately by a 
researcher to isolate sympathetic tone more precisely.
Real time stress percentage
The patch shows stress real time every four seconds.34 This stress depicts the result of an 
algorithm that uses HR and SDNN: Stress (%) = HR + α * SDNN.34 This stress algorithm was 
validated and has shown to be sensitive for acute changes in psychological stress.35 When 
stress occurs, HR will increase and SDNN will decrease. According to the manufacturer α is 
usually a negative number. The stress percentage is calibrated to the individual baseline HR. 
This is done by mapping stress to a cumulative distributive function (Gaussian CDF), ranging 
between 0 and 1 and multiplied by 100. The stress shown is also adapted to the personal range 
of daily stress by adjusting the Gaussian CDF to new stress data. The lowest stress level is 
‘0’ and highest stress level is ‘100’. The patch stops measuring the stress percentage when 
physical activity e.g. walking stairs is undertaken. Thus, only mental stress is recorded by the 
stress percentage.
Stress perception
For stress perception, the short version of the STAI was used (Table 1).41 This validated test 
consists of six items on a four-point scale and measures emotional, cognitive and physical 
stress. The STAI takes about 2 min to complete. Total STAI scores range from 6 to 24, whereby 
higher scores indicate an increase in perceived stress.
Table 1 State trait anxiety inventory.
Not at all Some-what Moderately so Very much
I feel calm 1 2 3 4
I feel tense 1 2 3 4
I feel upset 1 2 3 4
I am relaxed 1 2 3 4
I am content 1 2 3 4
I am worried 1 2 3 4
   
Data analysis
Participants were divided into groups according to gender and level of experience; consultants 
(two or more years of independent practice), fellows (surgeons with less than two years of 
independent practice), senior residents (postgraduate year (PGY) 5 or 6), and junior residents 
(PGY 4 or less). For analysis fellows and senior residents were grouped together. Daily activities 
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of participants were divided in baseline, surgical procedures, and non surgical activities (ward 
visits, outpatient clinic, and administrative work). Time with no clinical activities according to 
the personal logbook was excluded from further analysis. All surgical procedures performed 
by the participant during the day or evening were included. Surgical procedures were divided 
into short (<2 h) and long procedures (2 h) as a proxy for complexity of the operation and 
hypothetically a difference in stress. Only elective surgical procedures were included. All 
baseline, outpatient and ward activities were included in the analysis. For administrative 
work activities one representative period per participant was selected based on the logbook. 
Data were downloaded in *.CSV files (MS Excel 2007). Raw data were inspected for artifacts 
and further analyzed in SPSS version 20.0 (SPSS, Inc, Chicago, IL). A surgical procedure was 
defined as stressful when the postoperative STAI score was at least 1 point higher than the 
preoperative STAI score.33
Statistical analysis
All statistical data analyses were performed using MS Excel and SPSS. Descriptive statistics are 
presented as mean with standard deviation (SD) or median with range, depending on skewness 
of data distribution. To test for skewness, the Shapiro-Wilk test was used. Gender and duration 
of operation were compared using the Independent students’ t-test or Mann-Whitney test for 
nonnormally distributed data. Statistical significance between the different activities, between 
levels of experience and STAI scores was calculated using the ANOVA or Kruskal Wallis test. 
Stressful surgical procedures according to an increase in STAI scores were compared with 
non-stressful procedures using the independent students’ t-test or Mann Whitney U test. 
Pearson correlations were used to test for relationships between delta STAI scores and HRV 
and stress percentage. A p value less than 0.05 was considered significant.
RESULTS
Five consultants, seven fellows and senior residents, and eight junior residents (11 men and 
9 women) participated. The mean age (±SD) of the consultants, fellows and senior residents, 
and junior residents were respectively 46.20 (±7.16) years, 35.43 (±4.44) years, 32.25 (±1.83) 
years. The mean (±SD) years of experience at consultant level was 11.80 (±6.91) years. At the 
time of data collection, one fellow and one junior resident were pregnant for six weeks. One 
male fellow used beta-blockers. In all participants, data were collected during baseline and 
administrative work. Measurements involved sixty-three elective surgical procedures, 22 long 
and 41 short procedures. Data of eight participants were collected at the outpatient clinic and 
data of seven participants when at the surgical ward.
In two participants data was missing due to connection failures. In one participant two hours 
were missing during a surgical procedure, in the other participant four hours were missing
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during ward visits and administration. In two other participants, the patch lost complete skin 
contact after two days resulting in data interruptions on the third day. In two other participants, 
measurements were stopped after two days because of skin irritation. In 16 participants, 
baseline STAI scores were collected. In 42 of the 63 surgical procedures, STAI was completely 
filled in before and after the operation. In 21 procedures participants indicated time shortage 
completing the STAI preparing the next operation.
Stress measurement outcomes
A 40% decrease in SDNN, a 40% decrease in RMSSD, a 64% increase in the LF/HF ratio 
and a 300% increase in stress percentage were found during surgery in comparison with 
baseline, indicating increased stress (Table 2). SDNN and RMSSD were decreased and stress 
percentage increased during surgery in comparison with non-surgical activities (Figure 2). 
Stress measurement outcomes of non-operative activities did not differ between each other 
or from baseline.
Figure 2 Mean stress percentage and SDNN with 95% confidence intervals between activities. *p < 0.001.
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Demographic and surgical factors
Baseline stress measurements outcomes were comparable between men and women (Table 3). 
SDNN and RMSSD were significantly lower in women compared to men during surgery, also 
when excluding the two pregnant females and the male using betablockers. SDNN, RMSSD, LF/
HF ratio, and stress percentage were comparable between long and short surgical procedures 
(50.58 ± 14.18 vs. 51.23 ± 10.97, p = 0.250; 25.94 (14.53-54.21) vs. 23.46 (13.14-51.70), p = 0.697; 
6.33 ± 3.38 vs. 6.10 ± 2.89, p = 0.526; 63.43 ± 23.82 vs. 59.34 ± 24.58, p = 0.451, respectively). 
During surgery, fellows and senior residents had higher stress percentages and lower SDNN 
and RMSSD scores than consultants (Table 4; Figure 3). Lower RMSSD scores were also found 
in junior residents. These results indicate higher stress during surgery by less experienced 
participants. Three examples of the stress course of a day of operations and of outpatient clinic 
activities combined with debriefing data are given in Figure 4.
Stress perception
Baseline STAI score was higher in men than in women (9.67 ± 1.66 and 6.70 ± 0.95; p = 0.001). 
Levels of experience did not affect baseline STAI score. Significant difference was found 
between baseline STAI scores and preoperative STAI scores (8.38 ± 2.03 vs. 10.12 ± 2.85; p 
= 0.043). Fifteen of the 42 surgical procedures with complete STAI data were identified as 
stressful. Gender or level of experience did not differ between perceived stressful and non-
stressful procedures. SDNN, RMSSD, LF/HF ratio and stress percentage did not differ between 
stressful and nonstressful procedures (48.05 ± 7.09 vs. 51.47 ± 11.86, p = 0.250; 25.34 (16.19-
37.79) vs. 21.00 (13.14-54.21); p = 0.705; 6.13 ± 3.37 vs. 7.08 ± 3.32, p = 0.386; and 61.00 ± 22.93 
vs. 61.98 ± 24.63, p = 0.898, respectively). Delta STAI scores did not correlate with SDNN (r = 
-0.212, p = 0.178), RMSSD (r = 0.022, p = 0.892), LF/HF ratio (r= 0.033, p = 0.835) and stress 
percentage (r = -0.046, p=0.771). 
Table 3 HR, HRV and stress percentage between men and women
Baseline Surgery
Men Women Men Women
Heart rate (bpm) – 
median (min-max)
68.57 
(48.65-84.69)
70.61 
(59.50-75.46)
86.18 
(62.32-106.42)a
94.73 
(68.98-120.38)a
SDNN (ms) – mean ± SD 87.94 ± 30.31 72.57 ± 23.41 54.69 ± 11.66b 46.67 ±11.26b
RMSSD (ms) – median 
(min-max)
47.98 
(22.00-131.70)
31.29 
(22.57-77.78)
27.75 
(16.19-54.21)c
21.00 
(13.14-42.69)c
LF/HF ratio – mean  ± SD 3.95 ± 2.76 4.00 ± 2.31 6.22 ± 3.16 6.13 ± 2.96
Stress (%) – mean ± SD 16.63 ± 12.25 24.19 ± 14.45 55.35 ± 20.56 67.12 ± 26.86
SDNN = standard deviation of the R-R intervals; RMSSD = square root of the mean R-R interval; LF = low 
frequency; HF = high frequency. ap=0.050. bp=0.007. cp=0.001.
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DISCUSSION
Continuous stress monitoring in surgeons and surgical residents using a new, small and light 
weighted, wearable sensor patch reveals relevant and almost complete data on stress levels 
of surgeons and residents during their workday. Performing an operation was more stressful 
than other daily activities, particularly for fellows and residents, and based on different stress 
calculations. The patch did not interfere with the activities and was well tolerated by most 
participants, and measured actual time-related stress levels differences during real life 
situations, whereas a common subjective stress evaluation (STAI) did not find any difference.
Table 4 Recordings during surgical procedures; divided by level of experience
Consultants (n=5) Fellows and senior 
residents (n=7)
Junior residents (n=8)
Heart rate (bpm) – median (min-max) 75.00
(62.32-97.17)a, e
93.53 
(71.18-120.38)a
88.98 
(71.54-107.10)e
SDNN (ms) – mean ± SD 59.47 ± 13.82b 48.05 ± 10.38b 50.36 ± 11.68
RMSSD (ms) – median (min-max) 31.55 
(22.75-38.27)c, f
20.55 
(13.14-54.21)c
22.54 
(13.69-51.70)f
LF/HF ratio – mean ± SD 5.60 ± 1.61 6.59 ± 3.41 6.02 ± 3.16
Stress (%) – mean ± SD 42.76 ± 22.76d 70.56 ± 18.09d 58.60 ± 25.90
SDNN = standard deviation of the R-R intervals; RMSSD = square root of the mean R-R interval; LF = low 
frequency; HF = high frequency. aConsultants versus Fellows and senior residents, p=0.001. bConsultants 
versus Fellows and senior residents, p=0.024. cConsultants versus Fellows and senior residents, p=0.018. 
dConsultants versus Fellows and senior residents, p=0.003. eConsultants versus Junior residents, p=0.002. 
fConsultants versus Junior residents, p=0.036. 
We used various calculations for determining stress levels based on heart rate and heart 
rate variability data and the real time depicted stress percentage. Stress percentage results 
compared well with the calculated data. This outcome favors the use of stress percentage level 
as indicator of stress with this patch because this parameter is real time depicted, easy to read, 
can show rapid changes and is independent of physical activity. For the first time continuous 
(self)monitoring of stress for a long period is possible which could not be achieved with existing 
methods such as the Imperial Stress Assessment Tool and saliva cortisol.33 Parameters for 
parasympathetic and sympathetic activity (LF and HF) showed less significant differences and 
only between operations and baseline values. LF/HF ratio is more sensitive for artifacts and is 
less reliable over shorter periods.42 However, results should be interpreted with caution due to 
low numbers in subgroup analyses and possible inaccuracy in LF and HF data with a relatively 
low sample frequency of the patch.
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High stress levels during operations have been reported24,26-30 but comparisons with other 
daily activities was not yet examined. Performing an operation gave more mental stress than 
activities at the ward and the outpatient clinic, or when doing administration. Interpretation 
of these differences should be done with caution. Less than half of the participants had 
outpatient clinic or ward activities during the days the patch was worn and there could 
have been a selection bias in other activities. Also one period of administrative activity 
per person was taken into account albeit representative for these activities. Previous 
studies also showed lower stress levels in experienced surgeons in comparison with 
younger colleagues.13,29,43-48 This is possibly explained by differences in coping strategies.10 
Consultants seem more capable of recognizing internal signals indicating stress, such as 
Figure 3 Mean stress percentage and SDNN with 95% confidence intervals between levels of experience. 
*p < 0.001.
529563-L-bw-Weenk
Processed on: 11-3-2019 PDF page: 139
Stress measurements using a smart patch
139
7
Figure 4 a: Stress pattern (%) of a fellow during a surgical procedure (hemihepatectomy). Black arrow 
indicates start of operation; grey arrow indicates when senior surgeon enters the OR for supervision; blue 
arrow indicates end of the hardest part of the operation. b: Stress pattern (%) of a consultant during four 
surgical procedures (blue areas). c: Stress pattern (%) of a consultant during an afternoon of outpatient 
clinic. Blue areas indicate administrative work in between patient contact using a newly introduced 
electronic medical record system. (For interpretation of the references to colour in this figure legend, the 
reader is referred to the web version of this article).
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heart pounding and clouded judgment, and may have developed better coping strategies to 
deal with stress by for example physical relaxation methods, distancing techniques and self-
talk. In contrast to senior residents and fellows, no significant difference in stress levels was 
found between consultants and junior residents. This could possibly be explained by the fact 
that junior residents operate under more supervision than senior residents and fellows.
The increased stress during operation may be considered as ‘good stress’, reflecting increased 
focus. We cannot rule out that some elevations of the stress are due to increased focus and 
excitement. Due to the small sample size we could not analyze stress data in relation to intra 
operative problems, which might indicate ‘bad stress’. However, we observed long lasting stress 
levels during surgery corresponding with increased stress levels during other, potentially, 
more relaxing activities in some individuals, which may indicate ‘bad (chronic) stress’.
It was not an aim of this study to validate objective stress measured by this device against a 
subjective self perceived stress by the STAI questionnaire. We, however, compared outcomes 
of these two different stress measurements to have an impression about their relationship. As 
shown in the results section no correlation was found between subjective and objective stress 
measurements. Underreporting of perceived stress in general and specifically in surgical 
specialists has been reported.49 Perceived stress might have been affected by a short moment 
of the procedure and is dependent on recollection after the operation, whereas objective stress 
calculations encompassed the total operation and were expressed in mean or median. In 
contrast to STAI the device is potentially more suitable to pick up more and longer ‘unnoticed’ 
stress moments which is relevant for determination of chronic stress.
Strength of this study is the comparison of stress obtained by continuous registration, between 
all daily activities in a group of surgeons and residents and during two to three days in a row. 
Combining stress data with notes in the logbooks and daily debriefings also allowed for detailed 
insight in individual stress patterns. Frequent and long during high stress percentages were 
found in some individuals and at more than one daily activity (see Figure 4).
The small number of participants, the few demographics obtained and the missing patch and 
STAI data limited further subgroup analyses for stress risk factors. Measurements prematurely 
stopped in 20% participants due to patch dysfunction or irritation. The skin irritation in 10% 
participants would hamper use of the patch for more days in a row. Adhesive patches for 
sensitive skin are developed and may decrease skin irritation. Future studies should take the 
limitation of occasional patch dysfunction into account.
Regarding its ability to measure stress continuously and depict stress real time this sensor 
device has large potential in healthcare, both for healthcare workers and patients, both in daily 
practice and in a training environment, and both for an individual and a team effort. Particularly 
trainees may benefit recognizing stressors and stressful situations real time and learning 
to cope with or prevent stress. Operating room team simulation training using the patch in 
all participants would allow residents and consultants to train various crisis situations, to 
experience stress and to reflect on the consequences regarding quality and safety of the 
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operation. Other potential application is the early and simple assessment of chronic stress in 
patients and healthcare workers by computer analysis of continuous or serial time periods of 
patch data. Other means for chronic stress analysis such as hair analysis are costly and still 
need validation.50,51 Ongoing studies focus on stress monitoring in trainees and faculty during 
surgical simulation training and in patients and nurses at the surgical ward.
CONCLUSION
Continuous stress monitoring in surgeons and residents using a simple, easy to wear sensor 
patch reveals real time data on different stress levels of surgeons and residents during the day. 
With this new technique we could demonstrate that performing an operation is more stressful 
than other daily activities in the hospital, particularly with less surgical experience. The stress 
percentage allows for real time feedback of the stress level making the sensor patch suitable 
for a widespread application in healthcare.
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GENERAL DISCUSSION 
Main findings
In this thesis, we showed that using wearable devices for continuous or intensified periodic 
monitoring in patients is feasible, that the devices are user friendly and have great potential 
for early and accurate detection of clinical deterioration in the individual patient. Most studies 
focused on continuous monitoring using ViSi Mobile and HealthPatch at a surgical and internal 
medicine ward. Vital sign data obtained by the two devices was comparable with measurements 
by nurses. MEWS values calculated from device data were more accurate, mainly the respiratory 
rates. Patient and care givers share a positive attitude towards continuous monitoring with 
both devices. They reported early identification of clinical deterioration and increased feelings 
of safety as benefits. Barriers for device use were different for HealthPatch and ViSi Mobile, 
for example the ViSi Mobile has several wires and a bulky wrist part. In two studies we showed 
promising results of the use of the CheckMe device for measuring and intensified periodic 
monitoring in hypertension. This device is accurate and suitable to be operated by patients, 
holding promise for use at home. However, some drawbacks were reported considering 
operability and accuracy that needs to be addressed before routine application in chronic 
disease management or during rehabilitation.   
The HealthPatch was also studied for continuous stress monitoring in healthcare workers and 
identified meaningful variation in daily mental stress related to work activities and to the level 
of work experience.
Continuous monitoring at the general ward 
Patient perspective 
High user-friendliness of a wearable monitoring device is a prerequisite for sustainable use in- 
and outside the hospital by healthcare workers and by patients. Although patient acceptance is 
crucial for successful implementation of a new wearable device,1 only few studies investigated 
this.2 We showed that patients appreciate the ViSi Mobile and the HealthPatch, although 
several barriers regarding user friendliness still have to be addressed, such as the ViSi Mobile 
wires crossing the arm and chest, and the loss of skin contact of the HealthPatch in some 
individuals. Sotera Wireless (San Diego, USA) soon will launch a next version of the ViSi Mobile 
which is smaller, weighs less, and contains only one wire. Although the HealthPatch is small 
and often goes unnoticed by patients, it does not measure all vital signs which are at present 
deemed necessary for adequate in-hospital safety monitoring. However, it is expected that not 
all vital signs need to be measured continuously for proper clinical judgment in each patient or 
at any time.3 The type of device and the number of vital signs to be monitored might be selected 
on the actual clinical condition and comorbidity of the patient, the (change in) severity of his 
condition and the type of the intervention. This may allow for more personalized and precise 
patient monitoring.
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Continuous monitoring can result in earlier identification of clinical deterioration, improved 
survival and shorter hospital length of stay, but does not seem to affect the number of 
admissions to the Intensive Care Unit (ICU) and adverse events.4,5 However, design, setting 
and methodology of the few studies performed show relevant flaws: small sample sizes, no 
randomized controlled trials,4 use of devices without adequate alarming system6 or devices 
with multiple wires and connections reducing patient mobility.5,7 Good quality trials and large 
data base analyses may provide solid evidence for scaled up implementation of continuous 
monitoring at the general ward. Our group recently started to collect data of patients on 60 
hospital beds (30 at the gastro-intestinal surgery and surgical oncology ward and 30 at the 
internal medicine ward), who are continuously monitored with the ViSi Mobile system, to provide 
answers to questions regarding relevant efficacy and safety outcomes. Initial experiences point 
into the direction that availability of continuous vital sign risk scoring improves awareness of 
deterioration of patients but is insufficient to early predict adverse events. Predictive analytics 
using artificial intelligence have potential to early identify a patient at risk for developing 
an adverse event.8 Although the number of predictive analytic systems rapidly increases in 
healthcare, only few address the effect of early prediction on patient outcome.9 Clearly, more 
research is needed in this field focusing not only on prediction of deterioration but also on 
improvement. The latter may have beneficial organizational and logistic impact for example 
appropriate and timely discharge from hospital to home and reduction of readmissions.  
Availability of continuous (remote) monitoring at home could accelerate discharge and allow 
patients to rehabilitate in their own environment. However, ViSi Mobile will be less suitable 
for home monitoring due to its bulkiness and wires, and the necessity to daily calibrating. The 
HealthPatch is more comfortable and user friendly with potential for home monitoring as part 
of the continuously monitored patient journey from home to hospital and from hospital to home 
(see Figure 1). Obviously only selected patients may benefit from HealthPatch monitoring due 
to its limited features and impossibility to measure blood pressure. The whole concept of a 
continuously monitored patient journey with alternation of different wearable devices where 
appropriate is in its infancy and needs further clinical and socioeconomic exploration. 
Nurse perspective
Success of continuous monitoring of vital signs strongly depends on nurses’ engagement with 
the technology, starting with making them familiar with the technology and its purposes.2,10,11 
Lack of familiarity often leads to the perception of increased workload.2 Our preliminary 
experience to achieve widespread acceptance is that nurses should be involved from the 
beginning in all phases of preparation and implementation and preferably take part in clinical 
validation of the technology. Nurses should be trained in a simulated setting before use in 
patients, with frequent evaluations of retention of knowledge and skills. Such approach 
ensures that nurses feel more confident using the technology.2,12 New generation nurses are 
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expected to be intuitive and comfortable using new (digital) technology also as a result of new 
educational initiatives such as the ‘Nursing and Technology’ program.13
Figure 1 Patient journey.
Personalized vital sign monitoring in the hospital (example of elective surgical procedure): ‘heavy’ 
monitoring using the ViSi Mobile, ‘light’ monitoring using HealthPatch and CheckMe. Note, the original 
HealthPatch is shown here. 
Manual vital sign measurement contributes to the workload of nurses. Monitoring with devices 
is expected to reduce workload, allowing nurses to spend time on other care tasks and important 
social interaction with patients. A specifi c type of workload that can be reduced by continuous 
monitoring with wearable devices is care of patients who stay in contact-isolation rooms e.g. 
MRSA, tuberculosis, stem cell transplantation. At present, a nurse has to dress up in a gown, 
cap, mask and gloves three times a day for only ten minutes of vital sign measurements.
The main barrier of continuous monitoring for nurses is the alarm burden which can result in 
alarm fatigue and unsafe care2,12 An alarm can occur due to technical failure of the continuous 
monitoring system or due to real abnormalities of vital signs. Part of the technical failures is 
dealt with automatically by the device and used software. It is expected that this automatic 
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correction will increase with better devices and more intelligent software. Recently, machine 
learning algorithms have been reported reducing the number of clinically irrelevant alarms 
in high care patients.14-16 The burden of ‘real’ alarms depends on the disease severity of the 
patients monitored and (the possibility of) individual alarm settings. There were on average 10 
alarms per day per patient with ViSi Mobile at a combined medical surgical ward, which was 
considered acceptable regarding appropriate balance between number of alarms and risk of 
alarm fatigue.17 For more elaborated patients with a higher prevalence of deterioration and 
complications at a general ward the alarm burden and (risk of) alarm fatigue needs to be 
established and is part of our future research on continuous monitoring. Nurses fear that 
continuous monitoring leads to a shift of more complex patients to the general ward than at 
present, specifically an earlier step down from high care. This fear should be addressed before 
implementing continuous monitoring at the general ward taking into account the significantly 
lower nurse/patient ratio compared to high care units and the lower educational and experience 
level regarding management of a critically ill patient. Less time for interaction with a patient 
due to a low nurse/patient ratio, particularly at night, carries the risk of overreliance on 
continuous monitoring, which has shown to be a risk factor for missing clinical deterioration.18
Hospital
Important considerations for implementing continuous monitoring by a hospital organization 
are the quality of care improvement and associated costs. Both are scarcely investigated 
particularly considering relevant patient outcomes. Slight et al. implemented a monitoring 
system at the general ward and found it to be cost-effective regarding hospital length of stay 
and ICU length of stay.19 The system was installed at a 33-bed medical surgical ward and 
data were gathered for a 9-month period before and 9-month after implementation. The total 
hospital length of stay and ICU length of stay was reduced with 801 and 128 days, respectively. 
To be cost-effective, authors stated that it is essential that nurses promptly react to generated 
alarms for patients with signs of clinical deterioration and that a Rapid Response Team is 
available to treat these patients. Effect of the alarms on nurses’ workload and alarm fatigue 
were not investigated, underestimating the drawbacks of monitoring in this paper.
A clear picture of the potential harm as well as the benefit is important for decision making 
regarding wearable device monitoring.20 Harm can vary from skin allergy to false results 
of measurements. Approval of wearable devices by notifying bodies, such as the Food and 
Drug Agency (FDA), is mandatory to minimize the hazards and risks of a new wearable device 
and accessory software. Medical devices receive extensive scrutiny before FDA approval and 
manufacturers are obligated to report any adverse event regarding the device after approval, 
which could eventually result in device recall and great loss of investment. The costly 
undertaken of research, FDA approval and device performance surveillance could explain 
why particularly start-up companies primarily aim at the lifestyle market with devices that are 
potentially suitable for medical use. 
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The rapid development of devices makes it difficult for a hospital to purchase a device that is up 
to date for a longer period of time. In the studies, we used a Toughbook connected with the ViSi 
Mobile by Bluetooth which resulted in many disconnections and artifacts. At present there is a 
direct connection to our well-functioning and large capacity Wi-Fi network. The old version of 
ViSi Mobile is heavier in weight and has multiple wires connected to chest sensors compared 
to the new version. Also, the new version contains arrhythmia detection software which holds 
promise for use in cardiac patients. Present algorithms of ViSi Mobile are not robust enough 
for measuring (sudden changes in) body temperature and blood pressure, which drawback is 
announced to be dealt with in a next version. 
The current battery life of ViSi Mobile of about 12 hours implies that at least two batteries are 
needed per patient for 24 hours continuous monitoring. This increases the purchase costs 
of the device and nurse’s workload. Low power consumption and high energy efficiency are 
required for long-term monitoring devices.21,22
The data produced by the devices contains private and sensitive medical information. The Wi-
Fi system must securely transmit data between patient and the location of storage, such as 
the electronic health record (EHR), according to current legislation.23 All these barriers should 
be taken into account when hospitals aim at purchasing wearable devices for continuous 
monitoring. Some important barriers and solutions and/or requirements are listed in table 1.
Table 1 To be considered by a hospital before purchasing wearable devices for continuous monitoring at 
the general ward
Barrier Solution / requirements
Transmission and storage of a large amount of sensitive 
patient information
Strong and secured Wi-Fi system and Electronic Health 
Record (EHR) System
Resistance of nurses and physicians to use new 
monitoring technology 
- Formation of a team with super-users
- Early engagement of personnel
- Adequate training of medical personnel
- Easy-to-use device
Short battery life time of device - Low power consumption
- Other energy techniques (e.g. body heat)
- Battery change protocol
Storage and analysis of ‘big data’ Selection of analyzed data for storage in the EHR
High purchase costs - Cost-effectiveness analysis
- Rental/lease options
Earlier patient discharge from ICU to general ward Appropriate agreements and proper guidelines regarding 
patient transfer between wards
False positive alarms generated by devices; alarm fatigue - Better software and algorithms
- Possibility of individual thresholds
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We learned that early installing a multidisciplinary team to prepare for implementing 
continuous monitoring with a wearable device at the general ward is crucial for adoption of 
this new technology by healthcare workers and patients. Table 2 shows the composition of 
such team and the general description of the activities of each team member.     
Table 2 Multidisciplinary team composition before implementation of wearable devices for continuous 
monitoring at the general ward
Member Activities
Super-user -  Training nurses and physicians for appropriate use of 
devices
IT specialist
-CIO
-CMIO
-Data Security specialist
-  Preparing and installing the IT infrastructure and data 
security measures
- Preparing connection to EHR
Medical technology specialist -  Purchasing and testing hardware (server, monitors, 
adapters etc) 
- Support in case of technical issues
Physician and nurse - Preparing care protocols e.g. alarm management
- Sharing experiences with colleagues
Research team - Preparing research protocols and IRB agreement
Project manager - Project planning e.g. milestones, deliverables, meetings 
Strategic buying department (e.g. lawyers)  - Preparing contracts e.g. purchase conditions  
Patient - Input on care and research protocols e.g. evaluation 
Communication department - Preparing internal/external communication plan
Intensified periodic monitoring  
The CheckMe is a promising device for frequent measuring vital signs of and by patients inside 
and outside the hospital. Recovering patients at the general ward are able to reliably monitor 
their own vital signs, which leads to an increased number of observations, increased patient 
self-management and autonomy, and a reduced workload for nurses. 
The CheckMe has potential as home self-measurement device by patients with chronic 
diseases. This could give a more authentic representation of the patient’s condition and could 
reduce costs due to a shorter hospital length of stay.24 An initial study of 12 patients with 
hypertension shows feasibility in blood pressure measurement at home and good comparison 
with available cuff dependent devices.25 However, for full potential some serious limitations of 
the CheckMe have to be addressed and more research on accuracy in all conditions is needed, 
and research including cost-effectiveness. Calibration of blood pressure is cumbersome and 
may fail due to cold or shivering fingers. Other drawback is the inability to measure respiratory 
rate and diastolic blood pressure. Particularly respiratory rate seems important for prediction 
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of deterioration in chronic disease such as COPD exacerbation,26 and prediction of sepsis27 
and cardiac arrest.28,29 Although systolic blood pressure alone is a good predictor of risk of 
cardiovascular events, the combination of both systolic and diastolic blood pressure has shown 
to improve the risk prediction with subsequent treatment reducing cardiovascular events.30 
The next version of the CheckMe is announced to have a more simplified calibration protocol 
and addition of diastolic blood pressure measurement. With increased user friendliness and 
the added features, CheckMe favorably compares with several other home devices currently 
marketed for self-control by patients with hypertension,31 diabetes mellitus,32,33 and chronic 
obstructive pulmonary disease.34 Possibility of connection with an online personal health record 
allows patients to upload their medical data and to share this with their care givers either in 
or outside a hospital. Access to own medical data has shown to improve self-management35,36 
and therapy adherence.37 Furthermore, clinical outcome of several chronic diseases improves, 
such as better blood glucose levels in patients with diabetes mellitus.32,33
Stress monitoring in healthcare workers
We were able to continuously measure stress levels on the basis of heart rate variability in 
surgeons and surgical residents using the HealthPatch and to identify inter-individual and 
within person differences. Providing insight in (chronic) stress levels in surgeons and residents 
is important because the surgical professional is at high risk for the development of depression, 
burn out38,39 and cardiovascular diseases.40 Abnormal mental stress affects communication, 
team work and decision making41,42 and is associated with undesirable events in the operating 
room and compromised patient safety.43-46 We expect similar consequences of stress for other 
(para)medical and nurse professions. Taking into account the importance of the effect of stress 
on acquiring skills is reflected by stress and stress response adapted training procedures 
in the aviation and automotive industry.47-49 Continuous objective stress measurement may 
benefit effective training and coaching of the healthcare professionals in stress awareness 
and coping, knowing that some (healthcare) professionals tend to underreport their perceived 
stress and endanger quality of care.50 There are several other relevant areas in healthcare for 
researching and implementing continuous and reliable monitoring of stress for example in 
disease prevention, patient monitoring, skills training and fit to perform programs.
A change in vendor of the HealthPatch resulted in reduced availability of stress data impeding 
the repetition of studies regarding stress monitoring. Such actions as mentioned earlier 
hamper researchers, clinicians and policymakers to select a new device for safe, effective 
and sustainable use in healthcare. More transparency and open data access and collaboration 
between academic institutions and enterprises are needed to avoid waist of investments.         
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FUTURE PERSPECTIVES
The monitored patient journey
With devices becoming more user friendly and proven safe and effective, we foresee that various 
forms of continuous vital sign (and other parameter) monitoring becomes an important part of 
the patient journey starting at home, continuing in the hospital and remaining after discharge 
back at home.
At home
Before a planned hospitalization, for example prior to a major operation, patients need to 
visit the hospital often more than once and receive advices and treatments to improve their 
condition by several (para)medical specialties, e.g. physiotherapist, dietician, anesthesiologist, 
internist. Treatment of pre-existing disorders e.g. diabetes, hypertension and improving the 
patient’ cardiovascular and respiratory condition by exercises prior to hospitalization may 
reduce the number of adverse events, particularly after complex surgical procedures.51 These 
prehabilitation programs are time-consuming and costly and inherit the risk of adverse events 
during unsupervised exercises at home. Wearable devices embedded in virtual care initiatives 
such as by ForaHealthyMe Inc.52 will allow for complete patient prehabilitation at home by 
remote monitoring and analyses of vital signs and physical parameters and performing virtual 
consults with physicians and paramedics (see Figure 2). 
At the hospital
We expect that during hospitalization the choice of monitoring device and number of measured 
vital signs will depend on patient’s actual disease (state), co-morbidity, type of treatment 
and predicted risk of adverse events. For example, patients staying at the general ward after 
complex surgery or after emergency admission and who are prone to deteriorate are monitored 
more intensively by devices including blood pressure and oxygen saturation. Patients in a 
better clinical condition and who are able to walk around can measure their own vital signs 
discontinuously using devices like the CheckMe. More simple devices such as the HealthPatch 
can be used for continuous monitoring of respiratory and heart rate for example in patients 
with exacerbation of COPD or during treatment of pneumonia. The selective use of a range of 
different wearable devices may allow for personalized, efficient, affordable and sustainable 
vital sign monitoring in a hospital.
When using various devices and software for vital sign monitoring it is mandatory to have one 
data platform and a connection with the EHR system. This allows for optimal integration with 
other patient data such as demographics, laboratory results, clinical notes and medication and 
enables more precise and personalized prediction of adverse events and appropriate actionsto 
prevent these events. In addition to vital signs, pain, stress, sleep, activity and body posture 
are clinically relevant parameters for continuous monitoring of disease state and recovery. 
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Figure 2 Dashboard Virtual Care pre-and rehabilitation. Courtesy of Courtney Cole, ForaHealthyMe Inc, 
Markham, Ontario, Canada
Monitoring, analyzing and responding on all these data is undoable for personnel at the general 
ward and requires a different in-hospital care model. The Radboud university medical center 
recently took the initiative for a central unit of remote monitoring to analyze and respond to all 
types of (dis)continuous data coming from (wearable) devices of patients at the general wards. 
First, the unit will install predictive analytics based on vital signs and focusing on prevention of 
deterioration.53,54 A so-called Vital Risk Score (VRS) will be introduced with potential to indicate 
a trend in data towards deterioration. Second, the unit will direct the rapid response team 
to the ward based on VRS combined with centrally available other patient data. This central 
coordination is meant to effi ciently organize and to improve quality of acute care of patients at 
general wards (see Figure 3). At present, the predictive value of the VRS for adverse events is 
assessed by various studies from our research group. A work protocol to diagnose and treat 
patients with increased risk of deterioration based on VRS will be drafted and the subsequently 
altered way of work by nurses and doctors at the ward and by rapid response team members 
will be explored. Obviously more evidence on safety, effi cacy and (lean) organization of (remote) 
continuous monitoring and predictive analytics for deterioration in hospitalized patients is 
needed to start implement new care models for nurses and doctors.
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Back at home
Small and user-friendly devices monitoring patients at home regarding vital signs and other 
physical parameters will possibly enable earlier hospital discharge and decrease hospital 
costs.24 Moreover, patients will have the opportunity to recover in their own familiar environment, 
which may improve patients’ sleep and reduce stress. The hospital can receive medical data 
from the patients and sent an alarm in case of deterioration in vital signs and before adverse 
events occur. For such a remote monitoring and alarming approach, collaboration between 
hospitals, patients and healthcare workers in primary care should be optimized. It should be 
clear in particular which professional has to be alerted first in case of deterioration. There 
is still little experience with organizing care of patients who are discharged from hospital 
and remain continuously monitored by a hospital when at home.55,56 Hospitals can learn from 
existing independent medical service centers monitoring chronically ill patients with heart 
failure,57 COPD,34 hypertension,31 diabetes mellitus32 and dementia at home.58
Although still a few barriers have to be addressed, e.g. calibration and connection issues, the 
CheckMe and HealthPatch both might be suitable for home self-monitoring. For example, 
the HealthPatch could be used to predict hypoglycemia in diabetic patients using heart rate 
variability.59 An online platform as mentioned earlier could allow patients to collect their own 
medical data and share this with their general practitioners and medical specialists.
Patients’ access to their own medical data has shown to positively influence self-
management,34,35 improve health outcomes60,61 and therapy adherence.37 Furthermore, wireless 
technology which monitor patients at home could reduce the number of hospitalizations57 and 
costs.62
For use at home, patients need to receive proper instructions regarding use and technical 
issues of devices and should be able to easily approach a trained health care worker in case 
of technical issues and other concerns. This could be a trained nurse in the hospital, but also 
a trained district nurse or nurse in a nursing home. Also a 24/7 helpdesk is warranted. It is 
expected that patient acceptance and easy handling of wearable devices will increase in the 
future since new generations will be more familiar with wearable technology from the lifestyle 
industry. Monitoring patients at home will also have implications from societal and ethical point 
of view. The balance should be made between patients’ privacy versus the potential benefits of 
wireless monitoring, such as reduced number of hospital readmissions and early discharge. 
Sending data from home trough a wireless network might be a serious threat to the privacy of 
a patient. Also other reasons for privacy issues may arise, such as personal belief and cultural 
environment.63 Furthermore, other issues such as the stigma of wearing a wearable device and 
impact on daily activity should be considered.12 
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Figure 3 Today’s versus future’s situation of patient monitoring and RRT activation.
Taken all together future research of continuous monitoring of vital signs and other physical 
parameters during the patient journey should be broad and in the several domains of healthcare 
innovation including technical innovation, social innovation and business innovation, in order to 
provide answers to the many questions existing and coming up in this emerging fi eld of digital 
health technology.     
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SUMMARY
Introduction
Chapter 1 is the general introduction of this thesis. The focus of the thesis is to evaluate the 
feasibility of three wearable devices for vital sign monitoring and to give an overview of the user 
experiences. Measurement of vital signs in hospitalized patients is important to provide insight 
in the patients’ condition and to detect clinical deterioration.1 Clinical deterioration may lead 
to admission to the Intensive Care Unit (ICU), a longer hospital stay and mortality.2,3 To identify 
deteriorating patients, Early Warning Scores (EWS), such as the Modified Early Warning Scores 
(MEWS), have been developed for use by care givers.4,5 However, due to the intermittent nature 
of the MEWS measurements, clinical deterioration may occur between MEWS measurements 
and remain unnoticed, particularly during the night when less medical personnel is available.6,7 
Also, mistakes occur due to inaccurate and incomplete documentation in the Electronic Health 
Record (EHR).8,9 Repetitive measurements are increasingly important because patients in the 
hospital become more at risk for deterioration; they are older and undergo more complex 
interventions.10,11 Nowadays, continuous and remote monitoring is possible with wearable 
devices. Most devices are developed for fitness and wellness, but have the potential to monitor 
patients in and outside the hospital.12,13 To be suitable for patient monitoring, devices have to 
meet several demands, such as being able to monitor vital signs accurately and reliably, and to 
transmit data wireless to the EHR. Furthermore, devices have to be small and comfortable for 
patients.14 In this thesis, the use of ViSi Mobile (Sotera Wireless, CA, USA), HealthPatch (original 
version of VitalPatch; Vital Connect, CA, USA) and CheckMe (Viatom Technology, Shenzhen, 
People’s Republic of China) was evaluated; three devices that entered the healthcare market 
for intermittent and continuous monitoring of vital parameters. 
The following objectives of this thesis were formulated:
1.  To evaluate the (technical) feasibility and accuracy of continuous monitoring using ViSi 
Mobile and HealthPatch on the internal medicine and surgical wards
2.  To evaluate the using experiences of ViSi Mobile and HealthPatch by patients, relatives, 
nurses and physicians
3.  To evaluate the accuracy of self-measurement by patients using the CheckMe in the 
outpatient clinic and on the internal medicine ward
The feasibility of continuous monitoring using ViSi Mobile and the HealthPatch was first tested. 
The results are described in chapter 2. In this pilot study, 20 hospitalized patients at the internal 
medicine ward and surgical ward were included and wore the ViSi Mobile and HealthPatch for 
two to three days. Monitored vital sign data by ViSi Mobile and HealthPatch was compared with 
regular nurse MEWS measurements. Patient and nurse experiences were evaluated.
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In total, 86 out of 120 MEWS’ measurements by nurses were used for detailed analysis. Vital 
sign measurements by ViSi Mobile and HealthPatch were generally consistent with nurse 
measurements. In 30% of the cases, clinically relevant differences in MEWS were found mainly 
due to inconsistent nurse respiratory rate registrations. The predominant ViSi Mobile artifact 
was a connection failure in 70% of cases. Over 50% of all HealthPatch artifacts had an unknown 
cause, were self-limiting and did not take longer than one hour.
It was concluded that ViSi Mobile and HealthPatch are promising for vital sign monitoring at 
the general ward. The devices were well received and comfortable for most patients. 
Based on the results of this pilot study, we conducted a randomized controlled trial (RCT), 
of which the results are described in chapter 3. Focus of this RCT was to identify positive 
and negative effects, and barriers and facilitators for continuous monitoring using ViSi Mobile 
and HealthPatch. Ninety hospitalized patients at the internal medicine and surgical ward were 
included and randomly assigned to ViSi Mobile, HealthPatch or a control group with periodic 
vital sign monitoring by nurses. Patients’ user experiences and expectations and those of their 
relatives if applicable were evaluated using semi-structured interviews. Nurses, physician 
assistants and medical doctors involved in care of included patients, were interviewed as 
well. Interviews were analyzed using thematic content analysis. Patients’ stress levels during 
hospitalization were obtained using questionnaires and were compared between groups.
Data saturation was reached after 60 patients. We analyzed interviews of 20 nurses, 3 physician 
assistants, and 6 medical doctors. In total, 47 positive and 30 negative effects were identified 
and 19 facilitators and 36 barriers. Most mentioned topics regarded earlier identification of 
clinical deterioration, increased feelings of safety, and ViSi Mobile wires and electrodes. No 
differences were found in patients’ stress levels between randomization groups.
The results show a mainly positive attitude towards continuous monitoring and ViSi Mobile and 
HealthPatch by patients, relatives and caregivers. 
Part of this RCT was used to compare vital sign data by ViSi Mobile and HealthPatch with 
those by nurses. Results are presented in chapter 4. Sixty patients at the surgical and internal 
medicine ward were randomized to continuous monitoring with ViSi Mobile or HealthPatch for 
24 to 72 hours in addition to regular nurse measurements of the MEWS. MEWS measurements 
by nurses were compared with the calculated MEWS based on the ViSi Mobile and HealthPatch 
data. Vital signs not captured by ViSi Mobile or HealthPatch, such as consciousness and 
oxygen administration, were taken from nurse registrations to allow for MEWS calculation. 
Since HealthPatch does not measure oxygen saturation and blood pressure, and both devices 
are not able to measure core temperature, these measurements were taken from the EHR. 
The number of high MEWS (defined as MEWS ≥ 6) by ViSi Mobile and HealthPatch in between 
regular MEWS measurements by nurses were recorded to obtain an impression of potential 
meaningful deteriorations remaining undetected by nurses.
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Median MEWS, measured by ViSi Mobile (2.7 vs. 1.9) and HealthPatch (1.9 vs. 1.3) were higher 
than by nurse measurements mostly due to differences in respiratory rate measurements. 
During 1282 hours of ViSi Mobile and 1886 hours of HealthPatch monitoring, 71 (in 14 patients) 
and 32 (in 7 patients) high MEWS values were detected during the non-observed periods by 
nurses. Time between a ViSi Mobile and HealthPatch based high MEWS and the next regular 
nurse measurement ranged from 0 to 10 (ViSi Mobile) and 0 to 9 (HealthPatch) hours.
The results show that the calculated MEWS from vital sign measurements by ViSi Mobile and 
HealthPatch correspond well with those by nurses. Both devices measure respiratory rate 
more accurately than nurses. High MEWS based on device measurements are present in 
hospitalized patients at unobserved periods and may indicate deterioration at an early phase.
The CheckMe is a smart all-in-one device for intermittent vital sign measurement. The 
CheckMe records systolic blood pressure, oxygen saturation, skin temperature and a 1-lead 
electrocardiogram. The patient can handle the device himself with potential of better (more 
frequent measurements; automatic electronic health recording) daily patient monitoring and 
reduction of nurses’ workload. In chapter 5, we evaluated the performance of the CheckMe 
regarding systolic blood pressure measurement in comparison to a reference blood pressure 
measurement device at the hypertension outpatient clinic. Furthermore, we wanted to 
investigate whether the posture of the patient and the position of the device relative to the 
heart level would influence its outcomes. Fifty-two patients were recruited falling into three 
systolic blood pressure ranges: high (>160 mmHg), normal (130–160 mmHg), and low (<130 
mmHg), according to the European Society of Hypertension International Protocol (ESH-IP). 
All requirements for test environment, observer qualification, patient recruitment, and blood 
pressure measurements were met according to the ESH-IP for the validation of blood pressure 
measurement devices. After calibrating the CheckMe device, we measured systolic blood 
pressure using the CheckMe and using a validated, oscillometric reference blood pressure 
monitor (RM). Measurements were performed in randomized order both in supine and in 
upright position, and with CheckMe at and above heart level.
Of the 52 patients, we excluded 15 patients (12 due to calibration failure with Checkme, 3 due to 
other reasons). The remaining 37 patients fell into low (n=14), medium (n=13), and high (n=10) 
blood pressure ranges. There were 18 men and 19 women with a mean age of 54.1 (SD 14.5) 
years and a mean systolic BP at recruitment of 141.7 (SD 24.7) mmHg. The mean difference 
between the RM and CheckMe was -1.8 mmHg (SD 8.5) in the supine position and 2.6 mmHg 
(SD 12.1) in the upright position. Systolic blood pressure measured with Checkme above heart 
level was significantly lower than systolic blood pressure measured supine at heart level (mean 
130.7 mmHg, SD 27.7; mean 138.4 mmHg, SD 25.2 respectively).
It was concluded that blood pressure obtained with CheckMe correlates well with RM, 
particularly in the supine position.  
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In chapter 6, we evaluated self-measurement of vital signs using the CheckMe device compared 
to trained investigator measurement (gold standard) and nurse measurement to assess if self-
measurement is reliable and can replace nurse measurement in future hospital care. Patients 
admitted to the internal medicine ward were included in this prospective comparative study. 
Time-related measurement sessions were conducted on consecutive patients in a randomized 
order: vital sign measurement in duplicate by a trained investigator (gold standard) using an 
automated blood pressure measuring device, a CheckMe measurement by the patient, and 
a routine vital sign measurement using an automated blood pressure measuring device by a 
nurse. Vital signs and calculated MEWS based on patient-operated CheckMe measurements 
were compared with vital signs and calculated MEWS obtained by nurses and investigator. 
In 41 of 50 patients (82%), initial calibration of the CheckMe was successful and results of 
69 measurement sessions were eligible for analysis. The temperature results recorded by 
the patient with the CheckMe differed significantly from the gold standard core temperature 
measurements (mean difference 0.1 ± 0.3). Obtained differences in vital signs and calculated 
MEWS were small and were in range with predefined accepted discrepancies.
Patient-calculated MEWS using the CheckMe correlate well with investigator-calculated 
and nurse-calculated MEWS. The small differences observed between modalities seem 
insignificant for clinical decision making. Patients can accurately measure their own vital signs 
using the CheckMe, which may positively affect vital sign monitoring, patient’s autonomy and 
nurse’s workload at the general ward. 
Surgeons have a stressful profession and excessive levels of stress can jeopardize patient 
safety and quality of surgical care. Real-time stress measurement may identify stressing 
situations and activities.
In chapter 7 we explored stress patterns of surgeons and residents during daily work using 
the HealthPatch. Consultants and surgical residents wore the HealthPatch for two to three 
days. The patch measures heart rate variability (HRV) and calculates and displays a real-time 
stress percentage using a validated algorithm including heart rate (HR) and HRV. The ‘patch 
stress’, standard deviation of the interval between two heart beats (SDNN), square root of the 
mean R-R interval (RMSSD), and ratio between low frequency (LF) and high frequency (HF), 
and stress percentage,  was compared with self perceived stress reporting using the State Trait 
Anxiety Inventory (STAI). Each participant filled in a logbook including daily activities.   
A significant increase in HRV and stress percentage was shown in twenty surgeons and residents 
during surgery in comparison with other activities (outpatient clinic, ward, administrative work). 
Consultants showed lower stress levels while operating compared to fellows and residents. 
Stress according to the patch did not correlate with STAI outcome.
It is concluded that continuous stress monitoring using a wearable sensor patch reveals 
relevant data on actual stressors of surgeons and surgical residents. 
Chapter 8 provides the general discussion and future perspectives. 
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NEDERLANDSE SAMENVATTING 
Inleiding
De inleiding van dit proefschrift is beschreven in hoofdstuk 1. In dit proefschrift vermeldden 
wij de resultaten van onderzoeken naar het gebruik van twee nieuwe wearable devices 
voor het continu monitoren van vitale parameters bij opgenomen patiënten en één all-in-
one minimonitor voor zelfmetingen door patiënten. Tevens gaven wij een overzicht van de 
gebruikerservaringen van patiënten en zorgprofessionals. 
Het meten van vitale parameters bij opgenomen patiënten in het ziekenhuis is van belang voor 
het inschatten van de klinische conditie en voor het detecteren van klinische achteruitgang.1 
Klinische achteruitgang kan leiden tot een dure opname op de Intensive Care (IC) met een 
langere opnameduur tot gevolg en is geassocieerd met een verhoogde kans op overlijden.2,3 
Early Warning Scores (EWS), zoals de Modified Early Warning Score (MEWS), worden 
doorgaans elke dienst berekend uit vitale parameters die handmatig zijn afgenomen door een 
verpleegkundige. Deze worden gebruikt om vitaal bedreigde patiënten tijdig te signaleren.4,5 
Echter, doordat de MEWS vaak met ruime tussenpozen wordt bepaald bestaat het risico 
dat de patiënt klinisch achteruitgaat tussen twee MEWS bepalingen. Hierdoor kan klinische 
achteruitgang op het moment van voorkomen gemist worden en mogelijk pas laat worden 
ontdekt. Het grootste risico hierop is gedurende de nacht, wanneer er minder verplegend 
personeel aanwezig is.6,7 Een ander nadeel van handmatig meten van vitale parameters en 
berekenen van een MEWS is dat er fouten gemaakt kunnen worden, bijvoorbeeld tijdens het 
invoeren in het elektronisch medisch dossier.8,9 
Het adequaat en frequent meten van vitale parameters in het ziekenhuis wordt steeds 
belangrijker omdat de huidige patiëntenpopulatie in het ziekenhuis een toenemend risico loopt 
op klinische achteruitgang. Dit komt door de vergrijzing, multimorbiditeit en doordat meer 
complexe (operatieve) ingrepen worden uitgevoerd.10,11 Continue monitoring zou een mogelijke 
oplossing kunnen zijn voor bovenstaande problematiek en dit kan tegenwoordig met nieuw 
ontwikkelde en kleine ‘wearable devices’. Een aantal van deze devices wordt primair ontwikkeld 
voor de consumentenmarkt maar zouden in een aantal gevallen ook gebruikt kunnen 
worden voor het monitoren van patiënten, zowel in het ziekenhuis als in de thuissituatie.12,13 
Devices moeten aan verscheidene eisen voldoen voordat ze geschikt zijn voor toepassing in 
het medische domein. Ze moeten nauwkeurig zijn, voldoen aan strenge kwaliteitseisen en 
data draadloos kunnen overbrengen naar het elektronisch patiënten dossier. Daarnaast 
moeten ze klein en comfortabel genoeg zijn om patiënten langdurig te kunnen monitoren.14 
In dit proefschrift evalueerden we het gebruik van drie wearable devices die in staat zijn vitale 
parameters continu en periodiek te meten: ViSi Mobile (Sotera Wireless, CA, USA), HealthPatch 
(doorontwikkeld naar de VitalPatch; Vital Connect, CA, USA) en CheckMe (Viatom Technology, 
Shenzhen, People’s Republic of China).
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De primaire doelen van de studies in dit proefschrift waren:
1.  Evaluatie van de (technische) haalbaarheid en de nauwkeurigheid van continue monitoring 
van vitale parameters door ViSi Mobile en HealthPatch op twee reguliere verpleegafdelingen 
(interne geneeskunde en heelkunde)
2.  Verzamelen en evalueren van de gebruikerservaringen van patiënten, verpleegkundigen en 
artsen met ViSi Mobile en HealthPatch
3.  Evaluatie van de nauwkeurigheid van vitale parameter metingen met behulp van de 
CheckMe door patiënten zelf, zowel in een ambulante setting als tijdens een opname op een 
verpleegafdeling 
In hoofdstuk 2 evalueerden wij de haalbaarheid van continue monitoring door ViSi Mobile 
en HealthPatch op een reguliere verpleegafdeling. In een pilot studie werden 20 patiënten 
geïncludeerd op de verpleegafdeling interne geneeskunde en heelkunde. De patiënten 
droegen zowel de ViSi Mobile en de HealthPatch gedurende de eerste 2 tot 3 dagen van de 
opname. De gemeten vitale parameters door beide devices werd vergeleken met de handmatig 
gemeten waarden door de verpleegkundigen en de hieruit berekende MEWS. Ervaringen van 
verpleegkundigen en patiënten met beide devices werden geëvalueerd. 
Van de 120 MEWS metingen door verpleegkundigen bleken 86 MEWS metingen compleet en 
bruikbaar voor verdere analyse. In het algemeen kwamen de resultaten van de vitale parameters 
gemeten met de ViSi Mobile en HealthPatch overeen met die van de handmatige metingen 
door de verpleegkundigen. In 30% van de gevallen bleek de berekende MEWS verschillend, 
voornamelijk door verschillen in gemeten ademhalingsfrequentie tussen verpleegkundigen en 
beide devices. Er traden gedurende het continu monitoren bij beide devices artefacten op. Bij 
de ViSi Mobile metingen werd 70% hiervan veroorzaakt door connectieproblemen tussen het 
device en het platform (laptop). Bij de HealthPatch werden kortdurende onderbrekingen (tot 
maximaal een uur) waargenomen. In meer dan 50% van de gevallen was dit van onbekende 
oorzaak en loste het probleem zich meestal vanzelf op. De meeste patiënten waren enthousiast 
over het gebruik van de ViSi Mobile en HealthPatch en vonden de devices comfortabel. Uit deze 
resultaten trokken we de conclusie dat ViSi Mobile en HealthPatch veelbelovend zijn voor het 
continue monitoren van vitale parameters op de verpleegafdeling. 
Op basis van de resultaten van de pilotstudie ontwierpen we een randomized controlled 
trial (RCT), waarvan de resultaten worden beschreven in hoofdstuk 3. In deze studie 
evalueerden we gebruikerservaringen en verwachtingen ten aanzien van het gebruik van 
ViSi Mobile en HealthPatch voor continue monitoring. In totaal includeerden we 90 patiënten 
op de verpleegafdelingen interne geneeskunde en heelkunde. Deze patiënten werden 
gerandomiseerd in drie groepen, namelijk 1) monitoring met ViSi Mobile, 2) monitoring met 
HealthPatch en 3) een controlegroep (alleen reguliere MEWS bepaling door verpleegkundigen). 
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Positieve en negatieve effecten en belemmerende en bevorderende factoren voor het gebruik 
van beide devices voor continue monitoring werden in kaart gebracht door middel van 
semigestructureerde interviews. Behalve patiënten en eventuele familieleden interviewden we 
ook verpleegkundigen, physician assistants en artsen die betrokken waren bij de zorg van de 
geïncludeerde patiënten. De interviews werden geanalyseerd door middel van thematische 
inhoudsanalyse. De mate van ervaren stress door patiënten werd gemeten door middel van 
vragenlijsten en vergeleken tussen de drie groepen. 
Dataverzadiging werd bereikt na analyse van 60 patiënten interviews. Tevens analyseerden 
we de interviews bij 20 verpleegkundigen, drie physician assistants en zes artsen. We 
identificeerden in totaal 47 positieve en 30 negatieve effecten, en 19 bevorderende en 36 
belemmerende factoren. De meest genoemde onderwerpen waren het eerder ontdekken van 
klinische achteruitgang, gevoelens van veiligheid en de lijnen en elektrodes van de ViSi Mobile. 
We vonden geen verschillen in ervaren stress door patiënten tussen de verschillende groepen. 
De resultaten lieten zien dat patiënten, familieleden en zorgverleners overwegend positief 
staan tegenover het gebruik van ViSi Mobile en HealthPatch voor continue monitoring. 
Deze RCT werd ook gebruikt om de kwantitatieve resultaten van gemeten vitale parameters door 
ViSi Mobile en HealthPatch te vergelijken met gemeten vitale parameters door verpleegkundigen. 
De resultaten van deze vergelijking zijn beschreven in hoofdstuk 4. Zestig patiënten van de 
verpleegafdelingen interne geneeskunde en heelkunde waren gerandomiseerd voor continue 
monitoring door middel van ViSi Mobile of HealthPatch gedurende 24 en 72 uur. Tevens werden 
bij hen de reguliere metingen en MEWS berekening door verpleegkundigen verricht. Uit de 
vitale parameters gemeten door ViSi Mobile en HealthPatch werd een MEWS berekend en 
vergeleken met de MEWS op basis van metingen door verpleegkundigen. De resultaten van 
vitale parameters die niet gemeten konden worden door ViSi Mobile en HealthPatch, zoals 
bewustzijn en zuurstoftoediening, werden uit het elektronisch patiëntendossier geëxtraheerd. 
Daarnaast meet de HealthPatch geen zuurstofsaturatie en bloeddruk en meten beide devices 
huidtemperatuur in plaats van kerntemperatuur. Derhalve werden ook de resultaten hiervan 
verkregen uit het elektronisch patiëntendossier. Het aantal hoge MEWS (gedefinieerd als 
een MEWS ≥ 6), gemeten door ViSi Mobile en HealthPatch tussen de reguliere metingen 
van de verpleegkundigen werden geregistreerd. Hiermee werd een indruk verkregen van 
het voorkomen van situaties van potentiële klinische achteruitgang in de periode tussen de 
reguliere verpleegkundige metingen die mogelijk ook langdurig onopgemerkt zouden zijn 
gebleven. De mediane MEWS, berekend op basis van de ViSi Mobile (2.7 vs. 1.9) en HealthPatch 
(1.9 vs. 1.3), was hoger dan de MEWS gemeten door verpleegkundigen. Dit kwam voornamelijk 
door verschillen in gemeten ademhalingsfrequenties. In totaal werd met ViSi Mobile 1282 uur 
en met HealthPatch 1886 uur gemeten. Hierbij vonden we respectievelijk 71 (bij 14 patiënten) 
en 32 (bij 7 patiënten) hoge MEWS waarden (≥ 6) tussen de reguliere MEWS metingen van 
verpleegkundigen. De tijd tussen zo’n hoge MEWS meting en de eerstvolgende reguliere 
meting door de verpleegkundige kon oplopen tot  10 uur. 
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Hieruit valt op te maken dat de MEWS, berekend uit vitale parameters gemeten door beide 
devices goed correleert met de MEWS berekening door verpleegkundigen op het moment 
van hun metingen. Wel varieerde de ademhalingsfrequentie gemeten met de devices veel 
meer dan de meting door verpleegkundigen, waardoor de MEWS op basis van de devices 
regelmatig hoger uitviel. De indruk bestaat dat de ademhalingsfrequentie door beide devices 
betrouwbaarder gemeten wordt dan door verpleegkundigen. Tevens werd geconcludeerd dat 
tussen de reguliere MEWS meetmomenten er met continue monitoring frequent hoge MEWS 
uitslagen zijn die aanleiding zouden hebben gegeven tot inschakelen van een IC-team indien 
opgemerkt. Mogelijk kan continue monitoring met de ViSi Mobile en HealthPatch klinische 
achteruitgang al in een vroegere fase detecteren. 
The CheckMe is een klein ‘all-in-one’ device waarmee de patiënt zelf zijn eigen vitale parameters 
kan meten. Het device meet de systolische bloeddruk, zuurstofsaturatie, huidtemperatuur en 
maakt een eenvoudig electrocardiogram. Frequente zelfmeting door de ambulante patiënt 
met bijvoorbeeld de Checkme kan leiden tot betrouwbaardere meetresultaten dan eenmalige 
meting op een polikliniek. In hoofdstuk 5 rapporteerden we de resultaten van een studie waarbij 
we de systolische bloeddruk, gemeten door de CheckMe, vergelijken met die van een referentie 
bloeddrukmeter op de polikliniek Interne Geneeskunde. Daarnaast onderzochten we de invloed 
van de houding van de patiënt en de Checkme op de gemeten bloeddruk. We includeerden 52 
patiënten met hypertensie, die we onderverdeelden in drie subcategorieën volgens de European 
Society of Hypertension International Protocol (ESH-IP): hoge bloeddruk (>160 mmHg), 
normale bloeddruk (130-160 mmHg) en lage bloeddruk (<130 mmHg). Aan alle vereisten voor 
een vergelijkende studie van een bloeddrukmeter zoals beschreven in de ESH-IP werd voldaan, 
zoals studie omgeving, patiënt werving en wijze van bloeddrukmetingen. Na het calibreren 
van de CheckMe werd de bloeddruk gemeten zowel met de CheckMe als met een referentie 
bloeddrukmeter. Metingen werden verricht in zowel achteroverliggende als in zittende positie 
in willekeurige volgorde. Van de 52 potentieel geschikte patiënten werden 15 patiënten niet 
geïncludeerd (12 door calibratie problemen met de CheckMe en 3 om andere redenen). Van de 
overgebleven 37 patiënten hadden 14 patiënten een lage bloeddruk, 13 patiënten een normale 
bloeddruk en 10 patiënten een hoge bloeddruk. De studiepopulatie bestond uit 18 mannen en 
19 vrouwen met een gemiddelde leeftijd van 54.1 (SD 14.5) jaar. De gemiddelde bloeddruk op 
moment van inclusie was 141.7 (SD 24.7) mmHg. Het gemiddelde verschil tussen de referentie 
monitor en CheckMe bedroeg -1.8 mmHg (SD 8.5) in achteroverliggende positie en 2.6 mmHg 
(SD 12.1) in zittende positie. Wanneer de CheckMe boven harthoogte werd gehouden bleek 
de systolische bloeddruk significant lager dan wanneer deze op harthoogte werd gehouden 
(gemiddelde 130.7 mmHg, SD 27.7; gemiddelde 138.4 mmHg, SD 25.2 respectievelijk). 
Uit deze gegevens concludeerden we dat er een goede correlatie bestaat tussen de systolische 
bloeddrukmetingen gemeten door CheckMe en referentiemonitor, met name bij patiënten 
in achteroverliggende positie. Een formele validatiestudie van dit device konden we niet 
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verrichten omdat er nog geen protocol bestaat voor de validatie van de bloeddruk van cuffless 
bloeddrukmeters.
In hoofdstuk 6 werden door de patiënt gemeten vitale parameters met de CheckMe vergeleken 
met metingen door een getrainde onderzoeker (gouden standaard) en verpleegkundigen. Doel 
was te beoordelen of de zelfmetingen met de CheckMe betrouwbaar zijn, zodat in de toekomst 
Checkme de  reguliere metingen door verpleegkundigen kan vervangen. In deze prospectieve 
vergelijkende studie includeerden we patiënten die werden opgenomen op de verpleegafdeling 
interne geneeskunde. De verschillende metingen werden in willekeurige volgorde bij elke 
patiënt verricht: metingen door de getrainde onderzoeker in tweevoud (gouden standaard) 
met een elektronische bloeddrukmeter, meting met de CheckMe door de patiënt en reguliere 
meting door de verpleegkundige met een elektronische bloeddrukmeter. De vitale parameters 
gemeten door de CheckMe en de hieruit berekende MEWS werden vergeleken met de vitale 
parameters gemeten door de onderzoeker en verpleegkundige. 
Calibratie met de CheckMe was succesvol bij 41 van de 50 (82%) geïncludeerde patiënten. 
Bij deze patiënten konden 69 metingen worden gebruikt voor verdere analyse. We vonden 
significante verschillen tussen de gemeten temperatuur door de CheckMe en door de 
onderzoeker (gemiddeld verschil -0.7 ± 0.6). Verschillen tussen de andere vitale parameters, 
gemeten met de verschillende meetmethoden, waren klein en binnen de van tevoren 
vastgestelde en geaccepteerde grenzen. 
MEWS berekend uit vitale parameters door de CheckMe correleerde goed met de gemeten 
MEWS door onderzoeker en verpleegkundige. De kleine verschillen die we vonden tussen 
verschillende vitale parameters lijken niet relevant voor de klinische besluitvorming. We 
concludeerden dat patiënten met de CheckMe betrouwbaar hun eigen vitale parameters 
kunnen meten tijdens een opname. Dit  kan een positieve invloed hebben op het autonomie 
gevoel van patiënten in (en buiten) een ziekenhuis en de werkdruk van verpleegkundigen 
verlagen.
Chirurgen hebben een stressvol beroep. Hoge stress levels, ervaren door chirurgen, kunnen 
een negatief effect hebben op de patiëntveiligheid en kwaliteit van zorg. Het real-time meten 
van het stressniveau kan meer inzicht geven in stressvolle situaties en activiteiten, waarop 
mogelijk geanticipeerd kan worden. In hoofdstuk 7 hebben we stress gemeten door middel 
van de HealthPatch bij chirurgen en chirurgen in opleiding gedurende hun dagelijkse 
werkzaamheden. Alle deelnemers droegen de HealthPatch gedurende 2-3 dagen. Deze pleister 
berekent een stresspercentage met een gevalideerd algoritme op basis van hartslagvariabiliteit 
(HRV) en hartslag. Gemeten stress door de HealthPatch werd vergeleken met gerapporteerde 
subjectieve stress. Deze werd gestructureerd vastgelegd met een gevalideerde vragenlijst, 
de State Trait Anxiety Inventory (STAI). Daarnaast legde iedere deelnemer alle dagelijkse 
werkzaamheden vast in een dagboek.
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In totaal includeerden we 20 chirurgen en chirurgen in opleiding. Bij beide groepen vonden we 
een significante verhoging van het stresspercentage tijdens het opereren in vergelijking met 
andere werkzaamheden (werk op de polikliniek en verpleegafdeling, administratie). Ervaren 
chirurgen toonden een lager stress percentage tijdens het opereren dan fellow chirurgen en 
chirurgen in opleiding. De gemeten stress door de HealthPatch correleerde niet goed met de 
subjectieve stressbeleving (STAI resultaten). 
We concludeerden dat de HealthPatch gebruikt kan worden voor continue stress metingen bij 
chirurgen en chirurgen en in opleiding en dat dit inzicht geeft in stressoren tijdens dagelijkse 
werkzaamheden. 
Hoofdstuk 8 bevat de discussie en toekomstperspectieven. In dit proefschrift hebben we laten 
zien dat het gebruik van wearable devices voor zowel continue als periodieke monitoring van 
patiënten in het ziekenhuis haalbaar is. De huidige devices zijn gebruiksvriendelijk en hebben 
potentie om klinische achteruitgang in een vroeger stadium te detecteren. Op dit moment zijn 
er nog een aantal belemmerende factoren zoals de batterijduur van de devices, artefacten 
en de bedrading en elektrodes van de ViSi Mobile. Hiervoor verwachten we een technische 
oplossing op korte termijn.
Op basis van de in dit proefschrift gepresenteerde resultaten werd recent besloten om continue 
monitoring standaard te gaan toepassen op twee reguliere verpleegafdelingen ter vervanging 
van routinemetingen door verpleegkundigen en de opbrengst hiervan voor het herstel van de 
patiënt te onderzoeken. Primair wordt geëvalueerd of continue monitoring een meerwaarde 
heeft op het gebied van voorspellen van klinische achteruitgang en patiënt veiligheid in het 
algemeen, ten opzichte van het huidige MEWS protocol. Tevens zal de mogelijkheid van centrale 
monitoring op afstand, waarbij het inschakelen van een IC-team vanuit één centraal punt in 
het ziekenhuis wordt aangestuurd, worden onderzocht. Doel hiervan is om de coördinatie 
van de acute zorg in het ziekenhuis efficiënter te laten verlopen en om de kwaliteit ervan te 
verhogen. Andere studies hebben als doel (dis)continue monitoring met wearable devices in de 
thuissituatie te evalueren, zowel voor als na een geplande ziekenhuisopname en bij patiënten 
met langdurige aandoeningen bijvoorbeeld hoge bloeddruk, hartfalen en COPD. 
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zoals hij hier nu ligt en ben ik heel veel ervaringen rijker. Bedankt voor het vertrouwen, de 
steun en de tijd die je me gaf om deze droom en mijlpaal te verwezenlijken.
Dr. T.H. van de Belt, beste Tom. Je eerste promovendus! Je hebt je rol als copromotor met 
verve vervuld. Ik heb onwijs veel van je geleerd; onder andere op het gebied van de kwalitatieve 
analyses, mijn inziens één van de mooiste stukken in dit proefschrift. Bedankt voor je hulp, je 
gezelligheid en je optimisme. De deur stond altijd open. Het is fijn met je samen te werken.  
Dr. S.J.H. Bredie, beste Bas. Je kwam ons team verrijken met je kritische blik en enthousiasme. 
We hebben gezamenlijk een schitterende start gemaakt, resulterend in dit proefschrift. Ik ben 
zo trots als ik zie hoe de ViSi Mobile geïmplementeerd is en 60 patiënten inmiddels hiermee 
continu gemeten worden. En er staat nog veel meer op de planning! Succes met het vervolg en 
heel fijn dat je mijn copromotor wilde zijn!
Yassin en Roel, jullie hebben al fantastisch werk verzet. Veel succes met het vervolg!
Geachte leden van de manuscriptcommissie, prof. dr. Philip van der Wees, prof. dr. Hester 
Vermeulen en prof. dr. Karin Kaasjager, veel dank voor het kritisch lezen en beoordelen van dit 
proefschrift.
Onmisbaar voor dit proefschrift waren de patiënten van de verpleegafdelingen interne 
geneeskunde en heelkunde die de moeite namen om deel te nemen aan onze studies en hun 
ervaringen met ons wilden delen. Veel dank hiervoor!
Eveneens onmisbaar was de hulp van de verpleegkundigen van afdelingen interne geneeskunde 
en heelkunde. De projecten waren zonder jullie nooit zo’n succes geworden en inmiddels 
werken jullie dagelijks met de ViSi Mobile! Bedankt voor jullie hulp bij het includeren van 
patiënten en het delen van jullie ervaringen. Speciale dank aan Maaike Eeren, Inge Schouten, 
Joni Dummer, Jerome Deliege, Trix Terwindt en Jeu Delahaye voor alle hulp en het meedenken. 
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Alle collega’s van REshape, dank voor het sparren, het delen van nieuwe ideeën en uiteraard 
ook de gezelligheid. Lucien Engelen, zonder jou was dit proefschrift er niet geweest. Met een 
stickertje ‘Demo’ kwamen de eerste ViSi Mobiles Nederland binnen en konden wij er mee aan 
de slag. Dank voor het mogelijk maken van onze projecten! Mats Koeneman, precies op het 
juiste moment was je daar om me te helpen met de analyses die ik zelf niet kon. Dankjewel 
voor alle hulp en veel succes met je toekomstige projecten!
Max Sondag, Jos Beekmans en Jos Thannhauser. De ‘databazen’. Jullie hebben het tijdens 
mijn promotie net wat makkelijker gemaakt, daar waar ik het qua kennis tekort kwam. Zonder 
jullie was het allemaal nooit zo soepel en snel verlopen. Veel dank hiervoor!
Marjan, Roger, Edwin, Marja, Marlies, Marianne, Deniece, Anouk, Moira, Frans, Simon, Daan en 
alle andere collega-onderzoekers..  zonder jullie was het nooit zo leuk geweest. Ik heb de drie 
jaren als onderzoeker als leerzaam en supergezellig ervaren. Dankjulliewel voor de steun, het 
meedenken en de lekkere biertjes. Ook veel dank aan alle student-assistenten die hun steentje 
hebben bijgedragen aan onze projecten. Bas Frietman, heel wat uren heb jij rondgelopen op de 
verpleegafdelingen of op de IC om weer een storing op te lossen of een patiënt te includeren. 
Dank voor je hulp en veel succes met je verdere carrière binnen de chirurgie! 
Alle chirurgen en arts-assistenten van de afdeling heelkunde van het Radboudumc. Veel dank 
voor deelname aan mijn studies en voor de leuke en leerzame tijd die ik heb gehad als arts-
assistent!
HAIO’s van 3-2-3, wat een leuk eerste jaar hebben we met elkaar gehad! Bedankt voor de 
belangstelling voor mijn onderzoek, het leerzame jaar en de gezelligheid. HAIO’s van 8-2-B, 
dank voor het meehelpen aan de voorbereiding voor deze, voor mij, zo belangrijke dag. Annet 
Matser en Jacqueline Heygele, bedankt voor de leerzame tijd in het eerste jaar, maar ook de 
belangstelling voor mijn onderzoek en hulp bij het vormgeven van de rest van mijn carrière. Ook 
Marleen Jiskoot en Liesbeth Timmermans, dank voor jullie begeleiding en het meedenken!
Alle medewerkers van huisartsengroep Milbergen, wat een ongelooflijk leuke en leerzame tijd 
heb ik bij jullie gehad. Jullie zijn van onschatbare waarde geweest in mijn opleiding tot huisarts.
Andrew de Wilt, Lisanne Houben en Lisette van Zon, dank voor de begeleiding en de (leer)
gesprekken. Speciale dank aan Geert-Jan Janssen. Je was meteen geïntrigeerd door dit 
onderzoek en mogelijke gevolgen voor het vak als huisarts. Nu dit proefschrift af is kan ik 
daarmee verder. Dank voor je belangstelling, de steun, het leerzame jaar en bovenal ook de 
gezellige tijd. Ik had me geen betere praktijk en begeleiding kunnen wensen voor het eerste 
jaar. 
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Lieve familie, lieve vrienden. Pap & Jennie, mam & Johnny, ik heb altijd de vrijheid gehad om 
mijn eigen koers te varen, zolang ik er maar voor werkte en met twee benen op de grond bleef 
staan. Dank voor jullie onvoorwaardelijke steun. 
Lydia, Floor, Sharon, Heleen, Anouk, Romy, Marissa, Susannah, Ilse, Ellen, Karlijn, Lieke… bij 
jullie kan ik altijd mijn hoofd leeg maken. Het is fijn dat jullie er zijn! Jos, heel fijn dat je mij 
wilde helpen met het opmaken van figuren. Dankjewel. 
Lieve Ekin, zelden heb ik zo’n leuke collega gehad, wat een heerlijk mens ben je! Bedankt voor 
je hulp, het delen van alle leuke en minder leuke zaken rondom promoveren en de heerlijke 
wijntjes. Ik hoop dat we dat laatste in de toekomst nog vaak mogen doen. Fijn dat je vandaag 
mijn paranimf wil zijn!
Lieve Manon. Je bent er altijd voor me, onvoorwaardelijk. Als vriendin, en nu ook als paranimf. 
Bedankt voor je vriendschap, alle leuke dingen die we al hebben gedaan en nog gaan doen. Ik 
ben er trots op dat je naast me staat op deze belangrijke dag!
Lieve Sander, co-auteur en beste maatje. Je stond eerder al op twee andere plekken in dit 
dankwoord en steeds heb ik je weer verplaatst; eerst als collega-onderzoeker, toen als 
paranimf en nu op de laatste regels. Ik ben blij dat je hier staat en dat we ook nog eens deze 
dag en mijlpaal samen mogen beleven. Op ons, op onze promotie en op een heel mooi leven! Ik 
ben ervan overtuigd dat er nog veel moois gaat komen. Ik hou van jou. 
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TRAINING ACTIVITIES
a)  Courses & Workshops
- Laboratory Animal Science (artikel 9) 
- Introduction course for PhD students
- Basiscursus Regelgeving en Organisatie van Klinische Trials (BROK) 
- Scientific Integrity
- Biometrics 
- Scientific writing
2014
2015
2015
2016
2016-2017
2017
3.0
1.75
1.5
0.4
6.0
3.0
b) Seminars & lectures
- Nurses and E-health, Radboudumc (oral presentation)
- Lunch meeting ‘Continuous Monitoring’ for employees Radboudumc (oral presentation)
- Wetenschapsdag ‘Continue monitoring’, Radboud University (oral presentation)
2015
2015
2016
0.3
0.3
0.5
c) Symposia & congresses
- WATCH conference, AMC Amsterdam
-  Hacking Health Reshape Innovation Center, Radboudumc, Nijmegen (oral presentation)
- Chirurgendagen, NVvH (oral presentation)
- Academic Surgical Congress, Jacksonville, USA (oral presentation)
- Association for surgical education conference, Boston, USA (oral presentation)
- Academic Surgical Congress, Las Vegas, USA (oral presentation)
-  International Forum on Quality and Safety in Healthcare (BMJ), London, UK (poster 
presentation)
2015
2015
2015
2016
2016
2017
2017
0.5
0.4
0.5
1.25
1.75
1.25
1.0
d) Other
- Research meeting department of surgery 2014-2017 1.0
TEACHING ACTIVITIES
e) Lecturing
- Suturing course at medical faculty, Radboud University
- Lecture ‘Wearable devices’ at medical faculty, Radboud University
-  Lecture ‘Lichamelijk onderzoek: vitale functies’ at medical faculty, Radboud University
- ‘Student meets patient’ at medical faculty, Radboud University
2015
2015
2015
2015-2016
0.1
0.1
0.5
0.9
f) Supervision of internships / other
-  Supervisor profielwerkstuk B. Fikkers and H. Chen, Stedelijk Gymnasium, Nijmegen: 
‘Invloed van een jurypanel op stresservaring van een leerling tijdens een presentatie’
-  Supervisor master thesis F. Beldman, Radboud University: ‘Continuous monitoring of vital 
signs using wearable devices: patients’ and healthcare professionals’ view’
-  Supervisor scientific project P. Anvary and I. Smetsers, Radboud University: ‘Difference in 
stress levels between kidney transplantations during day and night’
2015
2016
2017
1.0
2.0
1.0
TOTAL 30.0
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